DexCom, Inc. v. Abbott Diabetes Care, Inc.
1:22-cv-00605
Overview
Case Number
1:22-cv-00605
Filing Date
2022-05-05
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Gregory B. Williams
Patents Involved
There are 5 patents involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | US10702193 | |
| - | US11000213 | |
| - | US10980452 | |
| - | US10993642 | |
| - | US10702215 |
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
2
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
2
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
2
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
2
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
2
COMPLAINT FOR PATENT INFRINGEMENT ( Filing fee $ 402 receipt number 0542-14969381). No Summons requested at this time, filed by DexCom, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Ainsworth, Charles) (Attachment 1 replaced on 6/30/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
2
Notice of Filing of Patent/Trademark Form (AO 120). AO 120 forwarded to the Director of the U.S. Patent and Trademark Office. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
RULE 7 DISCLOSURE STATEMENT filed by DexCom, Inc.. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
REQUEST FOR ISSUANCE OF SUMMONS by DexCom, Inc.. (Ainsworth, Charles) (Main Document 4 replaced on 6/30/2021) (lad). Both Requests were for the same party due to a PDF issue, so only one was issued. Party may request the other in a separate filing (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
Pro Hac Vice Letter. (Main doc is for Atty Lozano, Attachments: # 1 Attys Pak Clark Ducker and Lacey, # 2 Attys Hamstra and Kaplan)(lad) [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
Summons Issued as to Abbott Diabetes Care, Inc.. (lad) [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
REQUEST FOR ISSUANCE OF SUMMONS by DexCom, Inc.. (Ainsworth, Charles) (Main Document 7 replaced on 7/1/2021) (lad). [Transferred from Texas Western on 5/5/2022.] (Entered: 06/30/2021)
2021-06-30
1
All parties shall comply with the Standing Orders located at https://www.txwd.uscourts.gov/judges-information/standing-orders/. (lad) [Transferred from Texas Western on 5/5/2022.]
2021-06-30
1
No Actions
Summons Issued as to Abbott Diabetes Care Sales Corp.. (lad) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/01/2021)
2021-07-01
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Michelle A. Clark ( Filing fee $ 100 receipt number 0542-14977411) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/02/2021)
2021-07-02
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Philip C. Ducker ( Filing fee $ 100 receipt number 0542-14977846) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/02/2021)
2021-07-02
1
Text Order GRANTING 9 and 10 Motions to Appear Pro Hac Vice entered by Judge Alan D Albright. Before the Court are the Motions for Admission Pro Hac Vice. The Court, having reviewed the Motions, finds they should be GRANTED and therefore orders as follows: IT IS ORDERED the Motions for Admission Pro Hac Vice are GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) [Transferred from Texas Western on 5/5/2022.]
2021-07-05
1
No Actions
SUMMONS Returned Executed by DexCom, Inc.. Abbott Diabetes Care, Inc. served on 7/1/2021, answer due 7/22/2021. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/06/2021)
2021-07-06
1
SUMMONS Returned Executed by DexCom, Inc.. Abbott Diabetes Care Sales Corp. served on 7/1/2021, answer due 7/22/2021. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/06/2021)
2021-07-06
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Valerie Lozano ( Filing fee $ 100 receipt number 0542-14984283) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/07/2021)
2021-07-07
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Marc L. Kaplan ( Filing fee $ 100 receipt number 0542-14985894) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/07/2021)
2021-07-07
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Nathan A. Hamstra ( Filing fee $ 100 receipt number 0542-14986487) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/07/2021)
2021-07-07
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Catherine R. Lacey ( Filing fee $ 100 receipt number 0542-14989000) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/07/2021)
2021-07-07
1
SUPPLEMENT to 15 MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Nathan A. Hamstra ( Filing fee $ 100 receipt number 0542-14986487) by DexCom, Inc.. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/09/2021)
2021-07-09
1
Text Order GRANTING 13, 14, 15, and 16 Motions to Appear Pro Hac Vice. Before the Court are the Motions for Admission Pro Hac Vice. The Court, having reviewed the Motions, finds they should be GRANTED and therefore orders as follows: IT IS ORDERED the Motions for Admission Pro Hac Vice are GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) [Transferred from Texas Western on 5/5/2022.]
2021-07-09
1
No Actions
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Sean S. Pak ( Filing fee $ 100 receipt number 0542-15000415) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/12/2021)
2021-07-12
1
AMENDED COMPLAINT against Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. amending 1 Complaint,., filed by DexCom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/12/2021)
2021-07-12
1
REQUEST FOR ISSUANCE OF SUMMONS by DexCom, Inc.. as to Abbott Diabetes Care, Inc. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/13/2021)
2021-07-13
1
REQUEST FOR ISSUANCE OF SUMMONS by DexCom, Inc.. as to Abbott Diabetes Care Sales Corp. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/13/2021)
2021-07-13
1
Summons Issued as to Abbott Diabetes Care, Inc.. (ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/14/2021)
2021-07-13
1
Summons Issued as to Abbott Diabetes Care Sales Corp.. (ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/14/2021)
2021-07-13
1
DUPLICATED IN ERROR : Summons Issued as to Abbott Diabetes Care, Inc. (ir) Modified on 7/19/2021 (bw). [Transferred from Texas Western on 5/5/2022.] (Entered: 07/19/2021)
2021-07-13
1
Text Order GRANTING 18 Motion to Appear Pro Hac Vice. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) [Transferred from Texas Western on 5/5/2022.]
2021-07-13
1
No Actions
SUMMONS Returned Executed by DexCom, Inc.. Abbott Diabetes Care Sales Corp. served on 7/15/2021, answer due 7/29/2021. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/19/2021)
2021-07-19
1
SUMMONS Returned Executed by DexCom, Inc.. Abbott Diabetes Care, Inc. served on 7/15/2021, answer due 7/29/2021. (Ainsworth, Charles) Modified on 7/21/2021 (ir). [Transferred from Texas Western on 5/5/2022.] (Entered: 07/21/2021)
2021-07-21
1
NOTICE of Attorney Appearance by J. Stephen Ravel on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. Attorney J. Stephen Ravel added to party Abbott Diabetes Care Sales Corp.(pty:dft), Attorney J. Stephen Ravel added to party Abbott Diabetes Care, Inc.(pty:dft) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
Unopposed MOTION for Extension of Time to File Answer re 19 Amended Complaint, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Ellisen S. Turner ( Filing fee $ 100 receipt number 0542-15046864) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Amanda Hollis ( Filing fee $ 100 receipt number 0542-15046937) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Leland G. Hansen ( Filing fee $ 100 receipt number 0542-15046959) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Alexander M. Vogler ( Filing fee $ 100 receipt number 0542-15046998) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Edward A. Mas II ( Filing fee $ 100 receipt number 0542-15047031) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 07/23/2021)
2021-07-23
1
Text Order GRANTING 29, 30, 31, 32, and 33 Motions to Appear Pro Hac Vice. Before the Court are the Motions for Admission Pro Hac Vice. The Court, having reviewed the Motions, finds they should be GRANTED and therefore orders as follows: IT IS ORDERED theMotions for Admission Pro Hac Vice are GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) [Transferred from Texas Western on 5/5/2022.]
2021-07-27
1
No Actions
Text Order GRANTING 28 Motion for Extension of Time to Answer entered by Judge Alan D Albright. BE IT REMEMBERED on this day, there was presented to the Court the Unopposed Motion for Extension of Time to File a Response to Plaintiffs Amended Complaint for Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Abbott), and the Court, having reviewed the motion, enters the following order: IT IS ORDERED that the Unopposed Motion for Extension of Time to File a Response to Plaintiffs Amended Complaint is GRANTED, and Defendants deadline to respond to theAmended Complaint is extended through and including September 20, 2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) [Transferred from Texas Western on 5/5/2022.]
2021-07-27
1
No Actions
Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Attachments: # 1 Affidavit Declaration of Adam Cate, # 2 Sealed Document Ex 1 to Declaration of Adam Cate, # 3 Sealed Document Ex 2 to Declaration of Adam Cate, # 4 Sealed Document Ex 3 to Declaration of Adam Cate, # 5 Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Ex 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Ex 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Ex 6 to Declaration of Meghan Gamboa, # 9 Affidavit Declaration of Kristina Cary, # 10 Exhibit Ex 7 to Declaration of Kristina Cary, # 11 Exhibit Ex 8 to Declaration of Kristina Cary, # 12 Exhibit Ex 9 to Declaration of Kristina Cary, # 13 Exhibit Ex 10 to Declaration of Kristina Cary, # 14 Exhibit Ex 11 to Declaration of Kristina Cary, # 15 Exhibit Ex 12 to Declaration of Kristina Cary, # 16 Exhibit Ex 13 to Declaration of Kristina Cary, # 17 Sealed Document Ex 14 to Declaration of Kristina Cary, # 18 Exhibit Ex 15 to Declaration of Kristina Cary, # 19 Exhibit Ex 16 to Declaration of Kristina Cary, # 20 Exhibit Ex 17 to Declaration of Kristina Cary, # 21 Exhibit Ex 18 to Declaration of Kristina Cary, # 22 Affidavit Declaration of Todd York) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/20/2021)
2021-09-20
1
Opposed Sealed Motion Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Attachments: # 1 Affidavit Declaration of Susan Gellatly, # 2 Sealed Document Ex 2 to Declaration of Susan Gellatly, # 3 Affidavit Declaration of Marc Taub, # 4 Exhibit Ex 1 to Declaration of Marc Taub, # 5 Affidavit Declaration of Adam Heller, # 6 Affidavit Declaration of Jennifer Bergschneider, # 7 Affidavit Declaration of Kristina Cary, # 8 Sealed Document Ex A to Declaration of Kristina Cary, # 9 Exhibit Ex B to Declaration of Kristina Cary, # 10 Exhibit Ex C to Declaration of Kristina Cary, # 11 Exhibit Ex D Part 1 to Declaration of Kristina Cary, # 12 Exhibit Ex D Part 2 to Declaration of Kristina Cary, # 13 Exhibit Ex D Part 3 to Declaration of Kristina Cary, # 14 Exhibit Ex D Part 4 to Declaration of Kristina Cary, # 15 Exhibit Ex D Part 5 to Declaration of Kristina Cary, # 16 Exhibit Ex D Part 6 to Declaration of Kristina Cary, # 17 Exhibit Ex E to Declaration of Kristina Cary, # 18 Exhibit Ex F to Declaration of Kristina Cary, # 19 Exhibit Ex G to Declaration of Kristina Cary, # 20 Exhibit Ex H to Declaration of Kristina Cary, # 21 Exhibit Ex I to Declaration of Kristina Cary, # 22 Exhibit Ex J to Declaration of Kristina Cary, # 23 Exhibit Ex K to Declaration of Kristina Cary, # 24 Exhibit Ex L to Declaration of Kristina Cary, # 25 Exhibit Ex M to Declaration of Kristina Cary, # 26 Exhibit Ex N to Declaration of Kristina Cary, # 27 Exhibit Ex O to Declaration of Kristina Cary, # 28 Exhibit Ex P to Declaration of Kristina Cary, # 29 Errata Ex Q to Declaration of Kristina Cary, # 30 Exhibit Ex R to Declaration of Kristina Cary, # 31 Exhibit Ex S to Declaration of Kristina Cary, # 32 Exhibit Ex T to Declaration of Kristina Cary, # 33 Exhibit Ex U to Declaration of Kristina Cary, # 34 Exhibit Ex V to Declaration of Kristina Cary, # 35 Exhibit Ex W to Declaration of Kristina Cary, # 36 Exhibit Ex X to Declaration of Kristina Cary, # 37 Exhibit Ex Y to Declaration of Kristina Cary, # 38 Exhibit Ex Z to Ex P to Declaration of Kristina Cary, # 39 Exhibit Ex AA to Ex P to Declaration of Kristina Cary, # 40 Exhibit Ex AB to Ex P to Declaration of Kristina Cary, # 41 Exhibit Ex AC to Ex P to Declaration of Kristina Cary, # 42 Exhibit Ex AD to Ex P to Declaration of Kristina Cary, # 43 Exhibit Ex AE to Ex P to Declaration of Kristina Cary, # 44 Exhibit Ex AF to Ex P to Declaration of Kristina Cary, # 45 Sealed Document Ex AG to Ex P to Declaration of Kristina Cary, # 46 Sealed Document Ex AH to Ex P to Declaration of Kristina Cary, # 47 Exhibit Ex AI to Ex P to Declaration of Kristina Cary, # 48 Sealed Document Ex AJ to Ex P to Declaration of Kristina Cary, # 49 Exhibit Ex AK to Ex P to Declaration of Kristina Cary, # 50 Sealed Document Ex AL to Ex P to Declaration of Kristina Cary, # 51 Exhibit Ex AM to Ex P to Declaration of Kristina Cary, # 52 Sealed Document Ex AN to Ex P to Declaration of Kristina Cary, # 53 Exhibit Ex AO to Ex P to Declaration of Kristina Cary, # 54 Sealed Document Ex AP to Ex P to Declaration of Kristina Cary, # 55 Exhibit Ex AQ to Ex P to Declaration of Kristina Cary, # 56 Sealed Document Ex AR to Ex P to Declaration of Kristina Cary, # 57 Exhibit Ex AS to Ex P to Declaration of Kristina Cary, # 58 Sealed Document Ex AT to Ex P to Declaration of Kristina Cary, # 59 Exhibit Ex AU to Ex P to Declaration of Kristina Cary, # 60 Sealed Document Ex AV to Ex P to Declaration of Kristina Cary, # 61 Exhibit Ex AW to Ex P to Declaration of Kristina Cary, # 62 Sealed Document Ex AX to Ex P to Declaration of Kristina Cary, # 63 Exhibit Ex AY to Ex P to Declaration of Kristina Cary, # 64 Sealed Document Ex AZ to Ex P to Declaration of Kristina Cary, # 65 Exhibit Ex BA to Ex P to Declaration of Kristina Cary, # 66 Sealed Document Ex BB to Ex P to Declaration of Kristina Cary, # 67 Exhibit Ex BC to Ex P to Declaration of Kristina Cary, # 68 Sealed Document Ex BD to Ex P to Declaration of Kristina Cary, # 69 Exhibit Ex BE to Ex P to Declaration of Kristina Cary, # 70 Sealed Document Ex BF to Ex P to Declaration of Kristina Cary, # 71 Sealed Document Ex BG to Ex P to Declaration of Kristina Cary, # 72 Exhibit Ex BH to Ex P to Declaration of Kristina Cary, # 73 Sealed Document Ex BI to Ex P to Declaration of Kristina Cary, # 74 Exhibit Ex BJ to Ex P to Declaration of Kristina Cary, # 75 Sealed Document Ex BK to Ex P to Declaration of Kristina Cary, # 76 Exhibit Ex BL to Ex P to Declaration of Kristina Cary, # 77 Sealed Document Ex BM to Ex P to Declaration of Kristina Cary, # 78 Exhibit Ex BN to Ex P to Declaration of Kristina Cary, # 79 Sealed Document Ex BO to Ex P to Declaration of Kristina Cary, # 80 Exhibit Ex BP to Ex P to Declaration of Kristina Cary, # 81 Proposed Order) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/20/2021)
2021-09-20
1
RULE 7 DISCLOSURE STATEMENT filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/20/2021)
2021-09-20
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Nina Susan Tallon ( Filing fee $ 100 receipt number 0542-15266546) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
1
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
1
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Sealed Document Affidavit Declaration of Adam Cate, # 2 Sealed Document Sealed Document Ex. 1 to Declaration of Adam Cate, # 3 Sealed Document Sealed Document Ex. 2 to Declaration of Adam Cate, # 4 Sealed Document Sealed Document Ex. 3 to Declaration of Adam Cate, # 5 Sealed Document Affidavit Declaration of Meghan Gamboa, # 6 Sealed Document Sealed Document Ex. 4 to Declaration of Meghan Gamboa, # 7 Sealed Document Sealed Document Ex. 5 to Declaration of Meghan Gamboa, # 8 Sealed Document Sealed Document Ex. 6 to Declaration of Meghan Gamboa, # 9 Sealed Document Affidavit Declaration of Kristina Cary, # 10 Exhibit Exhibit Ex. 7 to Declaration of Kristina Cary, # 11 Exhibit Exhibit Ex. 8 to Declaration of Kristina Cary, # 12 Exhibit Exhibit Ex. 9 to Declaration of Kristina Cary, # 13 Exhibit Exhibit Ex. 10 to Declaration of Kristina Cary, # 14 Exhibit Exhibit Ex. 11 to Declaration of Kristina Cary, # 15 Exhibit Exhibit Ex. 12 to Declaration of Kristina Cary, # 16 Exhibit Exhibit Ex. 13 to Declaration of Kristina Cary, # 17 Sealed Document Sealed Document Ex. 14 to Declaration of Kristina Cary, # 18 Exhibit Exhibit 15 to Declaration of Kristina Cary, # 19 Exhibit Exhibit 16 to Declaration of Kristina Cary, # 20 Exhibit Exhibit 17 to Declaration of Kristina Cary, # 21 Exhibit Exhibit 18 to Declaration of Kristina Cary, # 22 Sealed Document Affidavit Declaration of Todd York)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
2
Redacted Public Version of 35 Opposed Sealed Motion Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Sealed Document SEALED Declaration of Susan Gellatly, # 2 Sealed Document SEALED Ex 2 to Susan Gellatly Decl, # 3 Sealed Document SEALED Declaration of Marc Taub, # 4 Sealed Document SEALED Ex 1 to Marc Taub Decl, # 5 Affidavit Declaration of Adam Heller, # 6 Sealed Document SEALED Declaration of Jennifer Bergschneider, # 7 Sealed Document SEALED Declaration of Kristina Cary, # 8 Sealed Document SEALED Ex. A to Declaration of Kristina Cary, # 9 Exhibit Exhibit B to Declaration of Kristina Cary, # 10 Exhibit Exhibit C to Declaration of Kristina Cary, # 11 Exhibit Exhibit D Part 1 to Declaration of Kristina Cary, # 12 Exhibit Exhibit D Part 2 to Declaration of Kristina Cary, # 13 Exhibit Exhibit D Part 3 to Declaration of Kristina Cary, # 14 Exhibit Exhibit D Part 4 to Declaration of Kristina Cary, # 15 Exhibit Exhibit D Part 5 to Declaration of Kristina Cary, # 16 Exhibit Exhibit D Part 6 to Declaration of Kristina Cary, # 17 Exhibit Exhibit E to Declaration of Kristina Cary, # 18 Exhibit Exhibit F to Declaration of Kristina Cary, # 19 Exhibit Exhibit G to Declaration of Kristina Cary, # 20 Exhibit Exhibit H to Declaration of Kristina Cary, # 21 Exhibit Exhibit I to Declaration of Kristina Cary, # 22 Exhibit Exhibit J to Declaration of Kristina Cary, # 23 Exhibit Exhibit K to Declaration of Kristina Cary, # 24 Exhibit Exhibit L to Declaration of Kristina Cary, # 25 Exhibit Exhibit M to Declaration of Kristina Cary, # 26 Exhibit Exhibit N to Declaration of Kristina Cary, # 27 Exhibit Exhibit O to Declaration of Kristina Cary, # 28 Exhibit Exhibit P to Declaration of Kristina Cary, # 29 Exhibit Exhibit Q to Declaration of Kristina Cary, # 30 Exhibit Exhibit R to Declaration of Kristina Cary, # 31 Exhibit Exhibit S to Declaration of Kristina Cary, # 32 Exhibit Exhibit T to Declaration of Kristina Cary, # 33 Exhibit Exhibit U to Declaration of Kristina Cary, # 34 Exhibit Exhibit V to Declaration of Kristina Cary, # 35 Exhibit Exhibit W to Declaration of Kristina Cary, # 36 Exhibit Exhibit X to Declaration of Kristina Cary, # 37 Exhibit Exhibit Y to Declaration of Kristina Cary, # 38 Exhibit Exhibit Z to Declaration of Kristina Cary, # 39 Exhibit Exhibit AA to Declaration of Kristina Cary, # 40 Exhibit Exhibit AB to Declaration of Kristina Cary, # 41 Exhibit Exhibit AC to Declaration of Kristina Cary, # 42 Exhibit Exhibit AD to Declaration of Kristina Cary, # 43 Exhibit Exhibit AE to Declaration of Kristina Cary, # 44 Exhibit Exhibit AF to Declaration of Kristina Cary, # 45 Sealed Document SEALED Document Ex. AG to Declaration of Kristina Cary, # 46 Sealed Document SEALED Document Ex. AH to Declaration of Kristina Cary, # 47 Exhibit Exhibit AI to Declaration of Kristina Cary, # 48 Sealed Document SEALED Document Ex. AJ to Declaration of Kristina Cary, # 49 Exhibit Exhibit AK to Ex P to Declaration of Kristina Cary, # 50 Sealed Document SEALED Document Ex. AL to Declaration of Kristina Cary, # 51 Exhibit Exhibit AM to Declaration of Kristina Cary, # 52 Sealed Document SEALED Document Ex. AN to Declaration of Kristina Cary, # 53 Exhibit Exhibit AO to Declaration of Kristina Cary, # 54 Sealed Document SEALED Document Ex. AP to Declaration of Kristina Cary, # 55 Exhibit Exhibit AQ to Declaration of Kristina Cary, # 56 Sealed Document Sealed Document Ex. AR to Declaration of Kristina Cary, # 57 Exhibit Exhibit AS to Declaration of Kristina Cary, # 58 Sealed Document Sealed Document Ex. AT to Declaration of Kristina Cary, # 59 Exhibit Exhibit AU to Declaration of Kristina Cary,, # 60 Sealed Document Sealed Document Ex. AV to Declaration of Kristina Cary, # 61 Exhibit Exhibit AW to Declaration of Kristina Cary, # 62 Sealed Document Sealed Document Ex. AX to Declaration of Kristina Cary, # 63 Exhibit Exhibit Ex. AY to Declaration of Kristina Cary, # 64 Sealed Document Sealed Document Ex. AZ to Declaration of Kristina Cary, # 65 Exhibit Exhibit Ex. BA to Declaration of Kristina Cary, # 66 Sealed Document Sealed Document Ex. BB to Declaration of Kristina Cary, # 67 Exhibit Exhibit Ex. BC to Declaration of Kristina Cary, # 68 Sealed Document Sealed Document Ex. BD to Declaration of Kristina Cary, # 69 Exhibit Exhibit BE to Declaration of Kristina Cary, # 70 Sealed Document Sealed Document Ex. BF to Declaration of Kristina Cary, # 71 Sealed Document Sealed Document Ex. BG to Declaration of Kristina Cary, # 72 Exhibit Exhibit Ex. BH to Declaration of Kristina Cary, # 73 Sealed Document Sealed Document Ex. BI to Declaration of Kristina Cary, # 74 Exhibit Exhibit Ex. BJ to Declaration of Kristina Cary, # 75 Sealed Document Sealed Document Ex. BK to Declaration of Kristina Cary, # 76 Exhibit Exhibit Ex. BL to Declaration of Kristina Cary, # 77 Sealed Document Sealed Document Ex. BM to Declaration of Kristina Cary, # 78 Exhibit Exhibit Ex. BN to Declaration of Kristina Cary, # 79 Sealed Document Sealed Document Ex. BO to Declaration of Kristina Cary, # 80 Exhibit Exhibit Ex. BP to Declaration of Kristina Cary, # 81 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/27/2021)
2021-09-27
1
STATUS REPORT Case Readiness Status Report by DexCom, Inc.. (Clark, Michelle) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/28/2021)
2021-09-28
1
ORDER GRANTING 37 Motion to Appear Pro Hac Vice for Attorney Nina Susan Tallon. Attorney added for DexCom, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (jkda) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/29/2021)
2021-09-29
1
NOTICE OF INTENT TO CONDUCT VENUE DISCOVERY AND ADOPT THE COURT'S BRIEFING SCHEDULE by DexCom, Inc. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/29/2021)
2021-09-29
1
NOTICE Defendants Notice of Opposition and Dexcoms Failure to Meet and Confer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. re 42 Notice (Other) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 09/30/2021)
2021-09-30
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Jon R. Carter ( Filing fee $ 100 receipt number 0542-15289009) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/01/2021)
2021-10-01
1
NOTICE of Appearance of Additional Counsel by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/01/2021)
2021-10-01
1
Response in Opposition to Motion, filed by DexCom, Inc., re 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. filed by Defendant Abbott Diabetes Care Sales Corp., Defendant Abbott Diabetes Care, Inc. (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/04/2021)
2021-10-04
1
ORDER GRANTING 44 Motion to Appear Pro Hac Vice for Attorney Jon R. Carter. Attorney added for Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (jkda) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/04/2021)
2021-10-04
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Kevin Gu ( Filing fee $ 100 receipt number 0542-15314827) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/08/2021)
2021-10-08
1
Standing Order Regarding Order Governing Proceedings Patent Cases. Signed by Judge Alan D Albright. [Transferred from Texas Western on 5/5/2022.] (Entered: 10/13/2021)
2021-10-08
1
Text Order GRANTING 48 Motion to Appear Pro Hac Vice for Attorney Kevin Gu for DexCom, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jc5) [Transferred from Texas Western on 5/5/2022.]
2021-10-08
1
No Actions
RESPONSE in Support, filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc., re 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. filed by Defendant Abbott Diabetes Care Sales Corp., Defendant Abbott Diabetes Care, Inc. Reply in Support of Motion to Dismiss (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/11/2021)
2021-10-11
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Alex Zuckerman ( Filing fee $ 100 receipt number 0542-15318835) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/12/2021)
2021-10-12
1
ORDER GRANTING 50 Motion to Appear Pro Hac Vice for Attorney Alex Zuckerman. Attorney added for DexCom, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (jkda) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/15/2021)
2021-10-15
1
NOTICE of Stipulation for Extension of Time to Submit Scheduling Order by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Cary, Kristina) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/26/2021)
2021-10-26
1
Scheduling Recommendations/Proposed Scheduling Order Joint Motion for Entry of Scheduling Order by DexCom, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Kaplan, Marc) [Transferred from Texas Western on 5/5/2022.] (Entered: 10/30/2021)
2021-10-30
1
DEFICIENCY NOTICE: re 54 Scheduling Recommendations/Proposed Scheduling Order (ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/01/2021)
2021-10-30
1
Scheduling Recommendations/Proposed Scheduling Order [CORRECTED per Dkt. 55] by DexCom, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/01/2021)
2021-11-01
1
SCHEDULING ORDER: Markman Hearing set for 5/3/2022 before Judge Alan D Albright. Joinder of Parties due by 6/14/2022. Amended Pleadings due by 8/23/2022. Dipositive and Daubert Motions due by 3/7/2023. Pretrial Conference set for 5/9/2023 09:00 AM before Judge Alan D Albright, Jury Selection set for 5/30/2023 before Judge Jeffrey C. Manske. Jury Trial set for 5/30/2023 before Judge Alan D Albright. Signed by Judge Alan D Albright. (ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/18/2021)
2021-11-16
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Isabel Redleaf ( Filing fee $ 100 receipt number 0542-15466072) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/22/2021)
2021-11-22
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Cory Edwards ( Filing fee $ 100 receipt number 0542-15473028) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/24/2021)
2021-11-24
1
Agreed MOTION to Amend/Correct 57 Scheduling Order, by DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/30/2021)
2021-11-30
1
FIRST AMENDED SCHEDULING ORDER: Markman Hearing set for 5/17/2022 09:00 AM before Judge Alan D Albright. Joinder of Parties due by 6/28/2022. Amended Pleadings due by 9/6/2022. Dispositive and Daubert Motions due by 3/21/2023. Pretrial Conference set for 5/23/2023 before Judge Alan D Albright. Jury Selection set for 6/13/2023 before Judge Jeffrey C. Manske. Jury Trial set for 6/13/2023 before Judge Alan D Albright. Signed by Judge Alan D Albright. (ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 11/30/2021)
2021-11-30
1
Unopposed MOTION to Withdraw as Attorney as to Caty Lacey by DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/02/2021)
2021-12-02
1
ORDER GRANTING 59 Motion to Appear Pro Hac Vice for Attorney Cory Edwards. Attorney added for DexCom, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (jkda) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/06/2021)
2021-12-06
1
ORDER, (Discovery Hearing set for 12/13/2021 09:30 AM before Judge Alan D Albright). Signed by Judge Alan D Albright. (bot1) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/08/2021)
2021-12-08
1
ORDER GRANTING 58 Motion to Appear Pro Hac Vice for Attorney Isabel Redleaf. Attorney added for DexCom, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (jkda) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/09/2021)
2021-12-09
1
NOTICE Notice of Appearance of Additional Counsel by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/09/2021)
2021-12-09
1
Minute Entry for proceedings held before Judge Alan D Albright: Discovery Hearing held on 12/13/2021. Case called for Discovery Hearing by Zoom. The Court heard arguments from both parties regarding discovery issues. The Court has taken this matter under advisement and will issue an Order within the next day or so. (Minute entry documents are not available electronically.) (Court Reporter Kristie Davis.)(ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/13/2021)
2021-12-13
1
12-13-21 Discovery Hearing Sealed Transcript filed (This transcript is not available electronically) (kd) [Transferred from Texas Western on 5/5/2022.] (Entered: 12/13/2021)
2021-12-13
1
DISCOVERY ORDER. ORDERED that the deadline for the conclusion of venue discovery, previously set for December 20, 2021, is hereby extended to January 20, 2021, by which time Abbott is expected to comply with this Order. Signed by Judge Alan D Albright. (ir) [Transferred from Texas Western on 5/5/2022.] (Entered: 01/06/2022)
2022-01-06
1
Sealed Document: Opposition to of 35 Opposed Sealed Motion Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by DexCom, Inc. (Attachments: # 1 Declaration of Alex Zuckerman, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13) (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/09/2022)
2022-02-09
1
Sealed Document: Opposition of 34 Opposed Sealed Motion SEALED Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by DexCom, Inc. (Attachments: # 1 Declaration of Alex Zuckerman, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5a, # 7 Exhibit 5b, # 8 Exhibit 5c, # 9 Exhibit 5d, # 10 Exhibit 6, # 11 Exhibit 7, # 12 Exhibit 8, # 13 Exhibit 9, # 14 Exhibit 10, # 15 Exhibit 11, # 16 Exhibit 12, # 17 Exhibit 13, # 18 Exhibit 14, # 19 Exhibit 15, # 20 Exhibit 16, # 21 Exhibit 17, # 22 Exhibit 18, # 23 Exhibit 19) (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/09/2022)
2022-02-09
1
Redacted Copy of 71 Sealed Document,, by DexCom, Inc.. (Attachments: # 1 Declaration of Alex Zuckerman, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5a, # 7 Exhibit 5b, # 8 Exhibit 5c, # 9 Exhibit 5d, # 10 Exhibit 6 (Public), # 11 Exhibit 7, # 12 Exhibit 8, # 13 Exhibit 9, # 14 Exhibit 10, # 15 Exhibit 11, # 16 Exhibit 12 (Public), # 17 Exhibit 13, # 18 Exhibit 14 (Public), # 19 Exhibit 15, # 20 Exhibit 16, # 21 Exhibit 17, # 22 Exhibit 18, # 23 Exhibit 19)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/16/2022)
2022-02-16
1
Redacted Copy of 70 Sealed Document, by DexCom, Inc.. (Attachments: # 1 Declaration of Alex Zuckerman, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4 (Public), # 6 Exhibit 5 (Public), # 7 Exhibit 6 (Public), # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/16/2022)
2022-02-16
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Benjamin A. Lasky ( Filing fee $ 100 receipt number 0542-15729336) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/17/2022)
2022-02-17
1
NOTICE Notice of Appearance of Additional Counsel by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/17/2022)
2022-02-17
1
ORDER GRANTING 74 Motion to Appear Pro Hac Vice for Attorney Benjamin A. Lasky. Attorney added for Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot1) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/18/2022)
2022-02-18
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Cary E. Adickman ( Filing fee $ 100 receipt number 0542-15742955) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/23/2022)
2022-02-23
1
Sealed Motion SEALED Reply ISO 35 Defendants Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Attachments: # 1 Affidavit Declaration of Kristina Cary, # 2 Exhibit BQ, # 3 Exhibit BR, # 4 Exhibit BS, # 5 Exhibit BT) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/23/2022)
2022-02-23
1
Sealed Motion SEALED Reply ISO 34 Defendants Opposed Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Attachments: # 1 Affidavit Declaration of Kristina Cary, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/23/2022)
2022-02-23
1
ORDER GRANTING 77 Motion to Appear Pro Hac Vice for Attorney Cary E. Adickman. Attorney added for DexCom, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot2) [Transferred from Texas Western on 5/5/2022.] (Entered: 02/25/2022)
2022-02-25
1
MOTION to Appear Pro Hac Vice by Charles L. Ainsworth on behalf of Jonathon M. Studer ( Filing fee $ 100 receipt number 0542-15766430) by on behalf of DexCom, Inc.. (Attachments: # 1 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/01/2022)
2022-03-01
1
ORDER GRANTING 81 Motion to Appear Pro Hac Vice for Attorney Jonathon M. Studer. Attorney added for DexCom, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot2) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/02/2022)
2022-03-02
1
Redacted Public Version of 78 Sealed Motion SEALED Reply ISO 35 Defendants Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Sealed Document Cary Declaration, # 2 Sealed Document Exhibit BQ, # 3 Sealed Document Exhibit BR, # 4 Sealed Document Exhibit BS, # 5 Sealed Document Exhibit BT)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/04/2022)
2022-03-04
1
Redacted Public Version of 79 Sealed Motion SEALED Reply ISO 34 Defendants Opposed Motion to Dismiss by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Sealed Document Cary Declaration, # 2 Sealed Document Exhibit 19, # 3 Sealed Document Exhibit 20, # 4 Sealed Document Exhibit 21, # 5 Sealed Document Exhibit 22)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/04/2022)
2022-03-04
1
Opposed Sealed Motion for Leave to File a Sur-Reply in Further Opposition to Defendants' Motion to Transfer by DexCom, Inc. (Attachments: # 1 Exhibit A, # 2 Proposed Order) (Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/07/2022)
2022-03-07
1
Parties shall comply with Judge Albright's updated standing orders and COVID-19 standing order available by clicking the included hyperlinks. The updated orders are as follows:1. Standing Order Regarding Notice of Readiness for Patent Cases 030722,2. Standing Order on Pretrial Procedures and Requirements in Civil Cases 030722,3. Standing Order Governing Proceedings 4.0 - Patent Cases 030722,4. Amended Standing Order Regarding Coronavirus (COVID-19) and Court Proceedings,5. Amended Standing Order Regarding Joint Or Unopposed Request To Change Deadlines 030722,6. Amended Standing Order Regarding Filing Documents Under Seal and Redacted Public Versions 030722. (jkda) [Transferred from Texas Western on 5/5/2022.]
2022-03-10
1
No Actions
STATUS REPORT Status Report re 34 Opposed Motion to Dismiss for Improper Venue and 35 Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit A)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/12/2022)
2022-03-12
1
Sealed Document: SEALED Response to Plaintiffs Motion for Leave to File a Sur-Reply in Further Opposition to Defendants Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Attachments: # 1 Affidavit Cary Declaration, # 2 Exhibit 1 to Cary Declaration, # 3 Exhibit A, # 4 Proposed Order) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/14/2022)
2022-03-14
1
Redacted Copy PUBLIC Version of 85 Opposed Sealed Motion for Leave to File a Sur-Reply in Further Opposition to Defendants' Motion to Transfer by DexCom, Inc. by DexCom, Inc.. (Attachments: # 1 Exhibit A, # 2 Proposed Order)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/15/2022)
2022-03-15
1
Sealed Document: SEALED Opening Claim Construction Brief by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Attachments: # 1 Sealed Document Exhibit 7) (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/15/2022)
2022-03-15
1
Redacted Public Version of 89 Sealed Document by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6 part 1 of 2, # 7 Exhibit 6 part 2 of 2, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21 part 1 of 4, # 22 Exhibit 21 part 2 of 4, # 23 Exhibit 21 part 3 of 4, # 24 Exhibit 21 part 4 of 4, # 25 Exhibit 22, # 26 Exhibit 23, # 27 Exhibit 24, # 28 Exhibit 25, # 29 Exhibit 26, # 30 Exhibit 27, # 31 Exhibit 28, # 32 Exhibit 29, # 33 Exhibit 30, # 34 Exhibit 31, # 35 Exhibit 32, # 36 Exhibit 33, # 37 Exhibit 34, # 38 Exhibit 35 part 1 of 2, # 39 Exhibit 35 part 2 of 2, # 40 Exhibit 36)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/15/2022)
2022-03-15
1
Redacted Public Version CV to 90 Declaration of Matthew Schurman of 89 Sealed Document by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/15/2022)
2022-03-15
1
Redacted Public Version Exhibit 26 (parts 1 & 2 of 2) of 89 Sealed Document by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit 26 part 2 of 2)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/16/2022)
2022-03-16
1
Redacted Public Version Opening Claim Construction Brief of 89 Sealed Document by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Sealed Document Exhibit 7)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/23/2022)
2022-03-23
1
Redacted Public Version Response to Plaintiffs Motion for Leave to File a Sur-Reply in Further Opposition to Defendants Motion to Transfer of 87 Sealed Document, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Sealed Document Cary Declaration, # 2 Sealed Document Exhibit 1 to Cary Declaration, # 3 Exhibit A, # 4 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/23/2022)
2022-03-23
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Ashley Ross ( Filing fee $ 100 receipt number 0542-15865553) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/29/2022)
2022-03-29
1
NOTICE Notice of Appearance of Additional Counsel by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/29/2022)
2022-03-29
1
ORDER GRANTING 95 Motion to Appear Pro Hac Vice for Attorney Ashle Ross. Attorney added for Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot1) [Transferred from Texas Western on 5/5/2022.] (Entered: 03/30/2022)
2022-03-30
1
BRIEF Plaintiff's Responsive Claim Construction Brief regarding 89 Sealed Document by DexCom, Inc.. (Attachments: # 1 Declaration Young, # 2 Declaration of Jafair, # 3 Declaration of Gall, # 4 Exhibit 37, # 5 Exhibit 38, # 6 Exhibit 39, # 7 Exhibit 40, # 8 Exhibit 41, # 9 Exhibit 42, # 10 Exhibit 43, # 11 Exhibit 44, # 12 Exhibit 45, # 13 Exhibit 46)(Ainsworth, Charles) [Transferred from Texas Western on 5/5/2022.] (Entered: 04/08/2022)
2022-04-08
1
Text Order GRANTING 62 Motion to Withdraw as Attorney entered by Judge Alan D Albright. IT IS THEREFORE ORDERED that Caty Lacey be allowed to withdraw and is hereby withdrawn as attorney of record for Plaintiff in this matter. The clerk shall discontinue all CM/ECF notices in this matter to Caty Lacey. (This is a text-only entry generated by the court. There is no document associated with this entry.) (RRlc) [Transferred from Texas Western on 5/5/2022.]
2022-04-13
1
No Actions
Standing Order Regarding Order Governing Proceedings Patent Cases. Signed by Judge Alan D Albright. [Transferred from Texas Western on 5/5/2022.] (Entered: 04/14/2022)
2022-04-14
1
MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Christopher T. Jagoe ( Filing fee $ 100 receipt number 0542-15943627) by on behalf of Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 04/20/2022)
2022-04-20
1
NOTICE Notice of Appearance of Additional Counsel by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 04/20/2022)
2022-04-20
1
STATUS REPORT Regarding Defendants Opposed Motion to Dismiss for Improper Venue and Opposed Motion to Transfer by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 04/20/2022)
2022-04-20
1
ORDER GRANTING re 100 MOTION to Appear Pro Hac Vice by J. Stephen Ravel on behalf of Christopher T. Jagoe ( Filing fee $ 100 receipt number 0542-15943627) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. Signed by Judge Alan D Albright. (sv) [Transferred from Texas Western on 5/5/2022.] (Entered: 04/22/2022)
2022-04-21
1
Text Order GRANTING 100 Motion to Appear Pro Hac Vice for Attorney Christopher T. Jagoe for Abbott Diabetes Care Sales Corp. and for Abbott Diabetes Care, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order. entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (zv) [Transferred from Texas Western on 5/5/2022.]
2022-04-21
1
No Actions
Reply Claim Construction Brief by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Affidavit Schurman Declaration, # 2 Exhibit 47, # 3 Exhibit 48, # 4 Exhibit 49, # 5 Exhibit 50, # 6 Exhibit 51, # 7 Exhibit 52)(Ravel, J.) [Transferred from Texas Western on 5/5/2022.] (Entered: 04/22/2022)
2022-04-22
1
Sealed Order. Signed by Judge Alan D Albright. (sv) [Transferred from Texas Western on 5/5/2022.] (Entered: 05/05/2022)
2022-05-05
1
Record of case transferred in from District of Texas Western; Case Number in Other District: 6:21-cv-00690. Copy of Docket Sheet and original file (Entered: 05/05/2022)
2022-05-05
1
Local Counsel Letter sent. Notice of Compliance deadline set for 6/6/2022. (srs) (Entered: 05/05/2022)
2022-05-05
1
CLAIM CONSTRUCTION SURREPLY BRIEF re 104 Reply Brief, filed by Dexcom, Inc.. (Attachments: # 1 Exhibit 53, # 2 Exhibit 54, # 3 Exhibit 55)(Hoeschen, Nathan) (Entered: 05/06/2022)
2022-05-06
1
NOTICE of Related Case by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Smith, Rodger) (Entered: 05/09/2022)
2022-05-09
1
NOTICE of Appearance by John W. Shaw on behalf of Dexcom, Inc. (Shaw, John) (Entered: 05/11/2022)
2022-05-11
1
Case Assigned/Reassigned
2022-05-11
1
No Actions
Case Assigned to Vacant Judgeship (2022). Please include the initials of the Judge (VAC) after the case number on all documents filed. (nms)
2022-05-11
1
No Actions
ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares on 5/13/22.(gvw) (Entered: 05/13/2022)
2022-05-13
1
Case Assigned/Reassigned
2022-05-13
1
No Actions
Case Reassigned to Judge Kent A. Jordan. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (gvw)
2022-05-13
1
No Actions
Case Reassigned. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (gvw)
2022-05-13
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Nathan Hamstra, Jonathon Studer, Valerie Lozano and Cary E. Adickman - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 05/17/2022)
2022-05-17
1
SO ORDERED, re 112 MOTION for Pro Hac Vice Appearance of Attorney Nathan Hamstra, Jonathon Studer, Valerie Lozano and Cary E. Adickman filed by Dexcom, Inc.. Ordered by Judge Kent A. Jordan on 05/17/2022. (smg) (Entered: 05/17/2022)
2022-05-17
1
SO ORDERED
2022-05-17
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney David Nelson, Nina S. Tallon and Alexander Rudis - filed by Dexcom, Inc.. (Shaw, John) (Entered: 05/19/2022)
2022-05-19
1
SO ORDERED
2022-05-20
1
No Actions
SO ORDERED, re 114 MOTION for Pro Hac Vice Appearance of Attorney David Nelson, Nina S. Tallon and Alexander Rudis filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 5/20/2022. (apk)
2022-05-20
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Ellisen Shelton Turner, Amanda J. Hollis, Jon R. Carter, Ashley Ross, Christopher T. Jagoe and Benjamin A. Lasky - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 05/24/2022)
2022-05-24
1
SO ORDERED
2022-05-24
1
No Actions
Status Conference
2022-05-24
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephonic Status Conference held on 5/24/2022. In preparation of the scheduling conference for 21-cv-1699 on May 31st, counsel is advised to prepare separate proposed scheduling orders for 22-cv-605 and 21-cv-1699, as well as a joint proposed scheduling order, to be submitted by close of business on Thursday, May 26th. Additionally, counsel shall confer on any pending motions to be ruled on, before the May 31st teleconference. (Counsel Present for DexCom, Inc: John Shaw. Counsel present for Abbott Diabetes Care, Inc.: Amanda Hollis and Roger Smith.)(Court Reporter Stacy Ingram. Contact: 302-658-6697) (smg)
2022-05-24
1
No Actions
SO ORDERED, re 115 MOTION for Pro Hac Vice Appearance of Attorney Ellisen Shelton Turner, Amanda J. Hollis, Jon R. Carter, Ashley Ross, Christopher T. Jagoe and Benjamin A. Lasky filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Signed by Judge Kent A. Jordan on 5/24/2022. (apk)
2022-05-24
1
No Actions
Joint STATEMENT Pursuant to D. Del. LR 81.2 - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 05/25/2022)
2022-05-25
1
MOTION to Stay - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 05/26/2022)
2022-05-26
1
[SEALED] OPENING BRIEF in Support re 117 MOTION to Stay filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 6/9/2022. (Attachments: # 1 Exhibits 1-10)(Smith, Rodger) (Entered: 05/26/2022)
2022-05-26
1
Letter to The Honorable Kent A. Jordan from John W. Shaw regarding proposed scheduling order for C.A. Nos. 21-1699-KAJ and 22-605-KAJ. (Attachments: # 1 Proposed Scheduling Order)(Shaw, John) (Entered: 05/26/2022)
2022-05-26
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s First Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 05/31/2022)
2022-05-31
1
Add Attorneys - PHV only
2022-06-01
1
No Actions
Pro Hac Vice Attorney Benjamin A. Lasky for Abbott Diabetes Care, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2022-06-01
1
No Actions
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s First Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 1-10) filed by Dexcom, Inc..(Shaw, John) (Entered: 06/06/2022)
2022-06-06
1
STIPULATION TO EXTEND TIME for plaintiff to file its answering brief in response to defendants' motion to stay (D.I. 117) and for defendants to file their reply brief to June 15, 2022 and June 28, 2022, respectively - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Blumenfeld, Jack) (Entered: 06/07/2022)
2022-06-07
1
SO ORDERED, re 122 STIPULATION TO EXTEND TIME for plaintiff to file its answering brief in response to defendants' motion to stay (D.I. 117 ) and for defendants to file their reply brief to June 15, 2022 and June 28, 2022, respectively filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Ordered by Judge Kent A. Jordan on 06/07/2022. (smg) (Entered: 06/07/2022)
2022-06-07
1
STIPULATION TO EXTEND TIME to submit a proposed scheduling order to June 13, 2022 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/07/2022)
2022-06-07
1
~Util - Set Briefing Schedule - open,ans,reply,surreply AND SO ORDERED
2022-06-07
1
No Actions
Add Attorneys - PHV only
2022-06-08
1
No Actions
Pro Hac Vice Attorney David A. Nelson, Jonathon M. Studer, Nathan Hamstra, Nina S. Tallon, and Valerie A Lozano for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2022-06-08
1
No Actions
NOTICE OF SERVICE of Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s First Set of Interrogatories to Dexcom, Inc. (Nos. 1-17) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 06/09/2022)
2022-06-09
1
Letter to The Honorable Kent A. Jordan from John W. Shaw regarding the parties competing scheduling order proposals. (Attachments: # 1 Proposed Scheduling Order)(Shaw, John) (Entered: 06/13/2022)
2022-06-13
1
Letter to The Honorable Kent A. Jordan from John W. Shaw regarding the parties competing scheduling order proposals. (Attachments: # 1 Proposed Scheduling Order)(Shaw, John) (Entered: 06/13/2022)
2022-06-13
2
[SEALED] ANSWERING BRIEF in Opposition re 117 MOTION to Stay filed by Dexcom, Inc..Reply Brief due date per Local Rules is 6/22/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Hoeschen, Nathan) (Entered: 06/15/2022)
2022-06-15
1
REDACTED VERSION of 127 Answering Brief in Opposition by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/22/2022)
2022-06-22
1
NOTICE OF SERVICE of ADC's First Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 1-175) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 06/22/2022)
2022-06-22
1
NOTICE OF SERVICE of ADC Parties' Response to DexCom's First Set of Requests for Production (Nos. 1-49) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 06/27/2022)
2022-06-27
1
[SEALED] REPLY BRIEF re 117 MOTION to Stay filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 11-16)(Smith, Rodger) (Entered: 06/28/2022)
2022-06-28
1
NOTICE OF SERVICE of (1) ADC Parties' Custodian and Non-Custodian Data Source Disclosures; and (2) ADC Parties' Disclosure of Sales Figures for Accused Products filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 06/30/2022)
2022-06-30
1
REDACTED VERSION of 118 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-10)(Smith, Rodger) (Entered: 07/05/2022)
2022-07-05
1
REDACTED VERSION of (37 in 1:21-cv-01699-KAJ) Reply Brief, (131 in 1:22-cv-00605-KAJ) Reply Brief - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 11-16)(Smith, Rodger) (Entered: 07/05/2022)
2022-07-05
1
NOTICE OF SERVICE of ADC Parties' Responses to DexCom's First Set of Interrogatories (Nos. 1-10) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 07/05/2022)
2022-07-05
1
NOTICE OF SERVICE of DexCom, Inc.'s Disclosures Pursuant to Section 3 of the Delaware Default Standard for Discovery filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/08/2022)
2022-07-08
1
NOTICE OF SERVICE of Dexcom, Inc.'s Objections and Responses to Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp.'s First Set of Interrogatories (Nos. 1-17) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/12/2022)
2022-07-12
1
PROPOSED ORDER -- Protective Order -- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 07/18/2022)
2022-07-18
1
SO ORDERED, re 138 Proposed Order -- Protective Order -- filed by Abbott Diabetes Care Sales Corp. and Abbott Diabetes Care, Inc. Signed by Judge Kent A. Jordan on 7/19/2022. (nmg) (Entered: 07/19/2022)
2022-07-19
1
SO ORDERED
2022-07-19
1
No Actions
SCHEDULING & CONSOLIDATION ORDER: C.A. No. 22-605 (KAJ) shall be consolidated with C.A. No. 21-1699 (KAJ) for all purposes, and all papers shall be filed in C.A. 22-605 (KAJ). ( Joinder of Parties due by 10/7/2022., Fact Discovery completed by 3/18/2023., Opening Expert Reports due by 3/30/2023., Rebuttal Expert Reports due by 5/12/2023., Expert Discovery due by 6/6/2023., Tutorial on the technology due by 6/27/2023., Dispositive Motions due by 6/27/2023., Answering Brief due 7/18/2023., Reply Brief due 8/1/2023., A Motion Hearing is set for 8/15/2023 at 10:00 AM in To Be Determined before Judge Kent A. Jordan, Claim Construction Opening Brief due by 6/27/2023., Claim Construction Answering Brief due by 7/18/2023., Claim Construction Reply Brief due by 8/1/2023., Proposed Pretrial Order due by 11/15/2023., A Pretrial Conference is set for 12/15/2023 at 10:00 AM in Chambers before Judge Kent A. Jordan., A 10-day Jury Trial is set for 1/16/2024 at 09:30 AM before Judge Kent A. Jordan.) Signed by Judge Kent A. Jordan on 07/21/2022. (Attachments: # 1 Proposed Final Pretrial Order) Associated Cases: 1:22-cv-00605-KAJ, 1:21-cv-01699-KAJ(smg) (Entered: 07/21/2022)
2022-07-21
1
TRIAL MANAGEMENT ORDER. Signed by Judge Kent A. Jordan on 07/21/2022. Associated Cases: 1:22-cv-00605-KAJ, 1:21-cv-01699-KAJ(smg) (Entered: 07/21/2022)
2022-07-21
1
ORDER, Oral argument on all pending motions will be heard on August 18, 2022 beginning at 10:30 a.m. and concluding at 12:00 p.m. in courtroom 6-B, 6th Floor, J. Caleb Boggs Federal Building, Wilmington, Delaware. Signed by Judge Kent A. Jordan on 7/25/2022. (srs) (Entered: 07/25/2022)
2022-07-25
1
NOTICE OF SERVICE of Dexcom Inc.'s Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s First Set of Requests for Production of Documents (Nos. 1 - 175) filed by Dexcom, Inc..(Shaw, John) (Entered: 07/25/2022)
2022-07-25
1
Add Attorneys - PHV only
2022-07-25
1
No Actions
Pro Hac Vice Attorney Cary E. Adickman for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2022-07-25
1
No Actions
NOTICE requesting Clerk to remove David Nelson as co-counsel.. (Shaw, John) (Entered: 07/27/2022)
2022-07-27
1
NOTICE OF SERVICE of 1. DexCom, Inc.'s Supplemental Disclosures Pursuant to Section 3 of the Delaware Default Standard for Discovery 2. DexCom Inc.'s Rule 26 Initial Disclosures filed by Dexcom, Inc..(Shaw, John) (Entered: 07/28/2022)
2022-07-28
1
MOTION for Pro Hac Vice Appearance of Attorney Theodore Kwong - filed by Dexcom, Inc.. (Shaw, John) (Entered: 07/28/2022)
2022-07-28
1
NOTICE OF SERVICE of ADC Parties' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Blumenfeld, Jack) (Entered: 07/28/2022)
2022-07-28
1
SO ORDERED, re 146 MOTION for Pro Hac Vice Appearance of Attorney Theodore Kwong filed by Dexcom, Inc. Ordered by Judge Kent A. Jordan on 08/02/2022. (smg) (Entered: 08/02/2022)
2022-08-02
1
SO ORDERED
2022-08-02
1
No Actions
Pro Hac Vice Attorney Theodore D. Kwong for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2022-08-02
1
No Actions
Add Attorneys - PHV only
2022-08-02
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Brian P. Biddinger - filed by Dexcom, Inc.. (Shaw, John) (Entered: 08/15/2022)
2022-08-15
1
SO ORDERED, re 149 MOTION for Pro Hac Vice Appearance of Attorney Brian P. Biddinger filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 8/15/2022. (srs) (Entered: 08/15/2022)
2022-08-15
1
SO ORDERED
2022-08-15
1
No Actions
NOTICE requesting Clerk to remove Nina S. Tallon as co-counsel.. (Shaw, John) (Entered: 08/16/2022)
2022-08-16
1
MOTION for Pro Hac Vice Appearance of Attorney David Bilsker, Kevin P.B. Johnson, and Margaret Shyr - filed by Dexcom, Inc.. (Shaw, John) (Entered: 08/17/2022)
2022-08-17
1
SO ORDERED, regarding D.I. 152 MOTION for Pro Hac Vice Appearance of Attorney David Bilsker, Kevin P.B. Johnson, and Margaret Shyr filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 8/17/2022. (apk)
2022-08-17
1
No Actions
SO ORDERED
2022-08-17
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Todd M. Briggs - filed by Dexcom, Inc.. (Russell, Andrew) (Entered: 08/18/2022)
2022-08-18
1
SO ORDERED, re 153 MOTION for Pro Hac Vice Appearance of Attorney Todd M. Briggs filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 8/18/22. (srs)
2022-08-18
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Oral Argument on all pending motions held on 8/18/2022. (Court Reporter Michele Rolfe, Michele_Rolfe@ded.uscourts.gov) (apk)
2022-08-18
1
No Actions
Pro Hac Vice Attorney Margaret Shyr, Kevin P.B. Johnson, David L. Bilsker, and Brian P. Biddinger for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2022-08-18
1
No Actions
SO ORDERED
2022-08-18
1
No Actions
Oral Argument
2022-08-18
1
No Actions
Add Attorneys - PHV only
2022-08-18
1
No Actions
Letter to The Honorable Kent A. Jordan from Jack B. Blumenfeld regarding corrected footnote - re 131 Reply Brief. (Blumenfeld, Jack) (Entered: 08/19/2022)
2022-08-19
1
Letter to The Honorable Kent A. Jordan from John W. Shaw regarding the parties scheduling order proposals. (Attachments: # 1 Proposed Amended Scheduling Order)(Shaw, John) (Entered: 08/22/2022)
2022-08-22
1
ORDER, the parties shall, by August 29, 2022, submit supplemental letter briefs, not to exceed ten double-spaced pages (in 12-point type, with standard margins), on the question of subject matter jurisdiction over the claims asserted in this matter. If the parties agree on the basis or bases for jurisdiction, a joint letter may be submitted by the same date. (See Order for further details) Signed by Judge Kent A. Jordan on 08/23/2022. (smg) (Entered: 08/23/2022)
2022-08-23
1
ORDER Setting Teleconference: Counsel for DexCom, Inc. shall initiate the teleconference call. A Telephone Conference is set for 8/30/2022 at 02:00 PM before Judge Kent A. Jordan. Signed by Judge Kent A. Jordan on 08/23/2022. (smg) (Entered: 08/23/2022)
2022-08-23
1
[SEALED] Letter to The Honorable Kent A. Jordan from Jack B. Blumenfeld regarding DexCom's new proposals - re 155 Letter. (Attachments: # 1 Exhibits A-D)(Blumenfeld, Jack) (Entered: 08/23/2022)
2022-08-23
1
[SEALED] Letter to The Honorable Kent A. Jordan from John W. Shaw regarding Scheduling Order Proposals. (Shaw, John) (Entered: 08/25/2022)
2022-08-25
1
[SEALED] Letter to The Honorable Kent A. Jordan from Karen E. Keller regarding the question of subject matter jurisdiction over the claims in this matter - re 156 Order,, Set Deadlines,. (Keller, Karen) (Entered: 08/29/2022)
2022-08-29
1
[SEALED] Letter to The Honorable Kent A. Jordan from Jack B. Blumenfeld regarding subject matter jurisdiction - re 156 Order,, Set Deadlines,. (Attachments: # 1 Exhibit 1)(Blumenfeld, Jack) (Entered: 08/29/2022)
2022-08-29
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Second Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Russell, Andrew) (Entered: 08/30/2022)
2022-08-30
1
REDACTED VERSION of 158 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 08/30/2022)
2022-08-30
1
Telephone Conference
2022-08-30
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephone Conference held on 8/30/2022. (Court Reporter Brian Gaffigan.) (apk)
2022-08-30
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Dallas Bullard - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 08/31/2022)
2022-08-31
1
SO ORDERED, re D.I. 164 MOTION for Pro Hac Vice Appearance of Attorney Dallas Bullard filed by Dexcom, Inc. Ordered by Judge Kent A. Jordan on 08/31/2022. (smg) (Entered: 08/31/2022)
2022-08-31
1
SO ORDERED
2022-08-31
1
No Actions
REDACTED VERSION of 159 Letter by Dexcom, Inc.. (Russell, Andrew) (Entered: 09/01/2022)
2022-09-01
1
Add Attorneys - PHV only
2022-09-01
1
No Actions
Pro Hac Vice Attorney Todd M. Briggs for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
2022-09-01
1
No Actions
REDACTED VERSION of 160 Letter by Dexcom, Inc.. (Russell, Andrew) (Entered: 09/02/2022)
2022-09-02
1
[SEALED] ANSWER to Complaint with Jury Demand, COUNTERCLAIM against Dexcom, Inc. by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits A-K)(Blumenfeld, Jack) (Entered: 09/02/2022)
2022-09-02
1
REDACTED VERSION of 161 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Blumenfeld, Jack) (Entered: 09/06/2022)
2022-09-06
1
REDACTED VERSION of 168 Answer to Complaint, Counterclaim by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 09/09/2022)
2022-09-09
1
Official Transcript of Teleconference held on 08.30.2022 before Judge Kent Jordan. Court Reporter/Transcriber Brian Gaffigan,Email: gaffigan.b@outlook.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/11/2022. Redacted Transcript Deadline set for 10/20/2022. Release of Transcript Restriction set for 12/19/2022. (Rolfe, Michele) (Entered: 09/19/2022)
2022-09-19
1
NOTICE OF SERVICE of 1. Plaintiff Dexcom, Inc.'s Second Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 11-17) 2. Plaintiff Dexcom, Inc.'s Third Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Russell, Andrew) (Entered: 09/21/2022)
2022-09-21
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Fourth Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Russell, Andrew) (Entered: 09/21/2022)
2022-09-21
1
PROPOSED ORDER Amended Scheduling Order by Dexcom, Inc.. (Keller, Karen) (Entered: 09/21/2022)
2022-09-21
1
[SEALED] ANSWER to 168 Answer to Complaint, Counterclaim, Counter COUNTERCLAIM against Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 09/23/2022)
2022-09-23
1
AMENDED SCHEDULING ORDER. Signed by Judge Kent A. Jordan on 9/26/2022. (apk) (Entered: 09/26/2022)
2022-09-26
1
NOTICE OF SERVICE of ADC Parties' Second Set of Interrogatories (Nos. 18-23) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 09/27/2022)
2022-09-27
1
STIPULATION and [Proposed Order] Regarding Document Discovery by Dexcom, Inc.. (Russell, Andrew) (Entered: 09/28/2022)
2022-09-28
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Third Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (No. 18) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 09/28/2022)
2022-09-28
1
NOTICE OF SERVICE of ADC Parties' Response to Dexcom's Second Set of Requests for Production (Nos. 50-71) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 09/29/2022)
2022-09-29
1
NOTICE OF SERVICE of ADC Parties' Second Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 176-245) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 09/30/2022)
2022-09-30
1
REDACTED VERSION of 175 Answer to Counterclaim, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 09/30/2022)
2022-09-30
1
NOTICE requesting Clerk to remove Alexander Rudis as co-counsel.. (Shaw, John) (Entered: 10/03/2022)
2022-10-03
1
NOTICE OF SERVICE of 1. Plaintiff's Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 2, 4, 5 and 6) 2. DexCom, Inc's First Supplemental Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s First Set of Requests for Production of Documents (Nos. 1 - 75) filed by Dexcom, Inc..(Keller, Karen) (Entered: 10/03/2022)
2022-10-03
1
NOTICE OF SERVICE of Dexcom Inc.'s Rule 26 Amended and Supplemental Initial Disclosures filed by Dexcom, Inc..(Russell, Andrew) (Entered: 10/04/2022)
2022-10-04
1
SO ORDERED, D.I. 178 Stipulation filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 10/4/2022. (apk) (Entered: 10/04/2022)
2022-10-04
1
SO ORDERED
2022-10-04
1
No Actions
NOTICE OF SERVICE of Plaintiff Dexcom Inc.'s Fifth Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/05/2022)
2022-10-05
1
NOTICE OF SERVICE of 1. Plaintiff's Corrected Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 2, 4, 5 and 6) 2. DexCom, Inc's Corrected First Supplemental Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s First Set of Requests for Production of Documents (Nos. 1 - 175) filed by Dexcom, Inc..(Russell, Andrew) (Entered: 10/07/2022)
2022-10-07
1
NOTICE OF SERVICE of 1. Dexcom, Inc.'s Rule 26 Second Amended and Supplemental Initial Disclosures 2. Dexcom, Inc.'s Amended and Supplemental Disclosures Pursuant to Section 3 of the Delaware Default Standard for Discovery filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/07/2022)
2022-10-07
1
NOTICE OF SERVICE of ADC Parties' Custodian and Non-Custodian Data Source Disclosures - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 10/11/2022)
2022-10-11
1
NOTICE OF SERVICE of DexCom Inc.'s Rule 26 Third Amended and Supplemental Initial Disclosures filed by Dexcom, Inc..(Russell, Andrew) (Entered: 10/13/2022)
2022-10-13
1
NOTICE OF SERVICE of ADC Parties' First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 10/13/2022)
2022-10-13
1
NOTICE OF SERVICE of ADC Parties' Third Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 246-255) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 10/14/2022)
2022-10-14
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Fourth Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (No. 19) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/14/2022)
2022-10-14
1
MOTION to Dismiss, MOTION to Strike -- ADC Parties' Motion to Dismiss Dexcom's First Counter-Counterclaim, and to Strike Dexcom's Second Affirmative Defense -- - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Blumenfeld, Jack) (Entered: 10/14/2022)
2022-10-14
1
[SEALED] OPENING BRIEF in Support re 195 MOTION to Dismiss MOTION to Strike -- ADC Parties' Motion to Dismiss Dexcom's First Counter-Counterclaim, and to Strike Dexcom's Second Affirmative Defense -- filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 10/28/2022. (Attachments: # 1 Exhibits 1-4)(Blumenfeld, Jack) (Entered: 10/14/2022)
2022-10-14
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s First Set of Requests for Admission to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/17/2022)
2022-10-17
1
NOTICE OF SERVICE of DexCom, Inc.'s First Notice of Rule 30(b)(6) Deposition to Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/18/2022)
2022-10-18
1
NOTICE OF SERVICE of 1) Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action directed to Guy Ruttenberg 2) Subpoena to Testify at a Deposition in a Civil Action directed to Guy Ruttenberg filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/21/2022)
2022-10-21
1
NOTICE OF SERVICE of (1) ADC Parties' Response to DexCom's Fourth Set of Requests for Production (Nos. 151-171); (2) ADC Parties' Response to DexCom's Third Set of Requests for Production (Nos. 72-150) and (3) ADC Parties' Responses to DexCom's Second Set of Interrogatories (Nos. 11-17) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 10/21/2022)
2022-10-21
1
NOTICE OF SERVICE of ADC Parties' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to DexCom, Inc. filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 10/21/2022)
2022-10-21
1
NOTICE OF SERVICE of ADC Parties' Second Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 10/25/2022)
2022-10-25
1
NOTICE OF SERVICE of DexCom, Inc.'s Rule 26 Fourth Amended and Supplemental Initial Disclosures filed by Dexcom, Inc..(Keller, Karen) (Entered: 10/25/2022)
2022-10-25
1
MOTION for Preliminary Injunction - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order)(Shaw, John) (Entered: 10/25/2022)
2022-10-25
1
[SEALED] OPENING BRIEF in Support re 204 MOTION for Preliminary Injunction filed by Dexcom, Inc..Answering Brief/Response due date per Local Rules is 11/8/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Shaw, John) (Entered: 10/25/2022)
2022-10-25
1
[SEALED] ANSWERING BRIEF in Opposition re 195 MOTION to Dismiss MOTION to Strike -- ADC Parties' Motion to Dismiss Dexcom's First Counter-Counterclaim, and to Strike Dexcom's Second Affirmative Defense -- filed by Dexcom, Inc..Reply Brief due date per Local Rules is 11/1/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Shaw, John) (Entered: 10/25/2022)
2022-10-25
1
REDACTED VERSION of 196 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-4)(Raucci, Anthony) (Entered: 10/25/2022)
2022-10-25
1
NOTICE of Subpoena to Rose Thiessen to Testify at a Deposition and Produce Documents, Information, or Objects by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Smith, Rodger) (Entered: 10/27/2022)
2022-10-27
1
NOTICE OF SERVICE of 1. Dexcom Inc.'s Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Second Set of Requests for Production of Documents (Nos. 176-245) 2. Dexcom, Inc.'s Objections and Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Second Set of Interrogatories (Nos. 18-23) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/28/2022)
2022-10-28
1
NOTICE OF SERVICE of Dexcom Inc.'s First Amended Notice of Rule 30(b)(6) Deposition to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/28/2022)
2022-10-28
1
NOTICE of Subsequent Authority to DexCom's Briefs in Support of its Motion to Dismiss for Failure to State a Claim in C.A. No. 21-1699 (D.I. Nos. 19 and 29) by Dexcom, Inc. (Shaw, John) (Entered: 10/28/2022)
2022-10-28
1
NOTICE OF SERVICE of (1) ADC Parties' Objections and Response to DexCom's Third Set of Interrogatories (No. 18); (2) ADC Parties' First Supplemental Responses to DexCom's Second Set of Interrogatories (Nos. 14, 16); and (3) ADC Parties' First Supplemental Response to DexCom's First Set of Interrogatories (No. 9) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 10/28/2022)
2022-10-28
1
NOTICE of Subpoena (Knobbe Martens Olson & Bear LLP) - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Smith, Rodger) (Entered: 10/31/2022)
2022-10-31
1
NOTICE of Subpoenas (John Lister) - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Smith, Rodger) (Entered: 10/31/2022)
2022-10-31
1
NOTICE of Subpoenas (William Schwartz) - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Smith, Rodger) (Entered: 10/31/2022)
2022-10-31
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding Abbott's disclosure of Dr. Garry Steil. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Hoeschen, Nathan) (Entered: 10/31/2022)
2022-10-31
1
NOTICE OF SERVICE of Plaintiff's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos, 2, 4, 5 and 6) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 10/31/2022)
2022-10-31
1
STIPULATION and Order Regarding Briefing on Motion to Dismiss and Motion for Preliminary Injunction by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 11/01/2022)
2022-11-01
1
NOTICE OF SERVICE of Subpoena to Testify at a Deposition in a Civil Actions as to Shannon Hansen filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/01/2022)
2022-11-01
1
Letter to The Honorable Kent A. Jordan from Jack B. Blumenfeld regarding objection to motion to disqualify Dr. Steil - re 216 Letter,. (Blumenfeld, Jack) (Entered: 11/01/2022)
2022-11-01
1
[SEALED] DECLARATION re 220 Letter -- Declaration of Garry M. Steil, Ph.D. - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Blumenfeld, Jack) (Entered: 11/01/2022)
2022-11-01
1
NOTICE OF SERVICE of DexCom's Responses to Abbott's Rule 30(b)(6) Deposition Notice Topics (1-49) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/01/2022)
2022-11-01
1
STIPULATION TO EXTEND TIME to submit proposed redacted versions of docket items 205 and 206 to November 4, 2022 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/01/2022)
2022-11-01
1
SO ORDERED, re 223 STIPULATION TO EXTEND TIME to submit proposed redacted versions of docket items 205 and 206 to November 4, 2022 filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 11/2/2022. (apk) (Entered: 11/02/2022)
2022-11-02
1
SO ORDERED, re 218 Stipulation filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (AN Oral Argument is set for 12/20/2022 at 10:00 AM before Judge Kent A. Jordan). Signed by Judge Kent A. Jordan on 11/2/2022. (apk) (Entered: 11/02/2022)
2022-11-02
1
REDACTED VERSION of 205 Opening Brief in Support, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/02/2022)
2022-11-02
1
REDACTED VERSION of 206 Answering Brief in Opposition, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/02/2022)
2022-11-02
1
[SEALED] Letter to The Honorable Kent A. Jordan from Karen E. Keller regarding withdraw of protective order dispute - re 216 Letter,. (Keller, Karen) (Entered: 11/02/2022)
2022-11-02
1
NOTICE of Subpoena to James H. Brauker to Testify at a Deposition by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Smith, Rodger) (Entered: 11/02/2022)
2022-11-02
1
NOTICE OF SERVICE of ADC Parties' Objections and Responses to DexCom's First Amended Notice of Rule 30(b)(6) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/02/2022)
2022-11-02
1
SO ORDERED
2022-11-02
1
No Actions
NOTICE OF SERVICE of (1) ADC Parties' Third Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) ADC Parties' Response to Dexcom's Fifth Set of Requests for Production (Nos. 172-180) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/04/2022)
2022-11-04
1
NOTICE to Take Deposition of Guy Ruttenberg on November 8, 2022 filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Ben Feldman on November 8, 2022 filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Susan Tall on November 9, 2022 filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/07/2022)
2022-11-07
1
NOTICE OF SERVICE of DexCom's First Supplemental Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Second Set of Requests for Production of Documents (Nos. 176-245) filed by Dexcom, Inc..(Keller, Karen) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Steven Pacelli on November 7, 2022 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Adam Noar on November 9, 2022 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Laura Johnson on November 9, 2022 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Apurv Kamath on November 9, 2022 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/07/2022)
2022-11-07
1
NOTICE to Take Deposition of Peter Simpson on November 14, 2022 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/07/2022)
2022-11-07
1
REDACTED VERSION of 216 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/07/2022)
2022-11-07
1
NOTICE OF SERVICE of Guy Ruttenberg, Esq.'s Objections and Responses to DexCom's Subpoenas to Testify at a Deposition and to Produce Documents Information or Objects filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/08/2022)
2022-11-08
1
NOTICE of Subpoena to John Lister to Testify at a Deposition and Produce Documents, Information, or Objects by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. (Raucci, Anthony) (Entered: 11/08/2022)
2022-11-08
1
[SEALED] BRIEF (Combined Answering and Reply) re 204 MOTION for Preliminary Injunction, 195 MOTION to Dismiss MOTION to Strike -- ADC Parties' Motion to Dismiss Dexcom's First Counter-Counterclaim, and to Strike Dexcom's Second Affirmative Defense -- filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 11/15/2022. (Attachments: # 1 Exhibits A-T)(Raucci, Anthony) (Entered: 11/08/2022)
2022-11-08
1
MOTION for Pro Hac Vice Appearance of Attorney Jason M. Wilcox P.C. - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 11/08/2022)
2022-11-08
1
REDACTED VERSION of 221 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 11/09/2022)
2022-11-09
1
NOTICE to Take Deposition of Adam Cate on November 11, 2022 filed by Dexcom, Inc..(Russell, Andrew) (Entered: 11/09/2022)
2022-11-09
1
NOTICE to Take Deposition of Marc Taub on November 11, 2022 filed by Dexcom, Inc..(Russell, Andrew) (Entered: 11/09/2022)
2022-11-09
1
MOTION for Pro Hac Vice Appearance of Attorney Cat Williams - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/09/2022)
2022-11-09
1
REDACTED VERSION of 228 Letter by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/09/2022)
2022-11-09
1
SO ORDERED, regarding D.I. 249 MOTION for Pro Hac Vice Appearance of Attorney Cat Williams. Signed by Judge Kent A. Jordan on 4/3/2024. (apk) (Entered: 04/03/2024)
2022-11-09
1
MOTION for Pro Hac Vice Appearance of Attorney Zak Randell - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/10/2022)
2022-11-10
1
SO ORDERED, re 245 MOTION for Pro Hac Vice Appearance of Attorney Jason M. Wilcox P.C. filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Signed by Judge Kent A. Jordan on 11/10/2022. (apk) (Entered: 11/10/2022)
2022-11-10
1
SO ORDERED
2022-11-10
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Gavin Frisch - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/11/2022)
2022-11-11
1
NOTICE to Take Deposition of Jason Pederson on November 15, 2022 filed by Dexcom, Inc..(Russell, Andrew) (Entered: 11/11/2022)
2022-11-11
1
NOTICE to Take Deposition of Todd York on November 14, 2022 filed by Dexcom, Inc..(Russell, Andrew) (Entered: 11/11/2022)
2022-11-11
1
NOTICE OF SERVICE of (1) ADC Parties' Responses to Dexcom's First Set of Requests for Admission; and (2) ADC Parties' Objections and Response to Dexcom's Fourth Set of Interrogatories (No. 19) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 11/14/2022)
2022-11-14
1
NOTICE OF SERVICE of 1. Response of Rose Thiessen to ADC Parties' Notice of Subpoena to Produce Documents, Information, or Objects 2. Response of William Schwartz to ADC Parties' Notice of Subpoena to Produce Documents, Information, or Objects 3. DexCom Inc.'s Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Third Set of Requests for the Production of Documents (Nos. 246-255) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/14/2022)
2022-11-14
1
SO ORDERED, re 253 MOTION for Pro Hac Vice Appearance of Attorney Gavin Frisch filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 11/14/2022. (apk)
2022-11-14
1
No Actions
SO ORDERED, re 251 MOTION for Pro Hac Vice Appearance of Attorney Zak Randell filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 11/14/2022. (apk)
2022-11-14
1
No Actions
SO ORDERED
2022-11-14
1
No Actions
Joint STIPULATION and [Proposed Order] to allow certain depositions to occur after the November 15, 2022 deadline by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/15/2022)
2022-11-15
1
SO ORDERED, regarding D.I. 258 Stipulation filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 11/15/2022. (apk) (Entered: 11/15/2022)
2022-11-15
1
NOTICE OF SERVICE of Response of John Lister to ADC Parties' Notice of Subpoena to Produce Documents, Information, or Objects filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/15/2022)
2022-11-15
1
[SEALED] REPLY BRIEF re 204 MOTION for Preliminary Injunction filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/15/2022)
2022-11-15
1
NOTICE OF SERVICE of (1) ADC Parties' Second Supplemental Response to DexCom's First Set of Interrogatories (No. 9); (2) ADC Parties' First Supplemental Objections and Response to DexCom's Third Set of Interrogatories (No. 18) and (3) ADC Parties' Second Supplemental Responses to DexCom's Second Set of Interrogatories (Nos. 14, 16) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/15/2022)
2022-11-15
1
REDACTED VERSION of 244 Brief (Combined Answering and Reply), by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits A-T)(Raucci, Anthony) (Entered: 11/15/2022)
2022-11-15
1
Pro Hac Vice Attorney Zak J.W. Randell for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2022-11-15
1
No Actions
SO ORDERED
2022-11-15
1
No Actions
Add Attorneys - PHV only
2022-11-15
1
No Actions
NOTICE OF SERVICE of Plaintiff's Third Supplemental Objections and Responses to Defendants' First Set of Interrogatories (No. 2) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/16/2022)
2022-11-16
1
STIPULATION TO EXTEND TIME for the parties to exchange privilege logs to December 1, 2022 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 11/21/2022)
2022-11-21
1
SO ORDERED, re 265 STIPULATION TO EXTEND TIME for the parties to exchange privilege logs to December 1, 2022 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Ordered by Judge Kent A. Jordan on 11/21/2022. (smg) (Entered: 11/21/2022)
2022-11-21
1
SO ORDERED
2022-11-21
1
No Actions
REDACTED VERSION of 261 Reply Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/22/2022)
2022-11-22
1
NOTICE to Take Deposition of Marc Taub on November 23, 2022 filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/22/2022)
2022-11-22
1
NOTICE OF SERVICE of (1) Expert Report of Eric E. Bensen, (2) Expert Report of Peter Chrocziel, (3) Expert Report of RT Hon Sir Christopher Floyd, (4) Expert Report and Disclosure of Christopher Gerardi, (5) Expert Report of Thomas A. Harrington, (6) Expert Report of Christopher G. Robertson, (7) Expert Report of Matthew Schurman, Ph.D., (8) Expert Report of John L. Smith, Ph.D. and (9) Expert Report of Garry M. Steil, Ph.D. filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 11/23/2022)
2022-11-23
1
NOTICE OF SERVICE of 1. Opening Expert Report of Dr. Ken Gall 2. Opening Expert Report of Dr. Roozbeh Jafari 3. Expert Report of Patrick F. Kennedy, Ph.D. 4. Opening Expert Report of Dr. Lori Laffel filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/23/2022)
2022-11-23
1
[SEALED] MEMORANDUM OPINION. Signed by Judge Kent A. Jordan on 11/29/2022.This Memorandum Opinion has been emailed to local counsel. (apk) (Entered: 11/29/2022)
2022-11-29
1
ORDER, Abbott's Sealed Opposed Motion to Dismiss (D.1. 34 ) in Civil Action No. 22-605 (KAJ) is DENIED; Abbott's Motion To Stay (D.I. 117 ) in Civil Action No. 22-605 (KAJ) pending resolution of Civil Action No. 21-1699(KAJ) is GRANTED; DexCom's Motion to Dismiss for Failure to State a Claim (D.I. 17) in Civil Action No. 21-1699 (KAJ) is GRANTED without prejudice with respect to Abbott's claim for breach of the implied covenant of good faith and fair dealing, and DENIED with respect to Abbott's claim for declaratory judgment. Abbott will be given leave to amend its complaint in Civil Action No. 21-1699 (KAJ). Signed by Judge Kent A. Jordan on 11/29/2022. (apk) (Entered: 11/29/2022)
2022-11-29
1
ORDER, Counsel shall provide the Court with proposed redactions to that document on or before the close of business on December 6, 2022. After that time the Court will unseal the Memorandum Opinion, setting forth the rulings, with any redactions deemed appropriate by the Court.( Notice of Compliance deadline set for 12/6/2022.) Signed by Judge Kent A. Jordan on 11/29/2022. (apk) (Entered: 11/29/2022)
2022-11-29
1
NOTICE OF SERVICE of (1) ADC Parties' Second Supplemental Objections and Response to Dexcom's Third Set of Interrogatories (No. 18); (2) ADC Parties' Third Supplemental Responses to Dexcom's Second Set of Interrogatories (Nos. 11-17) and (3) ADC Parties' Third Supplemental Response to Dexcom's First Set of Interrogatories (No. 9) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 12/05/2022)
2022-12-05
1
[SEALED] Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Proposed Redactions to Memorandum Opinion - re 271 Memorandum Opinion. (Attachments: # 1 Exhibit A)(Raucci, Anthony) (Entered: 12/06/2022)
2022-12-06
1
REDACTED VERSION of 271 Memorandum Opinion. (srs) (Entered: 12/07/2022)
2022-12-07
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding amended counterclaims. (Smith, Rodger) (Entered: 12/09/2022)
2022-12-09
1
MOTION for Pro Hac Vice Appearance of Attorney Sophie A. Hood - filed by Dexcom, Inc.. (Shaw, John) (Entered: 12/13/2022)
2022-12-13
1
[SEALED] ANSWER to Complaint with Jury Demand -- ADC Parties' Answer to Dexcom's First Amended Complaint in C.A. No. 22-605, Amended COUNTERCLAIM against Dexcom, Inc. by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. A-K)(Smith, Rodger) (Entered: 12/13/2022)
2022-12-13
1
[SEALED] AMENDED COMPLAINT in C.A. No. 21-1699 against Dexcom, Inc.- filed by Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. A-K)(Smith, Rodger) (Entered: 12/13/2022)
2022-12-13
1
SO ORDERED
2022-12-13
1
No Actions
SO ORDERED, regarding D.I. 278 MOTION for Pro Hac Vice Appearance of Attorney Sophie A. Hood filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 12/13/2022. (apk)
2022-12-13
1
No Actions
NOTICE OF SERVICE of (1) Rebuttal Expert Report of Garry M. Steil, Ph.D.; (2) Rebuttal Expert Report of John L. Smith, Ph.D.; (3) Rebuttal Expert Report of Matthew Schurman, Ph.D.; (4) Rebuttal Expert Report of Christopher Gerardi; and (5) Rebuttal Expert Report of Eugene E. Wright, Jr. MD - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 12/14/2022)
2022-12-14
1
Add Attorneys - PHV only
2022-12-14
1
No Actions
Pro Hac Vice Attorney Sophie A. Hood for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
2022-12-14
1
No Actions
NOTICE OF SERVICE of 1) Rebuttal Report of Patrick F. Kennedy, Ph.D. 2) Rebuttal Expert Report of Dr. Ken Gall in response to Opening Expert Report of Thomas A. Harrington, Christopher G. Robertson, Matthew Schurman, and John L. Smith 3) Rebuttal Expert Report of Dr. Roozbeh Jafari in response to Opening Expert Reports of John L. Smith and Garry Steil 4) Opening Expert Report of Professor the Rt. Hon. Sir Robin Jacob 5) Legal Expert Report of Professor Dr. Christoph Ann LL.M. 6) Expert Report of Louis P. Berneman 7) Opening Expert Report of Associate Dean John M. Whealan filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 12/15/2022)
2022-12-15
1
REDACTED VERSION of 275 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit A)(Raucci, Anthony) (Entered: 12/15/2022)
2022-12-15
1
MOTION to Stay Pending Completion of IPRs - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Blumenfeld, Jack) (Entered: 12/19/2022)
2022-12-19
1
[SEALED] OPENING BRIEF in Support re 284 MOTION to Stay Pending Completion of IPRs filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 1/3/2023. (Attachments: # 1 Exhibits 1-17)(Blumenfeld, Jack) (Entered: 12/19/2022)
2022-12-19
1
REDACTED VERSION of 285 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-17)(Blumenfeld, Jack) (Entered: 12/19/2022)
2022-12-19
1
NOTICE OF SERVICE of Plaintiff's Fourth Supplemental Objections and Responses to Defendants' First Set of Interrogatories (No. 2) filed by Dexcom, Inc..(Russell, Andrew) (Entered: 12/19/2022)
2022-12-19
1
Oral Argument
2022-12-20
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Oral Argument held on 12/20/2022. The Court heard arguments from both parties concerning the Motion to Dismiss (D.I. 195 ) and Motion for Preliminary Injunction (D.I. 204 ). Letter Reply from Plaintiff's Counsel concerning Defendant's Motion to Dismiss due by 12/28/2022. Defendant's Counsel Responsive Letter due 1/4/2023. Counsel present for Plaintiff: John Shaw, David Bilsker, Zak Randell. Counsel present for Defendant: Rodger Smith, Amanda Hollis, Ellisen Turner, Benjamin Lasky, Ashley Ross. (Court Reporter: John Donnelly, john.donnelly1963@yahoo.com). (twk)
2022-12-20
1
No Actions
REDACTED VERSION of 279 Answer to Complaint,, Counterclaim, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. A-K)(Smith, Rodger) (Entered: 12/22/2022)
2022-12-22
1
REDACTED VERSION of 280 Amended Complaint by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. A-K)(Smith, Rodger) (Entered: 12/22/2022)
2022-12-22
1
STIPULATION TO EXTEND TIME for DexCom, Inc. to file its answering brief in opposition to Abbott Diabetes Care Inc.'s motion to stay and for Abbott to file its reply brief to January 10, 2023 and January 24, 2023 respectively - filed by Dexcom, Inc.. (Shaw, John) (Entered: 12/22/2022)
2022-12-22
1
NOTICE OF SERVICE of (1) Reply Expert Report of Eric Bensen, (2) Reply Expert Report of Peter Chrocziel, (3) Reply Expert Report of Rt. Hon. Sir Christopher Floyd, (4) Reply Expert Report of Christopher Gerardi, (5) Reply Expert Report of Thomas A. Harrington, (6) Reply Expert Report of Christopher Robertson, (7) Reply Expert Report of Matthew Schurman, Ph.D., (8) Reply Expert Report of John L. Smith, Ph.D., and (9) Reply Expert Report of Garry M. Steil, Ph.D. filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 12/27/2022)
2022-12-27
1
NOTICE OF SERVICE of 1. Reply Expert Report of Dr. Ken Gall in Response to Rebuttal Expert Reports of Matthew Schurman and John L. Smith 2. Reply Expert Report of Dr. Lori Laffel 3. Reply Expert Report of Dr. Roozbeh Jafari in Response to Rebuttal Expert Reports of John L. Smith and Garry Steil 4. Reply Expert Report of Patrick F. Kennedy, Ph.D. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 12/27/2022)
2022-12-27
1
MOTION to Dismiss for Failure to State a Claim - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order)(Shaw, John) (Entered: 12/27/2022)
2022-12-27
1
[SEALED] OPENING BRIEF in Support re 293 MOTION to Dismiss for Failure to State a Claim filed by Dexcom, Inc..Answering Brief/Response due date per Local Rules is 1/10/2023. (Attachments: # 1 Exhibit A)(Shaw, John) (Entered: 12/27/2022)
2022-12-27
1
ANSWER to 279 Answer to Complaint,, Counterclaim,, Counter COUNTERCLAIM against Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Dexcom, Inc..(Shaw, John) (Entered: 12/27/2022)
2022-12-27
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding reply letter concerning Defendant's Motion to Dismiss - re Oral Argument,,. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Hoeschen, Nathan) (Entered: 12/28/2022)
2022-12-28
1
SO ORDERED, regarding D.I. 290 STIPULATION TO EXTEND TIME for DexCom, Inc. to file its answering brief in opposition to Abbott Diabetes Care Inc.'s motion to stay and for Abbott to file its reply brief to January 10, 2023 and January 24, 2023 respectively filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 1/4/2023. (apk) (Entered: 01/04/2023)
2023-01-04
1
STIPULATION TO EXTEND TIME to submit a proposed redacted version of DexCom, Inc.'s Opening Brief in Support of its Motion to Dismiss for Failure to State a Claim (D.I. 294) to January 5, 2023 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/04/2023)
2023-01-04
1
STIPULATION TO EXTEND TIME of certain case deadlines to various dates - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/04/2023)
2023-01-04
1
REDACTED VERSION of 296 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/04/2023)
2023-01-04
1
SO ORDERED, 298 STIPULATION TO EXTEND TIME to submit a proposed redacted version of DexCom, Inc.'s Opening Brief in Support of its Motion to Dismiss for Failure to State a Claim (D.I. 294) to January 5, 2023 and re 299 STIPULATION TO EXTEND TIME of certain case deadlines to various dates. Signed by Judge Kent A. Jordan on 1/4/2023. (srs) (Entered: 01/04/2023)
2023-01-04
1
[SEALED] Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding DexCom's December 28, 2022 letter - re 296 Letter,. (Attachments: # 1 Ex. 1)(Smith, Rodger) (Entered: 01/04/2023)
2023-01-04
1
MOTION to Strike Dexcom's Untimely Contention - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/04/2023)
2023-01-04
1
[SEALED] Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Motion to Strike - re 303 MOTION to Strike Dexcom's Untimely Contention. (Attachments: # 1 Exhibits A-F)(Raucci, Anthony) (Entered: 01/04/2023)
2023-01-04
1
SO ORDERED
2023-01-04
1
No Actions
REDACTED VERSION of 294 Opening Brief in Support by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/05/2023)
2023-01-05
1
MOTION to Dismiss, MOTION to Strike -- ADC Parties Renewed Motion To Dismiss Dexcom's First Counter-Counterclaim, and To Strike Dexcom's Second Affirmative Defense re 295 Answer to Counterclaim, - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/05/2023)
2023-01-05
1
Official Transcript of Motion Hearing held on 12/20/2022 before Judge Kent A. Jordan. Court Reporter/Transcriber Veritext, Contact: (302)571-0510. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 1/27/2023. Redacted Transcript Deadline set for 2/6/2023. Release of Transcript Restriction set for 4/6/2023. (smg) (Entered: 01/06/2023)
2023-01-06
1
[SEALED] Letter to The Honorable Kent A Jordan from Nathan R. Hoeschen regarding response to ADC's January 4, 2022 letter (D.I. 302). (Attachments: # 1 Exhibit A)(Hoeschen, Nathan) (Entered: 01/06/2023)
2023-01-06
1
ANSWERING BRIEF in Opposition re 284 MOTION to Stay Pending Completion of IPRs filed by Dexcom, Inc..Reply Brief due date per Local Rules is 1/17/2023. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Hoeschen, Nathan) (Entered: 01/10/2023)
2023-01-10
1
REDACTED VERSION of 304 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits A-F)(Raucci, Anthony) (Entered: 01/11/2023)
2023-01-11
1
REDACTED VERSION of 302 Letter - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 01/11/2023)
2023-01-11
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding DexCom's Answering Letter Brief in Opposition to the ADC Parties' Motion to Strike - re 303 MOTION to Strike Dexcom's Untimely Contention. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Hoeschen, Nathan) (Entered: 01/11/2023)
2023-01-11
1
RESPONSE to Motion re 306 MOTION to Dismiss, MOTION to Strike -- ADC Parties Renewed Motion To Dismiss Dexcom's First Counter-Counterclaim, and To Strike Dexcom's Second Affirmative Defense re 295 Answer to Counterclaim, (DexCom's Opposition) filed by Dexcom, Inc.. (Russell, Andrew) (Entered: 01/12/2023)
2023-01-12
1
REDACTED VERSION of 308 Letter by Dexcom, Inc.. (Russell, Andrew) (Entered: 01/13/2023)
2023-01-13
1
[SEALED] Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding Reply Letter Brief in Support of its Motion to Strike Dexcom's Untimely Contention. (Attachments: # 1 Ex. G, # 2 Ex. H, # 3 Ex. I, # 4 Ex. J)(Smith, Rodger) (Entered: 01/17/2023)
2023-01-17
1
Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding request for teleconference to address Motion to Strike - re 303 MOTION to Strike Dexcom's Untimely Contention. (Raucci, Anthony) (Entered: 01/18/2023)
2023-01-18
1
STIPULATION TO EXTEND TIME 1. for Abbott to file its Reply Brief in support of its Motion for a Continued Stay Pending Completion of IPRs (D.I. 284) and 2. for Dexcom to file its Reply Brief in support of its Motion to Dismiss under Rule 12(b)(6) (D.I. 293) to February 7, 2023 and February 28, 2023, respectively - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 01/18/2023)
2023-01-18
1
SO ORDERED
2023-01-18
1
No Actions
SO ORDERED, regarding D.I. 317 STIPULATION TO EXTEND TIME 1. for Abbott to file its Reply Brief in support of its Motion for a Continued Stay Pending Completion of IPRs (D.I. 284 ) and 2. for Dexcom to file its Reply Brief in support of its Motion to Dismiss under Rule 12(b)(6) (D.I filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Signed by Judge Kent A. Jordan on 1/18/2023. (apk)
2023-01-18
1
No Actions
STIPULATION TO EXTEND TIME for Dexcom, Inc. to file a public version of Dexcom's Answering Brief in Opposition to the ADC Parties' Motion to Strike (D.I. 312) to January 23, 2023 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 01/19/2023)
2023-01-19
1
ORDER, A discovery teleconference on Abbott's motion to strike(D.I. 303 ) is hereby scheduled for February 7, 2023, at 2:00 p.m. with the undersigned. Counsel for Abbott shall initiate the teleconference call. If there are out-of-state counsel working on this case, local counsel are reminded of their obligation to inform their out-of-state co-counsel of this order. (A Discovery Conference is set for 2/7/2023 at 02:00 PM in Telephonically before Judge Kent A. Jordan.) Signed by Judge Kent A. Jordan on 1/19/2023. (apk) (Entered: 01/19/2023)
2023-01-19
1
SO ORDERED
2023-01-19
1
No Actions
SO ORDERED, regarding D.I. 318 STIPULATION TO EXTEND TIME for Dexcom, Inc. to file a public version of Dexcom's Answering Brief in Opposition to the ADC Parties' Motion to Strike (D.I. 312) to January 23, 2023 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Signed by Judge Kent A. Jordan on 1/19/2023. (apk)
2023-01-19
1
No Actions
REDACTED VERSION of 312 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/23/2023)
2023-01-23
1
Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Abbotts' technology tutorial. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
NOTICE of filing the following Non-Paper material(s) in multi media format: DexCom, Inc.'s Technology Tutorial. Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Nathan Roger Hoeschen on behalf of Dexcom, Inc. (Hoeschen, Nathan) (Entered: 01/23/2023)
2023-01-23
1
MOTION for Summary Judgment that DexCom Breached the Parties Settlement and License Agreement and Against DexCom's Third Affirmative Defense - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] OPENING BRIEF in Support re 323 MOTION for Summary Judgment that DexCom Breached the Parties Settlement and License Agreement and Against DexCom's Third Affirmative Defense - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 2/6/2023. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 324 Opening Brief in Support, of Benjamin Lasky - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-9)(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] MOTION for Partial Summary Judgment, MOTION to Preclude Expert Opinions under Daubert - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order)(Hoeschen, Nathan) (Entered: 01/23/2023)
2023-01-23
1
MOTION to Preclude Opinions of Dr. Gall and Dr. Jafari Under Daubert - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] OPENING BRIEF in Support re 327 MOTION to Preclude Opinions of Dr. Gall and Dr. Jafari Under Daubert - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 2/6/2023. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 328 Opening Brief in Support, of Benjamin Lasky - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-17)(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
MOTION for Summary Judgment Against DexCom's Fourth and Eighth Affirmative Defenses - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] OPENING BRIEF in Support re 330 MOTION for Summary Judgment Against DexCom's Fourth and Eighth Affirmative Defenses - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 2/6/2023. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 331 Opening Brief in Support, of Benjamin Lasky - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-4)(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert (Declaration of Valerie Lozano) by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29)(Hoeschen, Nathan) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] OPENING BRIEF in Support re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert filed by Dexcom, Inc..Answering Brief/Response due date per Local Rules is 2/6/2023. (Hoeschen, Nathan) (Entered: 01/23/2023)
2023-01-23
1
MOTION for Summary Judgment that the "Subject Matter of a Patent or Patent Application" is not Limited to Only a Claim, as DexCom Argues, and Includes the Patent or Applications Disclosure - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] OPENING BRIEF in Support re 335 MOTION for Summary Judgment that the "Subject Matter of a Patent or Patent Application" is not Limited to Only a Claim, as DexCom Argues, and Includes the Patent or Applications Disclosure - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 2/6/2023. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 336 Opening Brief in Support, of Benjamin Lasky - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-24)(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
MOTION to Strike DexCom's Untimely Practicing Products Contentions and Expert Opinions - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] Letter to The Honorable Kent A. Jordan from Anthony D. Raucci - re 338 MOTION to Strike DexCom's Untimely Practicing Products Contentions and Expert Opinions. (Attachments: # 1 Exs. 1-12)(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
MOTION for Summary Judgment that DexCom Cannot Establish the "Nexus" Legally Required to Establish Secondary Considerations of Non-Obviousness - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] OPENING BRIEF in Support re 340 MOTION for Summary Judgment that DexCom Cannot Establish the "Nexus" Legally Required to Establish Secondary Considerations of Non-Obviousness - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 2/6/2023. (Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 341 Opening Brief in Support, of Benjamin Lasky (Volume 1 of 3) - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-12 (part 1), # 2 Exs. 12 (part 2)-15 (part 1), # 3 Ex. 15 (part 2))(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 341 Opening Brief in Support, of Benjamin Lasky (Volume 2 of 3) - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 16-18, # 2 Ex. 19 (part 1), # 3 Ex. 19 (part 2), # 4 Ex. 19 (part 3), # 5 Ex. 19 (part 4), # 6 Ex. 19 (Part 5))(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
[SEALED] DECLARATION re 341 Opening Brief in Support, of Benjamin Lasky (Volume 3 of 3) - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 20-22)(Raucci, Anthony) (Entered: 01/23/2023)
2023-01-23
1
- CORRECTING ENTRY
2023-01-23
1
No Actions
CORRECTING ENTRY: D.I. 321 "Plaintiffs" changed to Abbotts' per counsels' request. (vfm)
2023-01-23
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 293 MOTION to Dismiss for Failure to State a Claim - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 1/31/2023. (Raucci, Anthony) (Entered: 01/24/2023)
2023-01-24
1
STIPULATION TO EXTEND TIME for DexCom, Inc. to file its answering brief in opposition to the motion to strike (D.I. 338) and for Abbott to file its reply brief to February 8, 2023 and February 15, 2023, respectively - filed by Dexcom, Inc.. (Keller, Karen) (Entered: 01/26/2023)
2023-01-26
1
REDACTED VERSION of 315 Letter, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 01/26/2023)
2023-01-26
1
STIPULATION TO EXTEND TIME to file public versions of docket items 324, 325, 326, 328, 329, 331, 332, 333, 334, 336, 337, 339, 341, 342, 343, 344 and 345 to February 3, 2023 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/30/2023)
2023-01-30
1
REDACTED VERSION of 345 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 01/31/2023)
2023-01-31
1
SO ORDERED, re D.I. 348 STIPULATION TO EXTEND TIME to file public versions of docket items 324, 325, 326, 328, 329, 331, 332, 333, 334, 336, 337, 339, 341, 342, 343, 344 and 345 to February 3, 2023 filed by Dexcom, Inc. Ordered by Judge Kent A. Jordan on 02/01/2023. (smg) (Entered: 02/01/2023)
2023-02-01
1
SO ORDERED
2023-02-01
1
No Actions
[SEALED] AMENDED DOCUMENT by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. Amendment to 304 Letter (Corrected version of Exhibits A-F). (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 333 Declaration,,, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 334 Opening Brief in Support, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 324 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 325 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 328 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 329 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-17)(Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 331 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 332 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 336 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 337 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-24)(Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 341 Opening Brief in Support, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 342 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit 1 to Exhibit 12 (Part 1), # 2 Exhibit 12 (Part 2) to Exhibit 15 (Part 1), # 3 Exhibit 15 (Part 2))(Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 343 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 16-19)(Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
REDACTED VERSION of 344 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 20-22)(Raucci, Anthony) (Entered: 02/03/2023)
2023-02-03
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding DexCom's Answering Brief in Opposition to the Abbott Parties' Motion to Strike - re 338 MOTION to Strike DexCom's Untimely Practicing Products Contentions and Expert Opinions. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
REPLY BRIEF re 284 MOTION to Stay Pending Completion of IPRs - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Blumenfeld, Jack) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 340 MOTION for Summary Judgment that DexCom Cannot Establish the "Nexus" Legally Required to Establish Secondary Considerations of Non-Obviousness filed by Dexcom, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 369 Answering Brief in Opposition, (Declaration of Nathan Hamstra) by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50, # 51 Exhibit 51, # 52 Exhibit 52, # 53 Exhibit 53, # 54 Exhibit 54, # 55 Exhibit 55, # 56 Exhibit 56, # 57 Exhibit 57, # 58 Exhibit 58, # 59 Exhibit 59, # 60 Exhibit 60, # 61 Exhibit 61, # 62 Exhibit 62, # 63 Exhibit 63)(Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 330 MOTION for Summary Judgment Against DexCom's Fourth and Eighth Affirmative Defenses filed by Dexcom, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 371 Answering Brief in Opposition, [Declaration of Dallas Bullard in Support of DexCom's Opposition to Abbott's Motion for Summary Judgment on DexCom's Fourth and Eight Affirmative Defenses] by Dexcom, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 335 MOTION for Summary Judgment that the "Subject Matter of a Patent or Patent Application" is not Limited to Only a Claim, as DexCom Argues, and Includes the Patent or Applications Disclosure filed by Dexcom, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 373 Answering Brief in Opposition, (Declaration of Dallas Bullard) by Dexcom, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L)(Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] Letter to The Honorable Kent A. Jordan from Karen E. Keller regarding DexCom's Letter Correcting Error in D.I. 312 - re 312 Letter,. (Attachments: # 1 Exhibit 6, # 2 Exhibit 7)(Keller, Karen) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 323 MOTION for Summary Judgment that DexCom Breached the Parties Settlement and License Agreement and Against DexCom's Third Affirmative Defense filed by Dexcom, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 376 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-4)(Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 377 Answering Brief in Opposition, [Declaration of Valerie Lozano in Support of Dexcom's Opposition to Abbott's Motion for Summary Judgment that DexCom Breached the Parties Settlement and License Agreement and Against Dexcom's Third Affirmative Defense] by Dexcom, Inc.. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 327 MOTION to Preclude Opinions of Dr. Gall and Dr. Jafari Under Daubert filed by Dexcom, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert -- Answering Brief to Dexcom's Motion to Exclude Opinions of Abbott's Licensing Expert Eric E. Bensen filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 380 Answering Brief in Opposition [Declaration of Margaret Shyr in Support of DeCom's Opposition to Abbott's Motion to Exclude Opinions of Dr. Gall and Dr. Jafari Under Daubert] by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19)(Hoeschen, Nathan) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 381 Answering Brief in Opposition, -- Declaration of Benjamin Lasky in Support of Abbott's Answering Brief in Opposition to Dexcom's Motion To Exclude Opinions of Abbott's Licensing Expert Eric E. Bensen by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-3)(Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert -- Answering Brief to Dexcom's Motion for Summary Judgment on Contract Interpretation filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert -- Answering Brief in Opposition to Dexcom's Motion For Summary Judgment on Foreign Affiliates filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] ANSWERING BRIEF in Opposition re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert -- Answering Brief in Opposition to Dexcom's Motion for Summary Judgment of No Damages and Motion to Exclude Damages Expert Opinions Under Daubert filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 2/13/2023. (Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 384 Answering Brief in Opposition, -- Declaration of Benjamin Lasky in Support of Abbott's Answering Brief to Dexcom's Motion for Summary Judgment on Contract Interpretation by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-12, # 2 Exhibits 13-23)(Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 385 Answering Brief in Opposition, -- Declaration of Benjamin Lasky in Support of Abbott's Answering Brief in Opposition to Dexcom's Motion for Summary Judgment on Foreign Affiliates by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibits 5-14, # 5 Exhibits 15-24)(Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
[SEALED] DECLARATION re 386 Answering Brief in Opposition, -- Declaration of Benjamin Lasky in Support of Abbott's Answering Brief in Opposition to Dexcom's Motion for Summary Judgement of No Damages and Motion to Exclude Damages Expert Opinions Under Daubert by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-27)(Raucci, Anthony) (Entered: 02/06/2023)
2023-02-06
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Discovery Conference held on 2/7/2023. The Court heard arguments from both parties regarding motions to strike, D.I. 303 and D.I. 338, and the motion to stay pending IPR, D.I. 284 . The motions to strike are DENIED . The Court also DENIES the motion to stay pending IPR without prejudice to be filed at a later date. DexCom, Inc. and Abbott Diabetes Care, Inc. shall file letter briefs by February 17, 2023, presenting their stance on trying the license and infringement cases at one time along with the associated positives and negatives. The case continues to follow the Scheduling Order at D.I. 176 and shall stay consolidated with member case 21-1699. An appropriate Order shall be filed. (Court Reporter Brian Gaffigan.) (smg)
2023-02-07
1
No Actions
Discovery Conference
2023-02-07
1
No Actions
ORDER: The motions to strike, D.I. 303 and 338, are DENIED. The Court also DENIES the motion to stay pending IPR, D.I. 284 without prejudice to its being refiled at a later date. DexCom, Inc. and Abbott Diabetes Care, Inc. shall file letter briefs of no more than ten double-spaced pages (12 point type) by February 17, 2023, presenting their positions on the advisability of trying all issues in C.A. No. 21-1699 and C.A. No. 22-605 at one time. For the time being, the case continues to follow the current set Scheduling Order (D.I. 176 ). Signed by Judge Kent A. Jordan on 02/08/2023. (smg) (Entered: 02/08/2023)
2023-02-08
1
NOTICE requesting Clerk to remove Edward A. Mas II as co-counsel. Reason for request: no longer affiliated with case. (Smith, Rodger) (Entered: 02/09/2023)
2023-02-09
1
[SEALED] Letter to The Honorable Kent A. Jordan from Andrew E. Russell regarding amended Exhibit A to D.I. 372 - re 372 Declaration,. (Russell, Andrew) (Entered: 02/10/2023)
2023-02-10
1
REDACTED VERSION of 351 Amended Document (Corrected version of Exhibits A-F) by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/10/2023)
2023-02-10
1
STIPULATION TO EXTEND TIME to file public versions of docket items 339, 367, 369-389, and 392, as well as all sealed reply briefs and supporting papers to be filed on Monday, February 13, 2023 to February 24, 2023 - filed by Dexcom, Inc.. (Russell, Andrew) (Entered: 02/10/2023)
2023-02-10
1
Official Transcript of Telephone Conference held on 2/7/23 before Judge Jordan. Court Reporter/Transcriber Brian Gaffigan, Email: gaffigan.b@outlook.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 3/3/2023. Redacted Transcript Deadline set for 3/13/2023. Release of Transcript Restriction set for 5/11/2023. Associated Cases: 1:22-cv-00605-KAJ, 1:21-cv-01699-KAJ(RL) (Entered: 02/10/2023)
2023-02-10
1
SO ORDERED, re 394 STIPULATION TO EXTEND TIME to file public versions of docket items 339, 367, 369-389, and 392, as well as all sealed reply briefs and supporting papers to be filed on Monday, February 13, 2023 to February 24, 2023 filed by Dexcom, Inc. Ordered by Judge Kent A. Jordan on 02/10/2023. (smg) (Entered: 02/10/2023)
2023-02-10
1
SO ORDERED
2023-02-10
1
No Actions
[SEALED] REPLY BRIEF re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert [DexCom's Reply Brief in Support of DexCom's Motion for Summary Judgment of No Damages and DexCom's Motion to Exclude Mr. Gerardi's Opinions Under Daubert] filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] DECLARATION re 397 Reply Brief (Declaration of Jonathon Studer) by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] DECLARATION re 398 Reply Brief, [Reply Declaration of Valerie Lozano In Support of DexCom's Motion for Summary Judgment of No Damages and DexCom's Motion to Exclude Mr. Gerardi's Opinions Under Daubert] by Dexcom, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32)(Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert [DexCom's Reply Brief in Support of DexCom's Motion to Exclude Opinions of Eric Bensen Under Daubert] filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert (DexCom's Reply Brief in support of DexCom's Motion for Summary Judgment that DexCom did not breach the parties' settlement and license agreement) filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 326 MOTION for Partial Summary Judgment MOTION to Preclude Expert Opinions under Daubert [DexCom's Reply Brief In Support of DexCom's Motion for Summary Judgment on the Interpretation of the "Obvious Variant" Clause] filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 323 MOTION for Summary Judgment that DexCom Breached the Parties Settlement and License Agreement and Against DexCom's Third Affirmative Defense filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] DECLARATION re 404 Reply Brief, In Support of Its Motion for Summary Judgment That Dexcom Breached The Parties' Settlement and License Agreement and Against Dexcom's Third Affirmative Defense by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 10-11, # 2 Exhibits 12-14)(Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 330 MOTION for Summary Judgment Against DexCom's Fourth and Eighth Affirmative Defenses filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] DECLARATION re 406 Reply Brief In Support of Its Motion for Summary Judgment Against Dexcom's Fourth and Eighth Affirmative Defenses by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 5-7)(Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 327 MOTION to Preclude Opinions of Dr. Gall and Dr. Jafari Under Daubert filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] DECLARATION re 408 Reply Brief In Support of Its Motion to Exclude Opinions of Dr. Gall and Dr. Jafari Under Daubert by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 18-19)(Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 340 MOTION for Summary Judgment that DexCom Cannot Establish the "Nexus" Legally Required to Establish Secondary Considerations of Non-Obviousness filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] DECLARATION re 410 Reply Brief, In Support of Its Motion for Summary Judgment That Dexcom Cannot Establish The "Nexus" Legally Required to Establish Secondary Considerations of Non-Obviousness by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 23-26, # 2 Exhibits 27-28, # 3 Exhibits 29-30)(Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
[SEALED] REPLY BRIEF re 335 MOTION for Summary Judgment that the "Subject Matter of a Patent or Patent Application" is not Limited to Only a Claim, as DexCom Argues, and Includes the Patent or Applications Disclosure filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
Letter
2023-02-13
1
[SEALED] DECLARATION re 412 Reply Brief, In Support of Its Motion for Summary Judgment That The "Subject Matter of a Patent or Patent Application" Is Not Limited to Only a Claim, as Dexcom Argues, and Includes The Patent or Application's Disclosure by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 25-26)(Raucci, Anthony) (Entered: 02/13/2023)
2023-02-13
1
NOTICE requesting Clerk to remove Jon R. Carter as co-counsel. Reason for request: no longer with firm. (Raucci, Anthony) (Entered: 02/14/2023)
2023-02-14
1
CORRECTING ENTRY: D.I. 413 previously deleted. Document was filed in the incorrect civil action. (apk)
2023-02-14
1
No Actions
- CORRECTING ENTRY
2023-02-14
1
No Actions
[SEALED] Letter to The Honorable Kent A. Jordan from John W. Shaw regarding DexCom's Submission Regarding Case Schedule - re 390 Order,,, Terminate Motions,,, Set Deadlines,,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Shaw, John) (Entered: 02/17/2023)
2023-02-17
1
[SEALED] Letter to the Court from Anthony D. Raucci regarding Whether the Stay of Dexcom's Infringement Action Should Remain In Place. (Attachments: # 1 Exhibits A-J)(Raucci, Anthony) (Entered: 02/17/2023)
2023-02-17
1
REDACTED VERSION of 339 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-12)(Raucci, Anthony) (Entered: 02/22/2023)
2023-02-22
1
REDACTED VERSION of 392 Letter by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 379 Declaration, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 382 Declaration,, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 370 Declaration,,,,, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 367 Letter,, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 373 Answering Brief in Opposition, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 380 Answering Brief in Opposition by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 397 Reply Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 369 Answering Brief in Opposition, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 398 Reply Brief, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
Joint STIPULATION TO EXTEND TIME to file public versions of docket items 416 and 417 to March 3, 2023 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 371 Answering Brief in Opposition, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 376 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 378 Declaration by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 403 Reply Brief, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 381 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 383 Declaration, --Declaration of Benjamin Lasky-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 372 Declaration, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 384 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 385 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 374 Declaration, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 386 Answering Brief in Opposition, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 375 Letter by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 387 Declaration, --Declaration of Benjamin Lasky in Support of Abbott's Answering Brief to Dexcom's Motion for Summary Judgment on Contract Interpretation-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 388 Declaration, --Declaration of Benjamin Lasky in Support of Abbott's Answering Brief in Opposition to Dexcom's Motion for Summary Judgment on Foreign Affiliates-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 389 Declaration, --Declaration of Benjamin Lasky in Support of Abbott's Answering Brief in Opposition to Dexcom's Motion for Summary Judgement of No Damages and Motion to Exclude Damage s Expert Opinions Under Daubert-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 377 Answering Brief in Opposition, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 404 Reply Brief, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 405 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 406 Reply Brief by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 399 Declaration by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 407 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 408 Reply Brief by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 400 Declaration, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 409 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 410 Reply Brief, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 401 Reply Brief, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 412 Reply Brief, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 402 Reply Brief, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 414 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
REDACTED VERSION of 411 Declaration, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 23-25, # 2 Exhibits 26-28, # 3 Exhibits 29-30)(Raucci, Anthony) (Entered: 02/24/2023)
2023-02-24
1
[SEALED] REPLY BRIEF re 293 MOTION to Dismiss for Failure to State a Claim filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/28/2023)
2023-02-28
1
NOTICE OF SERVICE of (1) ADC Parties' First Set of Requests For Admission To Dexcom, Inc. (Nos. 1-98), (2) ADC Parties' Fourth Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 256-275) and (3) ADC Parties' Third Set of Interrogatories to Dexcom (Nos. 24-32) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 03/01/2023)
2023-03-01
1
REDACTED VERSION of 417 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits A-J)(Raucci, Anthony) (Entered: 03/03/2023)
2023-03-03
1
REDACTED VERSION of 416 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 03/03/2023)
2023-03-03
1
REDACTED VERSION of 460 Reply Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 03/07/2023)
2023-03-07
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephonic Status Conference held on 3/7/2023. Counsel present for Plaintiff: John W. Shaw, Brian P. Biddinger, David L. Bilsker, Nathan Hamstra, Valerie A Lozano, Dallas Ballard. Counsel present for Defendant: Amanda Hollis, Rodger Dallery Smith, II, Jack B. Blumenfeld, Benjamin A. Lasky. (Court Reporter: Bonnie Archer). (twk)
2023-03-07
1
No Actions
Status Conference
2023-03-07
1
No Actions
Official Transcript of teleconference held on March 7, 2023 before Judge Kent A. Jordan. Court Reporter/Transcriber Bonnie Archer,Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/29/2023. Redacted Transcript Deadline set for 4/10/2023. Release of Transcript Restriction set for 6/6/2023. (Archer, Bonnie) (Entered: 03/08/2023)
2023-03-08
1
[SEALED] Letter to The Honorable Kent A. Jordan from John W. Shaw regarding DexCom's Letter Submission in Response to the Court's Questions Raised at the March 7, 2023 Hearing. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Shaw, John) (Entered: 03/17/2023)
2023-03-17
1
[SEALED] Letter to The Honorable Kent A. Jordan from Jack B. Blumenfeld regarding the Court's Questions from the March 7, 2023 Hearing. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Blumenfeld, Jack) (Entered: 03/17/2023)
2023-03-17
1
Joint Letter to The Honorable Kent A. Jordan regarding Interim Status Report. (Raucci, Anthony) (Entered: 03/23/2023)
2023-03-23
1
REDACTED VERSION of 467 Letter - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 1, # 2 Ex. 2)(Raucci, Anthony) (Entered: 03/24/2023)
2023-03-24
1
REDACTED VERSION of 466 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 03/24/2023)
2023-03-24
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding Response to Abbott's Submission in Response to the Court's Questions Raised at the March 7th, 2023 Hearing. (Hoeschen, Nathan) (Entered: 03/24/2023)
2023-03-24
1
[SEALED] Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding response to DexCom's March 17, 2023 letter brief addressing the questions the Court raised during the March 7, 2023 hearing - re 466 Letter,. (Smith, Rodger) (Entered: 03/24/2023)
2023-03-24
1
[SEALED] MOTION to Seal Courtroom for Portions of the March 30, 2023 Hearing - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 03/29/2023)
2023-03-29
1
[SEALED] DECLARATION re 473 MOTION to Seal Courtroom for Portions of the March 30, 2023 Hearing -- Declaration of Jason Pederson -- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 03/29/2023)
2023-03-29
1
REDACTED VERSION of 473 MOTION to Seal Courtroom for Portions of the March 30, 2023 Hearing - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 03/29/2023)
2023-03-29
1
REDACTED VERSION of 474 Declaration - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 03/29/2023)
2023-03-29
1
Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding DexCom's Motion to Exclude Bensen's Testimony Under Daubert. (Hoeschen, Nathan) (Entered: 03/29/2023)
2023-03-29
1
Minute Entry for an Oral Argument held before Judge Kent A. Jordan - Oral Argument held on 3/30/2023. (Court Reporter Brian Gaffigan.) (apk)
2023-03-30
1
No Actions
Oral Argument
2023-03-30
1
No Actions
REDACTED VERSION of 472 Letter, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 03/31/2023)
2023-03-31
1
REDACTED VERSION of 471 Letter by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 03/31/2023)
2023-03-31
1
NOTICE OF SERVICE of 1. DexCom's Responses and Objections to ADC Parties' First Set of Requests for Admissions to DexCom, Inc. (Nos. 1-98) 2. DexCom's Responses and Objections to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Fourth Set of the Requests for Production of Documents (Nos. 256-275) 3. DexCom, Inc.'s Objections and Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Third Set of Interrogatories (Nos. 24-32) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/11/2023)
2023-04-11
1
Official Transcript of Oral Argument held on 03/30/2023 before Judge Kent A. Jordan. Court Reporter/Transcriber Brian Gaffigan,Email: gaffigan.b@outlook.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 5/2/2023. Redacted Transcript Deadline set for 5/12/2023. Release of Transcript Restriction set for 7/10/2023. (smg) (Entered: 04/11/2023)
2023-04-11
1
MEMORANDUM OPINION. Signed by Judge Kent A. Jordan on 04/12/2023.This Memorandum Opinion has been emailed to local counsel. (apk)
2023-04-12
1
ORDER, Abbott's Motion (D.I. 323 ) for Summary Judgment that DexCom Breached the Parties' Settlement and License Agreement and Against DexCom's Third Affirmative Defense is GRANTED-IN-PART and DENIED-IN-PART. Abbott's Motion (D.I. 330 ) for Summary Judgment Against DexCom's Fourth and Eighth Affirmative Defenses is DENIED-IN-PART AS MOOT. Abbott's Motion (D.I. 330 ) for Summary Judgment Against DexCom's Fourth and Eighth Affirmative Defenses is GRANTED-IN-PART insofar as Abbott argues for summary judgment on DexCom's Fourth Affirmative Defense of unclean hands. Abbott's Motion (D.I. 330 ) for Summary Judgment Against DexCom's Fourth and Eighth Affirmative is DENIED-IN-PART AS MOOT insofar as Abbott argues for summary judgment on DexCom's Eighth Affirmative Defense of unilateral mistake. Signed by Judge Kent A. Jordan on 04/12/2023.This order has been emailed to local counsel. (apk) (Entered: 04/12/2023)
2023-04-12
1
ORDER, D.I. 326 is GRANTED-IN-PART insofar as the "obvious variant" clause in paragraph A.13(c) of the Settlement and License Agreement ("SLA") invokes an obviousness-type double patenting analysis. DENIED-IN-PART insofar as DexCom argues to exclude the opinion of Mr. Gerardi under Daubert. DENIED-IN-PART AS MOOT insofar as DexCom argues to exclude the opinion of Mr. Bensen under Daubert. DENIED-IN-PART AS MOOT insofar as DexCom argues that the analysis in paragraph A.13(c) of the SLA must be conducted as of January 1, 2005. DENIED-IN-PART AS MOOT insofar as DexCom argues that the "Obvious Variant" clause requires a comparison to a single patent or patent application captured by paragraph A.13(a) of the SLA. Signed by Judge Kent A. Jordan on 04/12/2023.This order has been emailed to local counsel. (apk) (Entered: 04/12/2023)
2023-04-12
1
ORDER, DexCom's Motion (D.I. 293 ) to Dismiss Under Rule 12(b)(6) is DENIED. Abbott's Motion (D.I. 327 ) to Exclude Opinions of Dr. Gall and Dr. Jafari Under Daubert is DENIED AS MOOT. Abbott's Motion (D.I. 335 ) for Summary Judgment that the "Subject Matter" of a Patent of Patent Application" is Not Limited to Only a Claim, as DexCom Argues and Includes the Patent or Application's Disclosure is DENIED AS MOOT. Abbott's Motion (D.I. 340 ) for Summary Judgment that DexCom Cannot Establish the "Nexus" Legally Required to Establish Secondary Considerations of Non-Obviousness is DENIED AS MOOT. Abbott's Motion (D.I. 473 ) to Seal Courtroom for Portions of the March 30, 2023 Hearing is DENIED. Signed by Judge Kent A. Jordan on 04/12/2023. (apk) (Entered: 04/12/2023)
2023-04-12
1
ORDER, Abbott's Motion to Dismiss DexCom's First Counter-Counterclaim, and to Strike DexCom's Second Affirmative Defense (D.I. 195 ) in Civil Action No. 22-605 (KAJ) is DENIED AS MOOT. Abbott's Renewed Motion to Dismiss DexCom's First Counter-Counterclaim, and to Strike DexCom's Second Affirmative Defense (D.I. 306 ) in Civil Action No. 22-605 (KAJ) is DENIED and DexCom's Motion for Preliminary Injunction (D.I. 204 ) in Civil Action No. 21-1699 (KAJ) is DENIED. Signed by Judge Kent A. Jordan on 04/12/2023. (apk) (Entered: 04/12/2023)
2023-04-12
1
ORDER, Counsel shall provide the Court with proposed redactions to these documents on or before the close of business on April 19, 2023. After that time the Court will unseal the documents, with any redactions deemed appropriate by the Court. (Notice of Compliance deadline set for 4/19/2023) Signed by Judge Kent A. Jordan on 04/12/2023. (apk) (Entered: 04/12/2023)
2023-04-12
1
[SEALED] ANSWER to Complaint with Jury Demand [Plaintiff DexCom, Inc.'s Answer and Affirmative Defenses to Defendants' Amended Counterclaims], Counter COUNTERCLAIM against Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/13/2023)
2023-04-13
1
Joint Letter to The Honorable Kent A. Jordan regarding Response to the Court's April 12, 2023 Order - re 487 Order,, Set Deadlines,. (Raucci, Anthony) (Entered: 04/19/2023)
2023-04-19
1
NOTICE OF INTERLOCUTORY APPEAL of 482 Memorandum Opinion, 486 Order. Appeal filed by Dexcom, Inc. (Shaw, John) (Entered: 04/20/2023)
2023-04-20
1
NOTICE OF SERVICE of ADC Parties' First Set of Requests for Admission to Dexcom, Inc. (Nos. 1-13) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 04/20/2023)
2023-04-20
1
REDACTED VERSION of 488 Answer to Complaint,, Counterclaim, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 04/20/2023)
2023-04-20
1
ORDER, In accordance with the Court's April 12, 2023 Order (D.I. 487 ), the Clerk's Office is hereby directed to unseal the Memorandum Opinion and orders of April 12, 2023 (D.I. 482, 483, and 484 ). Signed by Judge Kent A. Jordan on 4/20/2023. (twk) (Entered: 04/20/2023)
2023-04-20
1
APPEAL - Credit Card Payment received re 490 Notice of Interlocutory Appeal (Federal Circuit) filed by Dexcom, Inc.. ( Filing fee $505, receipt number ADEDC-4117247.) (Shaw, John)
2023-04-20
1
No Actions
Notification regarding 490 Notice of Interlocutory Appeal (Federal Circuit) sent to Reporter Rolfe (smg)
2023-04-20
1
No Actions
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 490 Notice of Interlocutory Appeal (Federal Circuit). (smg)
2023-04-20
1
No Actions
Notification regarding 490 Notice of Interlocutory Appeal (Federal Circuit) sent to Reporter Archer (smg)
2023-04-20
1
No Actions
- APPEAL - Credit Card Payment (Attorneys Only)
2023-04-20
1
No Actions
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 490 Notice of Interlocutory Appeal (Federal Circuit) filed by Dexcom, Inc. USCA Case Number 23-1796. (smg) (Entered: 04/26/2023)
2023-04-26
1
[SEALED] MOTION for Reconsideration re 484 Order, 483 Order, MOTION for Reargument re 484 Order, 483 Order - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 04/26/2023)
2023-04-26
1
USCA Appeal Record Sent to Reporter Archer
2023-04-26
1
No Actions
USCA Appeal Record Sent to Reporter Rolfe
2023-04-26
1
No Actions
USCA Notice of Appeal and Docket Transmitted
2023-04-26
1
No Actions
NOTICE requesting Clerk to remove Dallas Bullard as co-counsel.. (Shaw, John) (Entered: 04/27/2023)
2023-04-27
1
NOTICE OF SERVICE of DexCom's Responses and Objections to ADC Parties' First Set of Requests for Admissions to DexCom, Inc. (Nos. 1-13) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/28/2023)
2023-04-28
1
REDACTED VERSION of 495 MOTION for Reconsideration re 484 Order,,,, Terminate Motions,,, 483 Order,,,, Terminate Motions,,, MOTION for Reargument re 484 Order,,,, Terminate Motions,,, 483 Order,,,, Terminate Motions,,, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 05/03/2023)
2023-05-03
1
ANSWER to 488 Answer to Complaint,, Counterclaim, -- ADC Inc.'s Answer to Dexcom's Counter-Counterclaim -- by Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/04/2023)
2023-05-04
1
TRANSCRIPT REQUEST by Dexcom, Inc. for proceedings held on 12/20/22 & 3/30/23 before Judge Kent A. Jordan, (Shaw, John) (Entered: 05/04/2023)
2023-05-04
1
Joint STIPULATION TO EXTEND TIME for the parties to file a Final Pretrial Order to May 10, 2023 - filed by Dexcom, Inc.. (DiBenedetto, Emily) (Entered: 05/08/2023)
2023-05-08
1
SO ORDERED, regarding D.I. 501 Joint STIPULATION TO EXTEND TIME for the parties to file a Final Pretrial (Proposed Pretrial Order due by 5/10/2023.) Signed by Judge Kent A. Jordan on 5/8/2023. (apk) (Entered: 05/08/2023)
2023-05-08
1
SO ORDERED AND ~Util - Set Deadlines
2023-05-08
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 495 MOTION for Reconsideration re 484 Order,,,, Terminate Motions,,, 483 Order,,,, Terminate Motions,,, MOTION for Reargument re 484 Order,,,, Terminate Motions,,, 483 Order,,,, Terminate Motions,,, filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 5/17/2023. (Smith, Rodger) (Entered: 05/10/2023)
2023-05-10
1
[SEALED] Proposed Pretrial Order by Dexcom, Inc.. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2D, # 3 Exhibit - 2P, # 4 Exhibit - 3D, # 5 Exhibit - 3P, # 6 Exhibit - 4, # 7 Exhibit - 5D, # 8 Exhibit - 5P, # 9 Exhibit - 6D, # 10 Exhibit - 6P, # 11 Exhibit - 7D, # 12 Exhibit - 7P, # 13 Exhibit - 8D, # 14 Exhibit - 8P Vol 1, # 15 Exhibit - 8P Vol. 2, # 16 Exhibit - 8P Vol. 3, # 17 Exhibit - 9)(Hoeschen, Nathan) (Entered: 05/10/2023)
2023-05-10
1
Remark: Pretrial Conference set for 06/08/2023 to be held in Courtroom 4A. (smg)
2023-05-11
1
No Actions
Remark
2023-05-11
1
No Actions
STIPULATION TO EXTEND TIME to submit a redacted version of the Proposed Final Pretrial Order to May 24, 2023 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 05/17/2023)
2023-05-17
1
SO ORDERED, regarding D.I. 505 STIPULATION TO EXTEND TIME to submit a redacted version of the Proposed Final Pretrial Order to May 24, 2023 (Proposed Pretrial Order due by 5/24/2023.) Signed by Judge Kent A. Jordan on 5/17/2023. (apk) (Entered: 05/17/2023)
2023-05-17
1
1 - Terminate Deadlines AND SO ORDERED AND ~Util - Set Deadlines
2023-05-17
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Trevor J. Quist and Sara L. Pollock - filed by Dexcom, Inc.. (Keller, Karen) (Entered: 05/22/2023)
2023-05-22
1
ORDER, A teleconference has been scheduled for May 31, 2023 at 2:00 p.m. with the undersigned. Counsel for Abbott Diabetes Care Inc., shall initiate theteleconference call. If there are out-of-state counsel working on this case, local counsel are reminded of their obligation to inform their out-of-state co-counsel of this order (A Telephone Conference is set for 5/31/2023 at 02:00 PM in Telephonically before Judge Kent A. Jordan). Signed by Judge Kent A. Jordan on 5/23/2023. (apk) (Entered: 05/23/2023)
2023-05-23
1
Pro Hac Vice Attorney Sara L. Pollock and Trevor J. Quist for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
2023-05-23
1
No Actions
SO ORDERED, regarding D.I. 507 MOTION for Pro Hac Vice Appearance of Attorney Trevor J. Quist and Sara L. Pollock. Signed by Judge Kent A. Jordan on 5/23/2023. (apk)
2023-05-23
1
No Actions
Add Attorneys - PHV only
2023-05-23
1
No Actions
SO ORDERED
2023-05-23
1
No Actions
STIPULATION TO EXTEND TIME to submit a redacted version of the Proposed Final Pretrial Order (D.I. 504) to May 25, 2023 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 05/24/2023)
2023-05-24
1
REDACTED VERSION of 504 Proposed Pretrial Order, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 05/25/2023)
2023-05-25
1
SO ORDERED, regarding D.I. 509 STIPULATION TO EXTEND TIME to submit a redacted version of the Proposed Final Pretrial Order (D.I. 504) through May 25, 2023 (Proposed Pretrial Order due by 5/25/2023.) Signed by Judge Kent A. Jordan on 5/26/2023. (apk)
2023-05-26
1
No Actions
SO ORDERED AND ~Util - Set Deadlines
2023-05-26
1
No Actions
Letter to The Honorable Kent A. Jordan from John W. Shaw regarding DexCom's Second Affirmative Defense of unclean hands. (Shaw, John) (Entered: 05/31/2023)
2023-05-31
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephone Conference held on 5/31/2023. Counsel may refer to the official transcript for confirmation of deadlines set during the hearing. (Court Reporter: Carrie Gold, Veritext). (twk)
2023-05-31
1
No Actions
Telephone Conference
2023-05-31
1
No Actions
Official Transcript of Oral A held on 5/31/2023 before Judge Kent A. Jordan. Court Reporter/Transcriber Veritext Legal Solutions. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 6/22/2023. Redacted Transcript Deadline set for 7/3/2023. Release of Transcript Restriction set for 8/30/2023. (apk) (Entered: 06/01/2023)
2023-06-01
1
[SEALED] REPLY BRIEF [DexCom's Reply Briefing in Support of its Motion in Limine No. 1] filed by Dexcom, Inc.. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 06/05/2023)
2023-06-05
1
[SEALED] REPLY BRIEF [DexCom's Reply Briefing in Support of its Motion in Limine No. 2] filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/05/2023)
2023-06-05
1
Proposed Voir Dire by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 06/05/2023)
2023-06-05
1
VERDICT SHEET by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. . (Smith, Rodger) (Entered: 06/05/2023)
2023-06-05
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding joint proposed juror questionnaire. (Attachments: # 1 Juror Questionnaire)(Smith, Rodger) (Entered: 06/05/2023)
2023-06-05
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding joint proposed juror questionnaire. (Attachments: # 1 Juror Questionnaire)(Smith, Rodger) (Entered: 06/05/2023)
2023-06-05
2
Proposed Jury Instructions by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. -- Joint Proposed Preliminary Jury Instructions --. (Smith, Rodger) (Main Document 518 replaced on 6/6/2023 per request of counsel) (nmg). (Entered: 06/05/2023)
2023-06-05
1
Proposed Jury Instructions by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. -- Joint Proposed Final Jury Instructions --. (Smith, Rodger) (Entered: 06/05/2023)
2023-06-05
1
[SEALED] REPLY BRIEF in Further Support of its Motions in Limine Nos. 1 and 2 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 29, # 2 Ex. 30, # 3 Ex. 31, # 4 Ex. 32)(Smith, Rodger) (Entered: 06/05/2023)
2023-06-05
1
Joint STIPULATION and [Proposed] Order for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 06/07/2023)
2023-06-07
1
SO ORDERED, re D.I. 521 Joint STIPULATION and [Proposed] Order for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices. Signed by Judge Kent A. Jordan on 06/07/2023. (smg) (Entered: 06/07/2023)
2023-06-07
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Final Pretrial Conference held on 6/8/2023. (Court Reporter: Heather Triozzi). (mpb)
2023-06-08
1
No Actions
Pretrial Conference
2023-06-08
1
No Actions
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding Abbott's Motion in Limine No. 1. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Hoeschen, Nathan) (Entered: 06/12/2023)
2023-06-12
1
[SEALED] MOTION for Reconsideration and Reargument of the Court's May 31, 2023 Oral Decision Under D. Del. LR 7.1.5 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-3)(Raucci, Anthony) (Entered: 06/12/2023)
2023-06-12
1
REDACTED VERSION of 513 Reply Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/13/2023)
2023-06-13
1
REDACTED VERSION of 514 Reply Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/13/2023)
2023-06-13
1
[SEALED] Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding DexCom's June 12, 2023 Letter - re 523 Letter,. (Attachments: # 1 Exs. 1-8)(Smith, Rodger) (Entered: 06/13/2023)
2023-06-13
1
REDACTED VERSION of 520 Reply Brief - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 29-32)(Raucci, Anthony) (Entered: 06/14/2023)
2023-06-14
1
STIPULATION TO EXTEND TIME for the parties to file public versions of D.I. 523, 524, and 527 to June 23, 2023 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 06/20/2023)
2023-06-20
1
SO ORDERED, re 529 STIPULATION TO EXTEND TIME for the parties to file public versions of D.I. 523, 524, and 527 to June 23, 2023 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Ordered by Judge Kent A. Jordan on 06/21/2023. (smg) (Entered: 06/21/2023)
2023-06-21
1
SO ORDERED
2023-06-21
1
No Actions
[SEALED] MOTION to Permit Live Remote Trial Testimony from Dr. John Smith - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 1)(Raucci, Anthony) (Entered: 06/22/2023)
2023-06-22
1
REDACTED VERSION of 524 MOTION for Reconsideration and Reargument of the Court's May 31, 2023 Oral Decision Under D. Del. LR 7.1.5 by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 06/23/2023)
2023-06-23
1
REDACTED VERSION of 527 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exs. 1-8)(Raucci, Anthony) (Entered: 06/23/2023)
2023-06-23
1
REDACTED VERSION of 523 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/23/2023)
2023-06-23
1
SO ORDERED, re 531 MOTION to Permit Live Remote Trial Testimony from Dr. John Smith. Ordered by Judge Kent A. Jordan on 6/26/2023. (twk) (Entered: 06/26/2023)
2023-06-26
1
ANSWERING BRIEF in Opposition re 524 MOTION for Reconsideration and Reargument of the Court's May 31, 2023 Oral Decision Under D. Del. LR 7.1.5 filed by Dexcom, Inc..Reply Brief due date per Local Rules is 7/3/2023. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 06/26/2023)
2023-06-26
1
SO ORDERED
2023-06-26
1
No Actions
STIPULATION Regarding Claim Narrowing - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 06/27/2023)
2023-06-27
1
SO ORDERED, re 537 STIPULATION Regarding Claim Narrowing. Ordered by Judge Kent A. Jordan on 6/29/2023. (twk) (Entered: 06/29/2023)
2023-06-29
1
SO ORDERED
2023-06-29
1
No Actions
REDACTED VERSION of 531 MOTION to Permit Live Remote Trial Testimony from Dr. John Smith by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 1)(Raucci, Anthony) (Entered: 07/05/2023)
2023-07-05
1
STIPULATION regarding covenant and SLA - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 07/06/2023)
2023-07-06
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding the parties revised versions of the proposed Voir Dire, Preliminary Jury Instructions and Verdict Form. (Attachments: # 1 Proposed Voir Dire, # 2 Proposed Preliminary Jury Instructions, # 3 Proposed Verdict Form)(Smith, Rodger) (Entered: 07/06/2023)
2023-07-06
1
ORDER, Counsel shall provide the Court with proposed redactions to those documents, and the reasons therefore, on of before the close of business on July 7, 2023. After that time the Court will unseal the orders, setting forth the ruling, with any redactions deemed appropriate by the Court. (Notice of Compliance deadline set for 7/7/2023). Signed by Judge Kent A. Jordan on 7/6/2023. (apk) (Entered: 07/06/2023)
2023-07-06
1
ORDER denying D.I. 524 Motion for Reconsideration. Signed by Judge Kent A. Jordan on 7/6/2023.This order has been emailed to local counsel. (apk) Security modified on 7/14/2023 per D.I. 560 Order (smg). (Entered: 07/06/2023)
2023-07-06
1
ORDER regarding D.I. 504 and accompanying Motions in Limine. Signed by Judge Kent A. Jordan on 7/6/2023.This order has been emailed to local counsel. (apk) Security modified on 7/14/2023 per D.I. 560 Order(smg). (Entered: 07/06/2023)
2023-07-06
1
Joint STIPULATION and [Proposed] Order for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 07/06/2023)
2023-07-06
1
Remark: The Jury Trial scheduled to begin July 10, 2023, will be held in Courtroom 2A. (smg)
2023-07-06
1
No Actions
Remark
2023-07-06
1
No Actions
STIPULATION AND ORDER regarding D.I. 545 . Signed by Judge Kent A. Jordan on 7/7/2023. (apk) (Entered: 07/07/2023)
2023-07-07
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding deposition designations - re 504 Proposed Pretrial Order,. (Attachments: # 1 Ex. A, # 2 Ex. B)(Smith, Rodger) (Entered: 07/09/2023)
2023-07-09
1
[SEALED] MOTION to Preclude Testimony of Shannon Hansen - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(Hoeschen, Nathan) (Entered: 07/09/2023)
2023-07-09
1
[SEALED] ANSWERING BRIEF in Opposition re 548 MOTION to Preclude Testimony of Shannon Hansen - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 7/17/2023. (Attachments: # 1 Exhibit 1)(Smith, Rodger) (Entered: 07/10/2023)
2023-07-10
1
PRELIMINARY Jury Instructions read to jury panel on 7/10/2023.(twk) (Entered: 07/11/2023)
2023-07-10
1
VOIR DIRE QUESTIONS propounded to jury pool on 7/10/2023.(twk) (Entered: 07/11/2023)
2023-07-10
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Jury Trial held on 7/10/2023. (Court Reporter: Deanna Warner). (twk)
2023-07-10
1
No Actions
STATEMENT -- Abbott's Bench Memorandum in Support of Trying Implied License to the Jury -- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 07/11/2023)
2023-07-11
1
Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding implied license. (Hoeschen, Nathan) (Entered: 07/11/2023)
2023-07-11
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Jury Trial - Day 1 held on 7/11/2023. (Court Reporter: Deanna Warner). (twk)
2023-07-11
1
No Actions
Jury Trial - Held
2023-07-11
1
No Actions
Jury Trial - Begun
2023-07-11
1
No Actions
[SEALED] Letter to Hon. Kent A. Jordan from Nathan R. Hoeschen regarding Deposition Designations. (Attachments: # 1 Exhibit Cate Deposition Trasncript)(Hoeschen, Nathan) (Entered: 07/12/2023)
2023-07-12
1
Proposed Jury Instructions by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. --[Joint Proposed] Final Jury Instructions--. (Raucci, Anthony) (Entered: 07/12/2023)
2023-07-12
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding revised versions of the Final Jury Instructions and Verdict Form. (Attachments: # 1 Proposed Final Jury Instructions, # 2 Proposed Verdict Form)(Smith, Rodger) (Entered: 07/12/2023)
2023-07-12
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Jury Trial - Day 2 held on 7/12/2023. (Court Reporter: Deanna Warner). (apk)
2023-07-12
1
No Actions
MOTION for Judgment as a Matter of Law - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 07/13/2023)
2023-07-13
1
OPENING BRIEF in Support re 557 MOTION for Judgment as a Matter of Law - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 7/27/2023. (Raucci, Anthony) (Entered: 07/13/2023)
2023-07-13
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Jury Trial - Day 2 held on 7/12/2023. (Court Reporter: Deanna Warner). (apk)
2023-07-13
1
No Actions
Jury Trial - Held
2023-07-13
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Jury Trial - Day 3 held on 7/13/2023. (Court Reporter: Deanna Warner) (apk)
2023-07-13
1
No Actions
ORDER: The Clerk's Office for the District Court of Delaware be and hereby is directed to furnish lunch for nine jurors engaged in the above-entitled case for Friday July 14, 2023. Signed by Judge Kent A. Jordan on 7/14/2023. (apk) (Entered: 07/14/2023)
2023-07-14
1
ORDER: In accordance with the Court's July 6, 2023 Order (D.I. 542 ), the Clerk's Office is hereby directed to unseal the orders of July 6, 2023 (D.I. 543 and 544 ). Signed by Judge Kent A. Jordan on 07/14/2023. (smg) (Entered: 07/14/2023)
2023-07-14
1
Final Jury Instructions (Read in Open Court) (apk) (Entered: 07/14/2023)
2023-07-14
1
[SEALED] JURY VERDICT. (apk) (Entered: 07/14/2023)
2023-07-14
1
JURY VERDICT. (apk) (Entered: 07/14/2023)
2023-07-14
1
Jury Trial - Held
2023-07-14
1
No Actions
Jury Trial - Completed
2023-07-14
1
No Actions
Minute Entry for the Final Day of a Jury Trial held before Judge Kent A. Jordan - Jury Trial completed on 7/14/2023. (Court Reporter Deana Warner.) (apk)
2023-07-14
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Jury Trial - Day 3 held on 7/13/2023. (Court Reporter: Deanna Warner) (apk)
2023-07-14
1
No Actions
STIPULATION TO EXTEND TIME to submit a redacted version of DexCom's Motion to Preclude the Testimony of Shannon Hansen (D.I. 548) to July 21, 2023 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 07/17/2023)
2023-07-17
1
SO ORDERED, re 564 STIPULATION TO EXTEND TIME to submit a redacted version of DexCom's Motion to Preclude the Testimony of Shannon Hansen (D.I. 548 ) to July 21, 2023. Signed by Judge Kent A. Jordan on 7/18/2023. (twk) (Entered: 07/18/2023)
2023-07-18
1
SO ORDERED
2023-07-18
1
No Actions
STIPULATION TO EXTEND TIME to submit a redacted version of DexCom's Letter (D.I. 554) to July 21, 2023 - filed by Dexcom, Inc.. (Keller, Karen) (Entered: 07/19/2023)
2023-07-19
1
SO ORDERED, re 566 STIPULATION TO EXTEND TIME to submit a redacted version of DexCom's Letter (D.I. 554 ) to July 21, 2023. Ordered by Judge Kent A. Jordan on 7/20/2023. (twk) (Entered: 07/20/2023)
2023-07-20
1
SO ORDERED
2023-07-20
1
No Actions
REDACTED VERSION of 548 MOTION to Preclude Testimony of Shannon Hansen by Dexcom, Inc.. (Keller, Karen) (Entered: 07/21/2023)
2023-07-21
1
REDACTED VERSION of 554 Letter by Dexcom, Inc.. (Keller, Karen) (Entered: 07/21/2023)
2023-07-21
1
STIPULATION TO EXTEND TIME for the parties to submit their positions on a schedule for post-trial briefing to August 2, 2023 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 07/28/2023)
2023-07-28
1
SO ORDERED, re D.I. 570 STIPULATION TO EXTEND TIME for the parties to submit their positions on a schedule for post-trial briefing to August 2, 2023. Ordered by Judge Kent A. Jordan on 07/31/2023. (smg) (Entered: 07/31/2023)
2023-07-31
1
SO ORDERED AND ~Util - Set Deadlines
2023-07-31
1
No Actions
- CORRECTING ENTRY
2023-08-01
1
No Actions
CORRECTING ENTRY: D.I. 547 has been placed under seal as it contains information within the Protective Order. (vfm)
2023-08-01
1
No Actions
Letter to The Honorable Kent A. Jordan from Andrew E. Russell regarding post-trial briefing. (Russell, Andrew) (Entered: 08/02/2023)
2023-08-02
1
Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding Abbott's Submission on Post-Trial Briefing Schedule. (Smith, Rodger) (Entered: 08/03/2023)
2023-08-03
1
Letter to The Honorable Kent A. Jordan from Andrew E. Russell regarding request for status conference. (DiBenedetto, Emily) (Entered: 08/10/2023)
2023-08-10
1
ORDER Setting Teleconference regarding post-trial briefing for 8/24/2023 at 02:00 PM before Judge Kent A. Jordan. Counsel for DexCom to initiate the call. Signed by Judge Kent A. Jordan on 08/11/2023. (smg) (Entered: 08/11/2023)
2023-08-11
1
Official Transcript of Jury Trial held on 7/10/23 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/11/2023. Redacted Transcript Deadline set for 9/19/2023. Release of Transcript Restriction set for 11/17/2023. (Warner, Deanna) (Entered: 08/19/2023)
2023-08-19
1
Official Transcript of Jury Trial held on 7/11/23 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/11/2023. Redacted Transcript Deadline set for 9/19/2023. Release of Transcript Restriction set for 11/17/2023. (Warner, Deanna) (Entered: 08/19/2023)
2023-08-19
1
Official Transcript of Jury Trial held on 7/12/23 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/11/2023. Redacted Transcript Deadline set for 9/19/2023. Release of Transcript Restriction set for 11/17/2023. (Warner, Deanna) (Entered: 08/19/2023)
2023-08-19
1
Official Transcript of Jury Trial held on 7/13/23 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/11/2023. Redacted Transcript Deadline set for 9/19/2023. Release of Transcript Restriction set for 11/17/2023. (Warner, Deanna) (Entered: 08/19/2023)
2023-08-19
1
Official Transcript of Jury Trial held on 7/14/23 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/11/2023. Redacted Transcript Deadline set for 9/19/2023. Release of Transcript Restriction set for 11/17/2023. (Warner, Deanna) (Entered: 08/19/2023)
2023-08-19
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephone Conference regarding post-trial briefing held on 8/24/2023. (Court Reporter: Bonnie Archer). (twk)
2023-08-24
1
No Actions
Telephone Conference
2023-08-24
1
No Actions
PROPOSED ORDER Regarding Stay - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Letter to The Honorable Kent A. Jordan)(Blumenfeld, Jack) (Entered: 08/28/2023)
2023-08-28
1
ORDER, The stay identified in paragraph 2 of the September 26, 2022 Amended Scheduling Order (D.I. 176 ) shall remain in place until November 10, 2023, after which the stay shall expire without the need for any additional motion or Court Order. (Deadline set for 11/10/2023) Signed by Judge Kent A. Jordan on 8/28/2023. (apk) (Entered: 08/28/2023)
2023-08-28
1
Joint STIPULATION and [Proposed] Order on Post-Trial Briefing by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 09/07/2023)
2023-09-07
1
Official Transcript of Teleconference held on August 24, 2023 before Judge Kent A. Jordan. Court Reporter/Transcriber Bonnie archer,Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/29/2023. Redacted Transcript Deadline set for 10/10/2023. Release of Transcript Restriction set for 12/7/2023. (Archer, Bonnie) (Entered: 09/08/2023)
2023-09-08
1
MOTION for Judgment as a Matter of Law (Renewed) - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order)(Hoeschen, Nathan) (Entered: 09/08/2023)
2023-09-08
1
[SEALED] OPENING BRIEF in Support re 585 MOTION for Judgment as a Matter of Law (Renewed) filed by Dexcom, Inc..Answering Brief/Response due date per Local Rules is 9/22/2023. (Attachments: # 1 Exhibit JTX-1, # 2 Exhibit JTX-7, # 3 Exhibit JTX-8, # 4 Exhibit PTX-0035 pt 1 of 5, # 5 Exhibit PTX-0035 pt 2 of 5, # 6 Exhibit PTX-0035 pt 3 of 5, # 7 Exhibit PTX-0035 pt 4 of 5, # 8 Exhibit PTX-0035 pt 5 of 5, # 9 Exhibit PTX-0415, # 10 Exhibit PTX-0542, # 11 Exhibit DTX-0427 pt 1 of 2, # 12 Exhibit DTX-0427 pt 2 of 2)(Hoeschen, Nathan) Modified on 9/11/2023 (vfm). (Entered: 09/08/2023)
2023-09-08
1
MOTION to Compel Specific Performance of the Parties' Settlement and License Agreement, or in the Alternative for a Permanent Injunction - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
OPENING BRIEF in Support re 587 MOTION to Compel Specific Performance of the Parties' Settlement and License Agreement, or in the Alternative for a Permanent Injunction - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 9/22/2023. (Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
MOTION for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
OPENING BRIEF in Support re 589 MOTION for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 9/22/2023. (Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
MOTION for Judgment as a Matter of Law - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
OPENING BRIEF in Support re 591 MOTION for Judgment as a Matter of Law - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 9/22/2023. (Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
[SEALED] DECLARATION re 589 MOTION for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott, 591 MOTION for Judgment as a Matter of Law, 587 MOTION to Compel Specific Performance of the Parties' Settlement and License Agreement, or in the Alternative for a Permanent Injunction -- Declaration of Jason Wilcox (Volume 1 of 2) -- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Volume 1-1 (Exs. 1-8, JTX-1, JTX-8), # 2 Volume 1-2 (PTX-35, part 1), # 3 Volume 1-3 (PTX-35, part 2), # 4 Volume 1-4 (PTX-35, part 3))(Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
[SEALED] DECLARATION re 589 MOTION for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott, 587 MOTION to Compel Specific Performance of the Parties' Settlement and License Agreement, or in the Alternative for a Permanent Injunction, 591 MOTION for Judgment as a Matter of Law -- Declaration of Jason Wilcox (Volume 2 of 2) -- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Volume 2-1 (PTX-35, part 4), # 2 Volume 2-2 (PTX-35, part 5, PTX-121, PTX-505, PTX-562, PTX-3551))(Smith, Rodger) (Entered: 09/08/2023)
2023-09-08
1
SO ORDERED, regarding D.I. 583 Stipulation (Post Trial Opening Brief due 9/8/2023., Post Trial Answering Brief due 10/13/2023., Post Trial Reply Brief due 11/3/2023.) Signed by Judge Kent A. Jordan on 9/11/2023. (apk) (Entered: 09/11/2023)
2023-09-11
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply AND ~Util - Set Deadlines
2023-09-11
1
No Actions
CORRECTING ENTRY: D.I. 586 Exhibit #2 description has been updated per counsel's request. (vfm)
2023-09-11
1
No Actions
- CORRECTING ENTRY
2023-09-11
1
No Actions
REDACTED VERSION of 593 Declaration,, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Volume 1-1, # 2 Volume 1-2, # 3 Volume 1-3, # 4 Volume 1-4)(Raucci, Anthony) (Entered: 09/15/2023)
2023-09-15
1
REDACTED VERSION of 594 Declaration,, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Volume 2-1, # 2 Volume 2-2)(Raucci, Anthony) (Entered: 09/15/2023)
2023-09-15
1
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
1
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
2
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
2
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
2
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
2
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
2
REDACTED VERSION of 586 Opening Brief in Support,, by Dexcom, Inc.. (Attachments: # 1 Exhibit JTX 1, 7 & 8, # 2 Exhibit PTX 35- Part 1, # 3 Exhibit PTX 35 - Part 2, # 4 Exhibit PTX 415, # 5 Exhibit PTX 542, # 6 Exhibit DTX 427)(Hoeschen, Nathan) (Entered: 09/15/2023)
2023-09-15
2
PROPOSED ORDER [Proposed] Protective Order on Confidentiality by DexCom, Inc.. (Hoeschen, Nathan) (Entered: 10/06/2023)
2023-10-06
1
PROPOSED ORDER --- [Proposed] Amended Scheduling Order by Dexcom, Inc.. (Attachments: # 1 Cover Letter)(Russell, Andrew) (Entered: 10/10/2023)
2023-10-10
1
CORRECTING ENTRY: The transcript previously filed at DI 601 has been deleted as it was incorrectly filed into the wrong civil action (apk)
2023-10-12
1
No Actions
- CORRECTING ENTRY
2023-10-12
1
No Actions
ORDER, a telephonic scheduling conference to be initiated by plaintiff's counsel shall be held on November 2, 2023 at 2:00 p.m. Counsel for plaintiff shall initiate the teleconference. If any party enters an appearance after the date of this order and before the teleconference set by this order, counsel for plaintiff shall notify said party of the teleconference and forward to that party a copy of these materials. Signed by Judge Kent A. Jordan on 10/13/2023. (mpb) (Entered: 10/13/2023)
2023-10-13
1
POST TRIAL BRIEF [ Dexcom's Answering Brief in Opposition to Abbott's Motion to Compel Specific Performance of The Parties' Settlement and License Agreement and for a Permanent Injunction] by Dexcom, Inc.. (Russell, Andrew) (Entered: 10/13/2023)
2023-10-13
1
POST TRIAL BRIEF [Dexcom Inc.'s Opposition to Plaintiff's Opening Brief in Support of its Rule 50(B) Motion for Judgment as a Matter of Law] by Dexcom, Inc.. (Russell, Andrew) (Entered: 10/13/2023)
2023-10-13
1
POST TRIAL BRIEF [Dexcom Inc.'s Opposition to Abbott's Motion for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott] by Dexcom, Inc.. (Russell, Andrew) (Entered: 10/13/2023)
2023-10-13
1
[SEALED] POST TRIAL BRIEF -- Abbott's Brief Opposing Dexcom's Renewed Motion for Judgment as a Matter of Law -- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit 1 - PDX-7, # 2 Exhibit 2 - DDX-7, # 3 Exhibit 3 - PDX-8, # 4 JTX-7, # 5 PTX-56, # 6 PTX-415, # 7 PTX-453 (part 1), # 8 PTX-453 (part 2), # 9 PTX-542, # 10 PTX-1140 (part 1), # 11 PTX-1140 (part 2))(Raucci, Anthony) (Entered: 10/13/2023)
2023-10-13
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Scheduling Conference held on 11/2/2023. (Court Reporter Deanna Warner.) (mpb)
2023-11-02
1
No Actions
Scheduling Conference
2023-11-02
1
No Actions
REPLY BRIEF re 587 MOTION to Compel Specific Performance of the Parties' Settlement and License Agreement, or in the Alternative for a Permanent Injunction filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 11/03/2023)
2023-11-03
1
REPLY BRIEF re 589 MOTION for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 11/03/2023)
2023-11-03
1
REPLY BRIEF re 591 MOTION for Judgment as a Matter of Law filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Entered: 11/03/2023)
2023-11-03
1
[SEALED] REPLY BRIEF re 585 MOTION for Judgment as a Matter of Law (Renewed) filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/03/2023)
2023-11-03
1
Official Transcript of Scheduling Conference held on 11/2/23 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/27/2023. Redacted Transcript Deadline set for 12/5/2023. Release of Transcript Restriction set for 2/2/2024. (Warner, Deanna) (Entered: 11/04/2023)
2023-11-04
1
SO ORDERED, regarding D.I. 599 PROPOSED Protective Order on Confidentiality. Signed by Judge Kent A. Jordan on 11/8/2023. (apk) (Entered: 11/08/2023)
2023-11-08
1
SO ORDERED
2023-11-08
1
No Actions
MOTION to Dismiss for Failure to State a Claim, MOTION to Strike 279 Answer to Complaint,, Counterclaim, [DexCom, Inc.'s Motion to Dismiss and to Strike] - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order)(Hoeschen, Nathan) (Entered: 11/10/2023)
2023-11-10
1
OPENING BRIEF in Support re 612 MOTION to Dismiss for Failure to State a Claim MOTION to Strike 279 Answer to Complaint,, Counterclaim, [DexCom, Inc.'s Motion to Dismiss and to Strike] filed by Dexcom, Inc..Answering Brief/Response due date per Local Rules is 11/27/2023. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Hoeschen, Nathan) (Entered: 11/10/2023)
2023-11-10
1
ANSWER to Complaint with Jury Demand ---Plaintiff DexCom, Inc.'s Answer and Affirmative Defenses to Defendants' Amended Counterclaims by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/10/2023)
2023-11-10
1
NOTICE OF SERVICE of 1. Plaintiff DexCom, Inc.'s Sixth Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 181 - 238) 2. Plaintiff DexCom, Inc.'s Fifth Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 20 - 28) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 11/13/2023)
2023-11-13
1
REDACTED VERSION of 609 Reply Brief in Support of Its Renewed Motion for Judgment as a Matter of Law by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 11/13/2023)
2023-11-13
1
PROPOSED ORDER -- [Proposed] Amended Scheduling Order by Dexcom, Inc.. (Attachments: # 1 Letter to the Honorable Kent A. Jordan from John W. Shaw regarding the parties proposed Scheduling Order)(Shaw, John) (Entered: 11/15/2023)
2023-11-15
1
AMENDED SCHEDULING ORDER: Amended Pleadings due by 1/12/2024., Fact Discovery completed by 6/4/2024., Opening Expert Reports due by 6/26/2024., Rebuttal Expert Reports due by 7/19/2024., Surreply Expert Reports due by 8/9/2024., Expert Discovery due by 9/13/2024., Dispositive Motions due by 9/27/2024., Answering Brief due 10/25/2024., Reply Brief due 11/8/2024., A Motion Hearing is set for 12/13/2024 at 10:00 AM in To Be Determined before Judge Kent A. Jordan, Claim Construction Opening Brief due by 2/23/2024., Claim Construction Answering Brief due by 3/8/2024., Claim Construction Reply Brief due by 3/22/2024., Claim Construction Surreply Brief due by 3/29/2024., Joint Claim Construction Brief due by 2/9/2024., A Final Pretrial Conference is set for 2/24/2025 at 10:00 AM in To Be Determined before Judge Kent A. Jordan., A 5 Day Jury Trial is set for 2/24/2025 - 2/28/2025 at 09:30 AM in a Courtroom To Be Determined before Judge Kent A. Jordan. (PLEASE SEE ORDER FOR FURTHER DETAILS AND DATES). Signed by Judge Kent A. Jordan on 11/15/2023. (apk) (Entered: 11/15/2023)
2023-11-15
1
TRIAL MANAGEMENT ORDER. Signed by Judge Kent A. Jordan on 11/15/2023. (apk) (Entered: 11/15/2023)
2023-11-15
1
STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to DexCom, Inc.'s Motion to Dismiss and to Strike (D.I. 612) and the deadline for DexCom to file its reply in support of its Motion -- to December 15, 2023, and January 12, 2024, respectively -- - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 11/17/2023)
2023-11-17
1
REDACTED VERSION of 605 POST Trial Brief, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 1 - PDX-7, # 2 Ex. 2 - DDX-7, # 3 Ex. 3 - PDX-8, # 4 JTX-7, # 5 PTX-56, # 6 PTX-415, # 7 PTX-453 (part 1), # 8 PTX-453 (part 2), # 9 PTX-542, # 10 PTX-1140)(Raucci, Anthony) (Entered: 11/17/2023)
2023-11-17
1
NOTICE OF SERVICE of 1) Abbott's Supplemental Custodian and Non-Custodian Data Source Disclosures; and 2) Abbott's Fourth Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/22/2023)
2023-11-22
1
NOTICE OF SERVICE of 1) Abbott's Fifth Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 276-311); 2) Abbott's Fourth Set of Interrogatories to Dexcom (Nos. 33-39); and 3) Abbott's Election of Interrogatories and Requests for Production filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 11/22/2023)
2023-11-22
1
SO ORDERED, regarding D.I. 620 STIPULATION TO EXTEND TIME for Defendants to file their answering brief in opposition to DexCom, Inc.'s Motion to Dismiss and to Strike (D.I. 612 ) and the deadline for DexCom to file its reply in support of its Motion -- to December 15, 2023 (Answering Brief due 12/15/2023., Reply Brief due 1/12/2024). Signed by Judge Kent A. Jordan on 11/27/2023. (apk) (Entered: 11/27/2023)
2023-11-27
1
NOTICE OF SERVICE of (1) DexCom's Rule 26 Fifth Amended and Supplemental Initial Disclosures and (2) DexCom's Election of Interrogatories and Requests for Production filed by Dexcom, Inc..(Russell, Andrew) (Entered: 11/27/2023)
2023-11-27
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2023-11-27
1
No Actions
NOTICE OF SERVICE of Notice of Intent to Serve Subpoena on Trelleborg Sealing Solutions US, Inc. filed by Dexcom, Inc..(Russell, Andrew) (Entered: 12/07/2023)
2023-12-07
1
NOTICE OF SERVICE of (1) Abbott's Objections and Responses to Dexcom's Fifth Set of Interrogatories (Nos. 20-28); and (2) Abbott's Objections and Responses to Dexcom's Sixth Set of Requests for Production (Nos. 181-238) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 12/11/2023)
2023-12-11
1
NOTICE OF SERVICE of Plaintiff Dexcom Inc.'s Supplemental Initial Disclosure of Asserted Claims and Infringement Contentions to Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 12/15/2023)
2023-12-15
1
ANSWERING BRIEF in Opposition re 612 MOTION to Dismiss for Failure to State a Claim MOTION to Strike 279 Answer to Complaint,, Counterclaim, [DexCom, Inc.'s Motion to Dismiss and to Strike] filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Raucci, Anthony) (Entered: 12/15/2023)
2023-12-15
1
EXHIBIT re 629 Answering Brief in Opposition, --Volume 1-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit A (part 1))(Raucci, Anthony) (Entered: 12/15/2023)
2023-12-15
1
EXHIBIT re 629 Answering Brief in Opposition, --Volume 2-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit A (part 2) - Exhibit B (part 1))(Raucci, Anthony) (Entered: 12/15/2023)
2023-12-15
1
EXHIBIT re 629 Answering Brief in Opposition, --Volume 3-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit B (part 2) - Exhibit C (part 1))(Raucci, Anthony) (Entered: 12/15/2023)
2023-12-15
1
EXHIBIT re 629 Answering Brief in Opposition, --Volume 4-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit C (part 2))(Raucci, Anthony) (Entered: 12/15/2023)
2023-12-15
1
EXHIBIT re 629 Answering Brief in Opposition, --Volume 5-- by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits D-E)(Raucci, Anthony) (Entered: 12/15/2023)
2023-12-15
1
NOTICE OF SERVICE of 1. Dexcom Inc.'s Supplemental Responses to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Elected Requests for the Production of Documents (Nos. 1 - 9, 11 - 12, 16 - 21, 24, 38 - 43, 44 - 110, 121 - 179, 193 - 196, 198 - 200, 211 - 212, 214 - 217, 219) 2. DexCom Inc.'s Responses and Objections to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Fifth Set of Requests for Production of Documents (Nos. 276 - 311) 3. Plaintiff DexCom, Inc.'s Supplemental Objections and Responses to Abbott's Elected Interrogatories (No. 1, 7 - 8, 10 - 16) 4. Plaintiff DexCom, Inc.'s Objections and Responses to Abbott's Fourth Set of Interrogatories (No. 33 - 39) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 12/26/2023)
2023-12-26
1
NOTICE OF SERVICE of 1. Dexcom Inc.'s Rule 26 Sixth Amended and Supplemental Initial Disclosures 2. Dexcom, Inc.'s Supplemental Custodian and Non-Custodian Data Source Disclosures filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 01/05/2024)
2024-01-05
1
ORDER: A Teleconference relating to a discovery dispute has been scheduled for February 9, 2024 at 2:00 p.m. with the undersigned. Counsel for DexCom shall initiate the teleconference call. If there are out-of-state counsel working on this case, local counsel are reminded of their obligation to inform their out-of-state co-counsel of this order. (A Telephone Conference is set for 2/9/2024 at 02:00 PM in Telephonically before Judge Kent A. Jordan) Signed by Judge Kent A. Jordan on 1/5/2024. (apk) (Entered: 01/05/2024)
2024-01-05
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Sixth Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (No. 29 - 30) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 01/10/2024)
2024-01-10
1
[SEALED] MOTION for Leave to File a Second Amended Complaint - filed by Dexcom, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1 - Amended Pleading, # 3 Exhibit 2 - Redline)(Hoeschen, Nathan) (Entered: 01/11/2024)
2024-01-11
1
Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding DexCom's Letter in Support of it's Motion for Leave to File a Second Amended Complaint - re 639 MOTION for Leave to File a Second Amended Complaint. (Hoeschen, Nathan) (Entered: 01/11/2024)
2024-01-11
1
REPLY BRIEF re 612 MOTION to Dismiss for Failure to State a Claim MOTION to Strike 279 Answer to Complaint,, Counterclaim, [DexCom, Inc.'s Motion to Dismiss and to Strike] filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/12/2024)
2024-01-12
1
NOTICE OF SERVICE of Trelleborg Sealing Solutions US, Inc.'s Objections and Responses to DexCom's Subpoenas to Produce Documents, Information, or Objects and to Testify at a Deposition - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 01/16/2024)
2024-01-16
1
[SEALED] Letter to The Honorable Kent A. Jordan from Rodger D. Smith II regarding Opposition to DexCom's Motion to Amend Complaint - re 639 MOTION for Leave to File a Second Amended Complaint. (Attachments: # 1 Ex. 1, # 2 Ex. 2)(Smith, Rodger) (Entered: 01/18/2024)
2024-01-18
1
STIPULATION TO EXTEND TIME to submit a redacted version of docket item 639 to January 23, 2024 - filed by Dexcom, Inc.. (Russell, Andrew) (Entered: 01/18/2024)
2024-01-18
1
SO ORDERED, regarding D.I. 644 STIPULATION TO EXTEND TIME, submitting a redacted version of D.I. 639 to January 23, 2024, filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 01/19/2024. (vfm) (Entered: 01/22/2024)
2024-01-19
1
NOTICE OF SERVICE of Abbott's Supplemental Initial Invalidity Contentions filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 01/22/2024)
2024-01-22
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding DexCom's Reply Letter Brief in Support of its Motion for Leave to File a Second Amended Complaint - re 639 MOTION for Leave to File a Second Amended Complaint. (Hoeschen, Nathan) (Entered: 01/22/2024)
2024-01-22
1
SO ORDERED AND ~Util - Set Deadlines
2024-01-22
1
No Actions
REDACTED VERSION of 639 MOTION for Leave to File a Second Amended Complaint by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/23/2024)
2024-01-23
1
NOTICE OF SERVICE of Abbott's Fifth Set of Interrogatories to Dexcom (No. 40) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 01/23/2024)
2024-01-23
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Seventh Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 239 - 338) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 01/24/2024)
2024-01-24
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Identification of Claim Terms for Construction filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 01/26/2024)
2024-01-26
1
NOTICE OF SERVICE of Abbott's Proposed Terms for Construction filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 01/29/2024)
2024-01-29
1
REDACTED VERSION of 647 Letter, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 01/29/2024)
2024-01-29
1
MOTION to Stay the '642 Patent Infringement Claims - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Proposed Order)(Smith, Rodger) (Entered: 01/30/2024)
2024-01-30
1
OPENING BRIEF in Support re 654 MOTION to Stay the '642 Patent Infringement Claims - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 2/13/2024. (Attachments: # 1 Exs. 1-15)(Smith, Rodger) (Entered: 01/30/2024)
2024-01-30
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Initial Proposed Claim Constructions filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 02/02/2024)
2024-02-02
1
REDACTED VERSION of 643 Letter, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Ex. 1, # 2 Ex. 2)(Smith, Rodger) (Entered: 02/05/2024)
2024-02-05
1
NOTICE OF SERVICE of Abbott's Identification of Proposed Claim Constructions filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 02/05/2024)
2024-02-05
1
[SEALED] Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Expert Objection. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Raucci, Anthony) (Entered: 02/06/2024)
2024-02-06
1
[SEALED] Letter to The Honorable Kent A. Jordan from Andrew E. Russell regarding Abbott's Expert Objection. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Russell, Andrew) (Entered: 02/07/2024)
2024-02-07
1
MANDATE of USCA as to 490 Notice of Interlocutory Appeal (Federal Circuit) filed by Dexcom, Inc.. USCA Decision: Affirmed. (Attachments: # 1 Opinion, # 2 Judgment)(mpb) (Entered: 02/09/2024)
2024-02-09
1
CLAIM Construction Chart by Dexcom, Inc.. (Attachments: # 1 Exhibit 1 - Claim Construction Chart, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50, # 51 Exhibit 51, # 52 Exhibit 52, # 53 Exhibit 53, # 54 Exhibit 54, # 55 Exhibit 55, # 56 Exhibit 56, # 57 Exhibit 57, # 58 Exhibit 58, # 59 Exhibit 59, # 60 Exhibit 60, # 61 Exhibit 61, # 62 Exhibit 62, # 63 Exhibit 63, # 64 Exhibit 64, # 65 Exhibit 65, # 66 Exhibit 66, # 67 Exhibit 67)(Keller, Karen) (Entered: 02/09/2024)
2024-02-09
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephone Conference held on 2/9/2024. (Court Reporter Deanna Warner.) Associated Cases: 1:22-cv-00605-KAJ, 1:23-cv-00239-KAJ(mpb)
2024-02-09
1
No Actions
Telephone Conference
2024-02-09
1
No Actions
NOTICE OF SERVICE of (1) Abbott's Supplemental Response to DexCom's Elected Requests for Production, (2) Abbott's Supplemental Responses to DexCom's Elected Interrogatories (Nos. 1, 5) and (3) Defendants' Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Responses to Plaintiff Dexcom, Inc.'s Sixth Set of Interrogatories (Nos. 29-30) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 02/12/2024)
2024-02-12
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Eighth Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 339-343) filed by Dexcom, Inc..(DiBenedetto, Emily) (Entered: 02/12/2024)
2024-02-12
1
NOTICE OF SERVICE of Abbott's Sixth Set of Requests for Production of Documents and Things to DexCom, Inc. (Nos. 312-341) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Blumenfeld, Jack) (Entered: 02/13/2024)
2024-02-13
1
[SEALED] ANSWERING BRIEF in Opposition re 654 MOTION to Stay the '642 Patent Infringement Claims filed by Dexcom, Inc..Reply Brief due date per Local Rules is 2/20/2024. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K)(Hoeschen, Nathan) (Entered: 02/13/2024)
2024-02-13
1
REDACTED VERSION of (90 in 1:23-cv-00239-KAJ, 659 in 1:22-cv-00605-KAJ) Letter by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited, Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/14/2024)
2024-02-14
1
REDACTED VERSION of (91 in 1:23-cv-00239-KAJ, 660 in 1:22-cv-00605-KAJ) Letter by DexCom, Inc.. (Hoeschen, Nathan) (Entered: 02/14/2024)
2024-02-14
1
NOTICE OF SERVICE of Abbott's Fifth Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 02/14/2024)
2024-02-14
1
STIPULATION and [Proposed] Order Regarding Document Discovery by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/15/2024)
2024-02-15
1
NOTICE OF SERVICE of Abbott's Disclosure of Sales Figures for Accused Products - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 02/15/2024)
2024-02-15
1
Official Transcript of Motion Hearing held on 2/9/24 before Judge Kent Jordan. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/12/2024. Redacted Transcript Deadline set for 3/22/2024. Release of Transcript Restriction set for 5/20/2024. (Warner, Deanna) (Entered: 02/20/2024)
2024-02-20
1
SO ORDERED, regarding D.I. 670 STIPULATION and [Proposed] Order Regarding Document Discovery - filed by Dexcom, Inc.. Signed by Judge Kent A. Jordan on 02/20/2024. (vfm) (Entered: 02/20/2024)
2024-02-20
1
REDACTED VERSION of 666 Answering Brief in Opposition, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 02/20/2024)
2024-02-20
1
[SEALED] REPLY BRIEF re 654 MOTION to Stay the '642 Patent Infringement Claims -- Abbott's Reply Brief in Further Support of Its Motion to Stay the '642 Patent Infringement Claims -- filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit 16-17)(Raucci, Anthony) (Entered: 02/20/2024)
2024-02-20
1
SO ORDERED
2024-02-20
1
No Actions
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Objections and Responses to Abbott's Fifth Set of Interrogatories (No. 40) filed by Dexcom, Inc..(DiBenedetto, Emily) (Entered: 02/22/2024)
2024-02-22
1
NOTICE OF SERVICE of (1) Abbott's Objections and Responses to Dexcom's Seventh Set of Requests for Production (Nos. 239-338); and (2) Abbott's Seventh Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 342-347) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 02/23/2024)
2024-02-23
1
[SEALED] CLAIM CONSTRUCTION OPENING BRIEF filed by Dexcom, Inc.. (Attachments: # 1 Exhibit 68, # 2 Exhibit 69, # 3 Exhibit 70, # 4 Exhibit 71, # 5 Exhibit 72, # 6 Exhibit 73, # 7 Exhibit 74)(Hoeschen, Nathan) (Entered: 02/23/2024)
2024-02-23
1
REDACTED VERSION of 675 Reply Brief, by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 02/27/2024)
2024-02-27
1
REDACTED VERSION of 678 Claim Construction Opening Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 03/01/2024)
2024-03-01
1
[SEALED] CLAIM CONSTRUCTION ANSWERING BRIEF filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibit 75, # 2 Exhibit 76, # 3 Exhibit 77, # 4 Exhibit 78, # 5 Exhibit 79, # 6 Exhibit 80, # 7 Exhibit 81, # 8 Exhibit 82, # 9 Exhibit 83, # 10 Exhibit 84, # 11 Exhibit 85, # 12 Exhibit 86, # 13 Exhibit 87, # 14 Exhibit 88, # 15 Exhibit 89, # 16 Exhibit 90, # 17 Exhibit 91, # 18 Exhibit 92, # 19 Exhibit 93, # 20 Exhibit 94, # 21 Exhibit 95, # 22 Exhibit 96, # 23 Exhibit 97, # 24 Exhibit 98, # 25 Exhibit 99)(Raucci, Anthony) (Entered: 03/08/2024)
2024-03-08
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Seventh Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (No. 31-38) filed by Dexcom, Inc..(Keller, Karen) (Entered: 03/08/2024)
2024-03-08
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Ninth Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 344 - 364) filed by Dexcom, Inc..(Russell, Andrew) (Entered: 03/11/2024)
2024-03-11
1
NOTICE OF SERVICE of Abbott's Objections and Responses to Dexcom's Eighth Set of Requests for Production (Nos.339-343) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 03/13/2024)
2024-03-13
1
NOTICE OF SERVICE of Dexcom Inc.'s Responses and Objections to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp's Sixth Set of Requests for Production of Documents and Things (Nos. 312 - 341) filed by Dexcom, Inc..(Russell, Andrew) (Entered: 03/14/2024)
2024-03-14
1
[SEALED] CLAIM CONSTRUCTION REPLY BRIEF filed by Dexcom, Inc.. (Attachments: # 1 Exhibit 100, # 2 Exhibit 101, # 3 Exhibit 102, # 4 Exhibit 103)(Hoeschen, Nathan) (Entered: 03/22/2024)
2024-03-22
1
NOTICE OF SERVICE of Dexcom Inc.'s Responses and Objections to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corps Seventh Set of Requests for Production of Documents and Things (Nos. 342 - 347) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 03/25/2024)
2024-03-25
1
Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding request to reschedule the Markman hearing currently set for April 11, 2024. (Hoeschen, Nathan) (Entered: 03/26/2024)
2024-03-26
1
ORDER: The April 11, 2024 Markman Hearing is cancelled; it will be rescheduled at the convenience of the Court. Signed by Judge Kent A. Jordan on 03/27/2024. (vfm) (Entered: 03/27/2024)
2024-03-27
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Eighth Set of Interrogatories to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (No. 39 - 42) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 03/28/2024)
2024-03-28
1
NOTICE OF SERVICE of Abbott's Sixth Set of Interrogatories to Dexcom, Inc. (Nos. 41-46) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 03/28/2024)
2024-03-28
1
[SEALED] CLAIM CONSTRUCTION SURREPLY BRIEF filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 104-117)(Raucci, Anthony) (Entered: 03/29/2024)
2024-03-29
1
REDACTED VERSION of 686 Claim Construction Reply Brief by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 04/01/2024)
2024-04-01
1
SO ORDERED
2024-04-03
1
No Actions
NOTICE OF SERVICE of 1. Plaintiff DexCom, Inc.'s Tenth Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (No. 365 - 393) 2. Notice of Intent to Serve Subpoena on the Galien Foundation Inc. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/08/2024)
2024-04-08
1
NOTICE OF SERVICE of Abbott's Responses to Dexcom's Seventh Set of Interrogatories (Nos. 31-38) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 04/08/2024)
2024-04-08
1
NOTICE OF SERVICE of Abbott's Objections and Responses to Dexcom's Ninth Set of Requests for Production (Nos. 344-364) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 04/10/2024)
2024-04-10
1
NOTICE OF SERVICE of Plaintiff DexCom Inc.'s Final Infringement Contentions filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/12/2024)
2024-04-12
1
NOTICE OF SERVICE of Abbott's Final Invalidity Contentions filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 04/22/2024)
2024-04-22
1
NOTICE OF SERVICE of Dexcom Inc.'s Notice of Rule 30(b)(6) Deposition to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/22/2024)
2024-04-22
1
STIPULATION TO EXTEND TIME to serve final supplemental responses to contention interrogatories and responses to outstanding sets of interrogatories to May 3, 2024 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 04/25/2024)
2024-04-25
1
SO ORDERED, re 701 STIPULATION TO EXTEND TIME to serve final supplemental responses to contention interrogatories and responses to outstanding sets of interrogatories to May 3, 2024 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Signed by Judge Kent A. Jordan on 4/25/2024. (mpb) (Entered: 04/25/2024)
2024-04-25
1
SO ORDERED AND ~Util - Terminate Motions
2024-04-25
1
No Actions
NOTICE OF SERVICE of 1. DexCom Inc.'s Notice of Deposition to Badia Boudaiffa 2. DexCom Inc.'s Notice of Deposition to Ben Feldman 3. DexCom Inc.'s Notice of Deposition to Erwin Budiman 4. DexCom Inc.'s Notice of Deposition to Jason Pederson 5. DexCom Inc.'s Notice of Deposition to Jeff Halpern 6. DexCom Inc.'s Notice of Deposition to Jean-Pierre Cole 7. DexCom Inc.'s Notice of Deposition to Louis Pace 8. DexCom Inc.'s Notice of Deposition to Marc Taub 9. DexCom Inc.'s Notice of Deposition to Naveen Thuramalla 10. DexCom Inc.'s Notice of Deposition to Scott Kosinski 11. DexCom Inc.'s Notice of Deposition to Todd York 12. DexCom Inc.'s Notice of Deposition to Udo Hoss 13. DexCom Inc.'s Notice of Deposition to Wesley Scott Harper filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/29/2024)
2024-04-29
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Eleventh Set of Requests for Production to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. (Nos. 394 - 414) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 04/30/2024)
2024-04-30
1
NOTICE to Take Deposition of Naresh Bhavaraju filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Mark Brister filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Matthew Dolan filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Laura Endres filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Andrea Facchinetti filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Paul Goode filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Laura Johnson filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Apurv Kamath filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Paul Lee filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Steve Masterson filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Jack Pryor filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Anna Leigh Rack-Gomer (Davis) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Peter Simpson filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Giovanni Sparacino filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Rose Thiessen filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE to Take Deposition of Matthew Wightlin filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE OF SERVICE of (1) Abbott's Sixth Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); (2) Abbott's Second Set of Requests for Admission to Dexcom, Inc. (Nos. 14-97); (3) Abbott's Seventh Set of Interrogatories to Dexcom (No. 47); (4) Abbott's Eighth Set of Requests for Production of Documents and Things to Dexcom, Inc. (Nos. 348-390); (5) Abbott's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) of Dexcom, Inc.; and (6) Abbott's Objections and Responses to Dexcom's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/03/2024)
2024-05-03
1
NOTICE OF SERVICE of 1. Plaintiff Dexcom, Inc.'s Second Supplemental Objections and Responses to Abbott's Elected Interrogatories (No. 1, 7, 8, 10, 11, 13, 16) 2. Plaintiff DexCom, Inc.'s Objections and Responses to Abbott's Sixth Set of Interrogatories (Nos. 41 - 46) 3. Plaintiff DexCom, Inc.'s Supplemental Objections and Responses to Abbott's Fifth Set of Interrogatories (No. 40) 4. Plaintiff DexCom, Inc.'s Supplemental Objections and Responses to Abbott's Fourth Set of Interrogatories (No. 33, 35 - 39) 5. Plaintiff DexCom, Inc.'s First Set of Requests for Admission to Defendants Abbott Diabetes Care, Inc. and Abbott Diabetes Care Sales Corp. filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 05/03/2024)
2024-05-03
1
NOTICE OF SERVICE of (1) Abbott's Second Supplemental Responses to Dexcom's Elected Interrogatories (Nos, 1, 5); (2) Abbott's First Supplemental Objections and Responses to Dexcom's Fifth Set of Interrogatories (Nos. 20-28); (3) Abbott's First Supplemental Responses to Dexcom's Sixth Set of Interrogatories (Nos. 29-30); (4) Abbott's First Supplemental Responses to Dexcom's Seventh Set of Interrogatories (Nos. 31-38); and (5) Abbott's Responses to Dexcom's Eighth Set of Interrogatories (Nos. 39-42) filed by Abbott Diabetes Care Inc., Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/06/2024)
2024-05-06
1
NOTICE OF SERVICE of Abbott's Objections and Responses to Dexcom's Tenth Set of Requests for Production (Nos. 365-393) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/07/2024)
2024-05-07
1
ORDER: A Discovery Dispute Teleconference is hereby scheduled for May 29, 2024 at 2:00 p.m. Counsel for DexCom shall initiate the teleconference call. If there are out-of-state counsel working on this case, local counsel are reminded of their obligation to inform their out-of-state- co-counsel of this Order. Signed by Judge Kent A. Jordan on 5/9/2024. (mpb) (Entered: 05/09/2024)
2024-05-09
1
STIPULATION TO EXTEND TIME for Deadlines Related to Fact and Expert Discovery to - various deadlines outlined in the attached - - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 05/10/2024)
2024-05-10
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Third Supplemental Objections and Responses to Abbott's Elected Interrogatories (Nos. 13) filed by Dexcom, Inc..(Russell, Andrew) (Entered: 05/17/2024)
2024-05-17
1
NOTICE OF SERVICE of Plaintiff Dexcom, Inc.'s Objections and Responses to Abbott's Notice of DepositionPursuant to Fed. R. Civ. P. 30(b)(6) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 05/21/2024)
2024-05-21
1
NOTICE OF SERVICE of DexCom, Inc.'s Rule 26 Seventh Amended and Supplemental Initial Disclosures filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 05/22/2024)
2024-05-22
1
[SEALED] Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Discovery Disputes and Schedule Extension. (Attachments: # 1 Exhibits 1-15)(Raucci, Anthony) (Entered: 05/24/2024)
2024-05-24
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding Discovery Dispute. (Hoeschen, Nathan) (Entered: 05/24/2024)
2024-05-24
1
[SEALED] DECLARATION re 731 Letter [Declaration of Cary E. Adickman in Support of Dexcom's Motion to Disqualify Abbott's Experts and Compel Discovery] by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Hoeschen, Nathan) (Entered: 05/24/2024)
2024-05-24
1
[SEALED] Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Response to Dexcom's May 24, 2024 Letter - re (731 in 1:22-cv-00605-KAJ) Letter. (Attachments: # 1 Exhibits 16-19)(Raucci, Anthony) (Entered: 05/28/2024)
2024-05-28
1
[SEALED] Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding Response to Abbott's Letter to Judge Jordan for the 5/29 Hearing. (Hoeschen, Nathan) (Entered: 05/28/2024)
2024-05-28
1
[SEALED] DECLARATION re 734 Letter [Declaration of Cary E. Adickman in Support of DecxCom's Response to Abbott's Letter to Judge Jordan for the 5/29 Hearing] by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Hoeschen, Nathan) (Entered: 05/28/2024)
2024-05-28
1
Letter to The Honorable Kent A. Jordan from Anthony D. Raucci regarding Follow-up to May 24, 2024 Letter - re (730 in 1:22-cv-00605-KAJ) Letter. (Attachments: # 1 Exhibits 20-22)(Raucci, Anthony) (Entered: 05/28/2024)
2024-05-28
1
MOTION for Pro Hac Vice Appearance of Attorney John P. Galanek - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 05/29/2024)
2024-05-29
1
Pro Hac Vice Fee - Credit Card Payment received for John P. Galanek. ( re 737 MOTION for Pro Hac Vice Appearance of Attorney John P. Galanek )( Payment of $ 50, receipt number ADEDC-4418083).(Hoeschen, Nathan) (Entered: 05/29/2024)
2024-05-29
1
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephone Conference held on 5/29/2024. (Court Reporter Bonnie Archer.) (jfm)
2024-05-29
1
No Actions
Telephone Conference
2024-05-29
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2024-05-29
1
No Actions
SO ORDERED, regarding D.I. 737 MOTION for Pro Hac Vice Appearance of Attorney John P. Galanek filed by Dexcom, Inc. Signed by Judge Kent A. Jordan on 5/30/2024. (apk) (Entered: 05/30/2024)
2024-05-30
1
ORDER: A teleconference relating to DexCom's motion to dismiss-strike (D.I. 612 ); DexCom's motion for leave to file a second amended complaint (D.I. 639 ), and Abbott's motion to stay '642 patent infringement claims (D.I. 654 ) has been scheduled for June 5, 2024 at 2:00 p.m. with the undersigned. Counsel for DexCom shall initiate the teleconference call. If there are out-of-state counsel working on this case. Local counsel are reminded of their obligation to inform their out-of-state co-counsel of this order. Signed by Judge Kent A. Jordan on 5/30/2024. (apk) (Entered: 05/30/2024)
2024-05-30
1
NOTICE OF SERVICE of Abbott's Objections and Responses to Dexcom's Eleventh Set of Requests for Production (Nos. 394-414) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 05/30/2024)
2024-05-30
1
SO ORDERED
2024-05-30
1
No Actions
Add Attorneys - PHV only
2024-05-30
1
No Actions
Pro Hac Vice Attorney John Galanek for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2024-05-30
1
No Actions
STIPULATION TO EXTEND TIME to submit proposed public versions of D.I. No. 730-735 to June 7, 2024 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 05/31/2024)
2024-05-31
1
[SEALED] MEMORANDUM OPINION. Signed by Judge Kent A. Jordan on 5/31/2024.This order has been emailed to local counsel. (rlr) (Entered: 05/31/2024)
2024-05-31
1
ORDER, DexCom's Renewed Motion for Judgment as a Matter of Law (D.I. 585 ) is DENIED. Abbott's Rule 50(b) Motion for Judgment as a Matter of Law (D.I. 591 ) is GRANTED IN PART. Abbott's Rule 50(b) Motion for Judgment as a Matter of Law (D.I. 591 ) is DENIED IN PART. Abbott's Motion for Judgment that the Claims of the '452 Patent are Impliedly Licensed to Abbott (D.I. 589 ) is DENIED. Abbott's Motion to Compel Specific Performance of the Parties' Settlement and License Agreement, or in the Alternative for a Permanent Injunction (D.I. 587 ) is DENIED. (See Order for further details.) Signed by Judge Kent A. Jordan on 5/31/2024. (rlr) (Entered: 05/31/2024)
2024-05-31
1
ORDER, Counsel shall provide the Court with proposedredactions to those documents (D.I. 743 SEALED Memorandum Opinion), and the reasons therefore, on or before the close ofbusiness on June 7, 2024. Signed by Judge Kent A. Jordan on 5/31/2024. (rlr) (Entered: 05/31/2024)
2024-05-31
1
SO ORDERED, re 742 STIPULATION TO EXTEND TIME to submit proposed public versions of D.I. No. 730-735 to June 7, 2024 filed by Dexcom, Inc.. Ordered by Judge Kent A. Jordan on 06/03/2024. (vfm) (Entered: 06/03/2024)
2024-06-03
1
MOTION for Pro Hac Vice Appearance of Attorney Gregg F. LoCascio, Abigail Lauer Litow, Tera J. Stone, Daniel P. Gross, Kristina R. Cary, S. Adina Stohl and Tareq M. Alosh - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 06/03/2024)
2024-06-03
1
Pro Hac Vice Fee - Credit Card Payment received for Gregg F. LoCascio, Abigail Lauer Litow, Tera J. Stone, Daniel P. Gross, and Kristina R. Cary. ( re 747 MOTION for Pro Hac Vice Appearance of Attorney Gregg F. LoCascio, Abigail Lauer Litow, Tera J. Stone, Daniel P. Gross, Kristina R. Cary, S. Adina Stohl and Tareq M. Alosh )( Payment of $ 250, receipt number ADEDC-4421375).(Raucci, Anthony) (Entered: 06/03/2024)
2024-06-03
1
Pro Hac Vice Fee - Credit Card Payment received for S. Adina Stohl and Tareq M. Alosh. ( re 747 MOTION for Pro Hac Vice Appearance of Attorney Gregg F. LoCascio, Abigail Lauer Litow, Tera J. Stone, Daniel P. Gross, Kristina R. Cary, S. Adina Stohl and Tareq M. Alosh )( Payment of $ 100, receipt number ADEDC-4421376).(Raucci, Anthony) (Entered: 06/03/2024)
2024-06-03
1
SO ORDERED, re 747 MOTION for Pro Hac Vice Appearance of Attorney Gregg F. LoCascio, Abigail Lauer Litow, Tera J. Stone, Daniel P. Gross, Kristina R. Cary, S. Adina Stohl and Tareq M. Alosh filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. Ordered by Judge Kent A. Jordan on 06/03/2024. (vfm) (Entered: 06/03/2024)
2024-06-03
1
NOTICE OF SERVICE of Abbott's Responses to Dexcom's Requests for Admission (Nos. 1-14) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 06/03/2024)
2024-06-03
1
NOTICE OF SERVICE of 1. Plaintiff DexCom, Inc.'s Fourth Supplemental Objections and Responses to Abbott's Elected Interrogatories (No. 11) 2. Dexcom Inc.'s Responses and Objections to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp's Eighth Set of Requests for Production of Documents (Nos. 348 - 390) 3. Dexcom Inc.'s Responses and Objections to ADC Parties' Second Set of Requests for Admission to DexCom, Inc. (Nos. 14 - 97) 4. Plaintiff DexCom, Inc.'s Objections and Responses to Abbott's Seventh Set of Interrogatories (No. 47) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 06/03/2024)
2024-06-03
1
SO ORDERED
2024-06-03
1
No Actions
-District Court Pro Hac Vice Fee - 05 Attorneys Credit Card Payment
2024-06-03
1
No Actions
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2024-06-03
1
No Actions
Telephone Conference
2024-06-05
1
No Actions
Minute Entry for proceedings held before Judge Kent A. Jordan - Telephone Conference held on 6/5/2024. (Court Reporter Veritext, Contact: (302)571-0510.) (vfm)
2024-06-05
1
No Actions
REDACTED VERSION of 734 Letter by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/07/2024)
2024-06-07
1
REDACTED VERSION of 735 Declaration, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/07/2024)
2024-06-07
1
REDACTED VERSION of 730 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 1-15)(Raucci, Anthony) (Entered: 06/07/2024)
2024-06-07
1
REDACTED VERSION of 733 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Exhibits 16-19)(Raucci, Anthony) (Entered: 06/07/2024)
2024-06-07
1
REDACTED VERSION of 731 Letter by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/07/2024)
2024-06-07
1
REDACTED VERSION of 732 Declaration,, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/07/2024)
2024-06-07
1
NOTICE requesting Clerk to remove Jonathan Studer as co-counsel.. (Hoeschen, Nathan) (Entered: 06/07/2024)
2024-06-07
1
ORDER: DexCom's Motion to Dismiss and to Strike Abbott's counterclaims and affirmative defenses of inequitable conduct as to U.S. Patent Nos. 10,702,193; 11,000,213; 10,980,452; and 10,993,642 (D.I. 612 ) is DENIED. DexCom's Motion for Leave to File a Second Amended Complaint attached as Exhibit 1 to the motion for leave. Abbott's Motion to Stay the '642 Patent Infringement Claims (D.I. 654 ) is DENIED WITHOUT PREJUDICE. Signed by Judge Kent A. Jordan (apk) (Entered: 06/10/2024)
2024-06-10
1
MOTION for Pro Hac Vice Appearance of Attorney Zhaoxin Yin - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/10/2024)
2024-06-10
1
Pro Hac Vice Fee - Credit Card Payment received for Zhaoxin Yin. ( re 761 MOTION for Pro Hac Vice Appearance of Attorney Zhaoxin Yin )( Payment of $ 50, receipt number ADEDC-4426599).(Hoeschen, Nathan) (Entered: 06/10/2024)
2024-06-10
1
SO ORDERED, regarding D.I. 761 MOTION for Pro Hac Vice Appearance of Attorney Zhaoxin Yin. Signed by Judge Kent A. Jordan on 6/10/2024. (apk) (Entered: 06/10/2024)
2024-06-10
1
[SEALED] Second AMENDED COMPLAINT for Patent Infringement against Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.- filed by Dexcom, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Hoeschen, Nathan) (Entered: 06/10/2024)
2024-06-10
1
SO ORDERED
2024-06-10
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2024-06-10
1
No Actions
STIPULATION and [Proposed] Order to Extend Certain Deadlines in the Scheduling Order - by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Smith, Rodger) (Main Document 765 replaced on 6/13/2024) (mpb). (Entered: 06/12/2024)
2024-06-12
1
Unopposed MOTION and [Proposed] Order for the Issuance of Letters of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 06/12/2024)
2024-06-12
1
[SEALED] OPENING BRIEF in Support re 766 Unopposed MOTION and [Proposed] Order for the Issuance of Letters of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..Answering Brief/Response due date per Local Rules is 6/26/2024. (Attachments: # 1 Annexure A-F, # 2 Exhibit 1-15)(Raucci, Anthony) (Attachment 1 replaced on 6/17/2024 per request of counsel) (nmg). (Entered: 06/12/2024)
2024-06-12
1
SO ORDERED, re 765 Stipulation filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Ordered by Judge Kent A. Jordan on 6/13/2024. (mpb) (Entered: 06/13/2024)
2024-06-13
1
CORRECTING ENTRY: Per Counsel's request, D.I. 765 Main Document has been replaced to reflect correct stipulated dates. (mpb)
2024-06-13
1
No Actions
1 - Terminate Deadlines AND 1 - Terminate Scheduling Order Deadlines AND SO ORDERED AND ~Util - Set Deadlines AND ~Util - Set Scheduling Order Deadlines
2024-06-13
1
No Actions
- CORRECTING ENTRY
2024-06-13
1
No Actions
Letter to The Honorable Kent A. Jordan from Nathan R. Hoeschen regarding confirmation that DexCom, Inc. does not oppose - re (766 in 1:22-cv-00605-KAJ) Unopposed MOTION and [Proposed] Order for the Issuance of Letters of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad, (155 in 1:23-cv-00239-KAJ) Unopposed MOTION and [Proposed] Order for the Issuance of Letters of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad . (Hoeschen, Nathan) (Entered: 06/14/2024)
2024-06-14
1
REDACTED VERSION of 764 Amended Complaint, by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 06/17/2024)
2024-06-17
1
ORDER: Abbott's Unopposed Motion for the Issuance of Letters of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad (D.I. 766 ) is GRANTED. The Court will issue the Letters of Request in the form attached to Abbott's briefing as Annexures A-F to the relevant Central Authority in Rome, Italy. The Court will sign the Letters of Request, including the Italian translations, and directs the Clerk of Court to authenticate the Court's signature under the seal of this Court. Thereafter, the Clerk is directed to return the Letters of Request to counsel for Abbott for delivery to the proper authority in Italy. Signed by Judge Kent A. Jordan on 6/17/2024. (mpb) (Entered: 06/18/2024)
2024-06-17
1
[SEALED] Letter of Request for International Judicial Assistance Pursuant to the Hague Convention of 18 March 1970 on the Taking of Evidence Abroad in Civil or Commercial Matters. Signed by Judge Kent A. Jordan on 6/17/2024. (Attachments: # 1 Italian Translation of Letter) Associated Cases: 1:22-cv-00605-KAJ, 1:23-cv-00239-KAJ(mpb) (Entered: 06/18/2024)
2024-06-17
1
[SEALED] Letter of Request for International Judicial Assistance Pursuant to the Hague Convention of 18 March 1970 on the Taking of Evidence Abroad in Civil or Commercial Matters. Signed by Judge Kent A. Jordan on 6/17/2024. (Attachments: # 1 Italian Translation of Letter) Associated Cases: 1:22-cv-00605-KAJ, 1:23-cv-00239-KAJ(mpb) (Entered: 06/18/2024)
2024-06-17
1
[SEALED] Letter of Request for International Judicial Assistance Pursuant to the Hague Convention of 18 March 1970 on the Taking of Evidence Abroad in Civil or Commercial Matters. Signed by Judge Kent A. Jordan on 6/17/2024. (Attachments: # 1 Italian Translation of Letter)Associated Cases: 1:22-cv-00605-KAJ, 1:23-cv-00239-KAJ(mpb) (Entered: 06/18/2024)
2024-06-17
1
Remark: Certified Copies of Letter Request (D.I. 772, 773, and 774 ) are ready for pick-up by Abbot's Local Counsel at the Clerk's Office. Office Hours are 8:30 a.m. - 4:00 p.m. (mpb)
2024-06-18
1
No Actions
Remark
2024-06-18
1
No Actions
REDACTED VERSION of (156 in 1:23-cv-00239-KAJ) Opening Brief in Support, (767 in 1:22-cv-00605-KAJ) Opening Brief in Support,, by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited, Abbott Diabetes Care Sales Corp.. (Attachments: # 1 Annexures A-F, # 2 Exhibits 1-15)(Raucci, Anthony) (Entered: 06/20/2024)
2024-06-20
1
STIPULATION TO EXTEND TIME for Abbott to File an Answer to the Second Amended Complaint (D.I. 764) to July 1, 2024 - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 06/20/2024)
2024-06-20
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Fifth Supplemental Objections and Responses to Abbott's Elected Interrogatories (No. 7, 13, 14, 15) filed by Dexcom, Inc..(DiBenedetto, Emily) (Entered: 06/20/2024)
2024-06-20
1
NOTICE OF SERVICE of Abbott's Second Supplemental Responses to DexCom's Sixth Set of Interrogatories (No. 29) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 06/20/2024)
2024-06-20
1
NOTICE OF SERVICE of Abbott's Second Supplemental Objections and Responses to Dexcom's Fifth Set of Interrogatories (Nos. 20, 22, 24) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 06/21/2024)
2024-06-21
1
SO ORDERED, regarding D.I. 776 STIPULATION TO EXTEND TIME for Abbott to File an Answer to the Second Amended Complaint (D.I. 764 ) to July 1, 2024. Ordered by Judge Kent A. Jordan on 06/24/2024. (vfm) (Entered: 06/24/2024)
2024-06-24
1
SO ORDERED AND ~Util - Set/Reset Answer Deadline
2024-06-24
1
No Actions
NOTICE to Take Deposition of Sean Benfield on July 19, 2024 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 06/25/2024)
2024-06-25
1
NOTICE to Take Deposition of Aiden OSullivan on July 24, 2024 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 06/25/2024)
2024-06-25
1
NOTICE to Take Deposition of Anne Santoro on July 26, 2024 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 06/25/2024)
2024-06-25
1
NOTICE to Take Deposition of Neeta Sharma on August 6, 2024 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 06/25/2024)
2024-06-25
1
NOTICE OF SERVICE of Abbott's Third Supplemental Responses to Dexcom's Elected Interrogatories (No. 1) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 07/01/2024)
2024-07-01
1
[SEALED] ANSWER to Amended Complaint, re: 764 Amended Complaint, with Jury Demand --ADC Parties' Answer to Dexcom's Second Amended Complaint, and Counterclaims--, COUNTERCLAIM against Dexcom, Inc. by Abbott Diabetes Care, Inc., Abbott Diabetes Care Sales Corp..(Smith, Rodger) (Entered: 07/01/2024)
2024-07-01
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Second Supplemental Objections and Responses to Abbott's Elected Interrogatories (No. 10) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/03/2024)
2024-07-03
1
STIPULATION TO EXTEND TIME to respond to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Counterclaims (D.I. 786) to July 29, 2024 - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 07/11/2024)
2024-07-11
1
SO ORDERED, re 788 STIPULATION TO EXTEND TIME to respond to Abbott Diabetes Care Inc. and Abbott Diabetes Care Sales Corp.'s Counterclaims (D.I. 786) to July 29, 2024 filed by Dexcom, Inc.Ordered by Judge Kent A. Jordan on 7/17/2024. (mpb)
2024-07-17
1
No Actions
SO ORDERED AND ~Util - Terminate Motions
2024-07-17
1
No Actions
NOTICE to Take Deposition of Jason Halac on August 6, 2024 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 07/18/2024)
2024-07-18
1
NOTICE OF SERVICE of Abbott's Second Supplemental Responses to Dexcom's Seventh Set of Interrogatories (No. 31) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 07/18/2024)
2024-07-18
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Supplemental Objections and Responses to Abbott's Sixth Set of Interrogatories (Nos. 42 - 44) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/19/2024)
2024-07-19
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Sixth Supplemental Objections and Responses to Abbott's Elected Interrogatories (No. 13) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/22/2024)
2024-07-22
1
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Amended Objections and Responses to Abbotts Sixth Set of Interrogatories (No. 46) filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/24/2024)
2024-07-24
1
NOTICE to Take Deposition of Stefania Guerra on August 6, 2024 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 07/25/2024)
2024-07-25
1
NOTICE to Take Deposition of Chris Bennell on August 6, 2024 filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/26/2024)
2024-07-26
1
NOTICE to Take Deposition of Shridhara Alva on August 6, 2024 filed by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/26/2024)
2024-07-26
1
ANSWER to 786 Answer to Amended Complaint,, Counterclaim, [ Plaintiff Dexcom, Inc.'s Answer and Affirmative Defenses to Defendants' Amended Counterclaims] by Dexcom, Inc..(Hoeschen, Nathan) (Entered: 07/29/2024)
2024-07-29
1
MOTION for Pro Hac Vice Appearance of Attorney Elliot Choi - filed by Dexcom, Inc.. (Hoeschen, Nathan) (Entered: 07/29/2024)
2024-07-29
1
Pro Hac Vice Fee - Credit Card Payment received for Elliot Choi. ( re 798 MOTION for Pro Hac Vice Appearance of Attorney Elliot Choi )( Payment of $ 50, receipt number ADEDC-4462950).(Hoeschen, Nathan) (Entered: 07/29/2024)
2024-07-29
1
NOTICE OF SERVICE of Abbott's Third Supplemental Objections and Responses to Dexcom's Fifth Set of Interrogatories (No. 24) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 07/29/2024)
2024-07-29
1
SO ORDERED, re 798 MOTION for Pro Hac Vice Appearance of Attorney Elliot Choi filed by Dexcom, Inc. Ordered by Judge Kent A. Jordan on 7/29/2024. (mpb)
2024-07-29
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2024-07-29
1
No Actions
SO ORDERED AND ~Util - Terminate Motions
2024-07-29
1
No Actions
NOTICE OF SERVICE of Abbott's Amended Second Supplemental Responses to Dexcom's Seventh Set of Interrogatories (No. 31) filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Raucci, Anthony) (Entered: 07/30/2024)
2024-07-30
1
Add Attorneys - PHV only
2024-07-31
1
No Actions
Pro Hac Vice Attorney Elliot Choi for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws)
2024-07-31
1
No Actions
NOTICE OF SERVICE of Plaintiff DexCom, Inc.'s Supplemental Objections and Responses to Abbott's Seventh Set of Interrogatories (No. 47) filed by Dexcom, Inc..(DiBenedetto, Emily) (Entered: 08/02/2024)
2024-08-02
1
MOTION for Pro Hac Vice Appearance of Attorney Anna Martinez - filed by Dexcom, Inc.. (DiBenedetto, Emily) (Entered: 08/05/2024)
2024-08-05
1
Pro Hac Vice Fee - Credit Card Payment received for Anna Martinez. ( re 803 MOTION for Pro Hac Vice Appearance of Attorney Anna Martinez )( Payment of $ 50, receipt number ADEDC-4468799).(DiBenedetto, Emily) (Entered: 08/05/2024)
2024-08-05
1
STIPULATION TO EXTEND TIME for Certain Case Deadlines to Various Dates - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Raucci, Anthony) (Entered: 08/05/2024)
2024-08-05
1
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2024-08-05
1
No Actions
SO ORDERED, re 803 MOTION for Pro Hac Vice Appearance of Attorney Anna Martinez filed by Dexcom, Inc. Ordered by Judge Kent A. Jordan on 8/15/2024. (mpb) (Entered: 08/16/2024)
2024-08-15
1
SO ORDERED, re 805 STIPULATION TO EXTEND TIME for Certain Case Deadlines to Various Dates filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc. Fact Discovery is to be completed by 8/21/2024. Opening Expert Reports are due by 9/16/2024. Rebuttal Expert Reports are due by 10/9/2024. Reply Expert Reports are due by 10/25/2024. Expert Discovery is due by 11/13/2024. Opening Summary Judgment and Daubert Briefs are due by 11/26/2024. Summary Judgment and Daubert Briefs are due 12/20/2024. Reply Summary Judgment and Daubert Briefs are due 1/17/2024. Ordered by Judge Kent A. Jordan on 8/15/2024. (mpb) (Entered: 08/16/2024)
2024-08-15
1
SO ORDERED AND ~Util - Terminate Motions
2024-08-16
1
No Actions
Pro Hac Vice Attorney Anna Martinez for Dexcom, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws)
2024-08-16
1
No Actions
1 - Terminate Scheduling Order Deadlines AND SO ORDERED AND Scheduling Order - General AND ~Util - Terminate Motions
2024-08-16
1
No Actions
Add Attorneys - PHV only
2024-08-16
1
No Actions
NOTICE OF SERVICE of 1. Plaintiff Dexcom, Inc.'s Second Supplemental Objections and Responses to Abbott's Fifth Set of Interrogatories (No. 40) 2. Plaintiff Dexcom, Inc.'s Second Supplemental Objections and Responses to Abbott's Sixth Set of Interrogatories (Nos. 41 - 46) 3. Plaintiff Dexcom, Inc.'s Supplemental Objections and Responses to Abbott's Fourth Set of Interrogatories (No. 39) 4. Dexcom, Inc.'s Seventh Supplemental Objections and Responses to Abbotts Elected Interrogatories (Nos. 1, 7, 8, 11, 12, 13, 15) filed by Dexcom, Inc..(Gellar, Lindsey) (Entered: 08/21/2024)
2024-08-21
1
NOTICE OF SERVICE of (1) Abbotts Fourth Supplemental Objections and Responses to DexComs Fifth Set of Interrogatories (Nos. 2028); (2) Abbotts Third Supplemental Responses to DexComs Sixth Set of Interrogatories (Nos. 29-30); (3) Abbotts Fourth Supplemental Responses to DexComs Elected Interrogatories (Nos. 1, 5); (4) Abbotts First Supplemental Responses to DexComs Eighth Set of Interrogatories (Nos. 39-42); and (5) Abbotts Third Supplemental Responses to DexComs Seventh Set of Interrogatories (Nos. 31-38) - filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 08/21/2024)
2024-08-21
1
Case Assigned/Reassigned
2024-08-21
1
No Actions
Case Reassigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:22-cv-00605-GBW, 1:21-cv-01699-GBW, 1:23-cv-00239-GBW (rjb)
2024-08-21
1
No Actions
NOTICE OF SERVICE of 1) Opening Expert Report of Bruce Gale, Ph.D. 2) Opening Expert Report of Ken Gall, Ph.D. 3) Opening Expert Report of Barry Keenan, Ph.D. 4) Expert Report of Patrick F. Kennedy, Ph.D. 5) Opening Expert Report of Lori Laffel, MD, MPH 6) Declaration of Seth James Nielson, Ph.D. 7) Expert Report of Jeffrey T. Prince, Ph.D. 8) Expert Report of Bryce M. Whited, Ph.D. filed by Dexcom, Inc..(DiBenedetto, Emily) (Entered: 09/17/2024)
2024-09-17
1
NOTICE OF SERVICE of (1) Opening Expert Report of Paul Braun, Ph.D.; (2) Expert Report of Raeann Gifford, Ph.D.; (3) Expert Report of Professor David Hricik; (4) Expert Report of Bobak Mortazavi; (5) Opening Expert Report of Kevin W. Plaxco, Ph.D. Regarding Invalidity of U.S. Patent Nos. 11,000,213, 10,993,642, and 10,980,452; (6) Expert Report of Majid Sarrafzadeh, Ph.D. Regarding Invalidity of U.S. Patent No. 10,702,215; and (7) Expert Report of Matthew Schurman, Ph.D. Regarding Invalidity of U.S. Patent No. 10,980,452 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 09/17/2024)
2024-09-17
1
Letter to The Honorable Gregory B. Williams from Rodger D. Smith II regarding request for the scheduling of a discovery teleconference. (Smith, Rodger) (Entered: 09/24/2024)
2024-09-24
1
ORAL ORDER: The Court HEREBY ORDERS an in-person discovery dispute hearing and scheduling conference in Civil Action Nos. 22-605, 21-1699, 21-977, and 23-239 on Friday, October 4, 2024, at 10:00 am, in Courtroom 6B. The agenda for the hearing will be as follows:Civil Action Nos. 22-605/21-1699 (1) Discovery Hearing to resolve the discovery dispute identified in D.I. 812 filed in Civil Action No. 22-605 (relating to Abbott's request for an extension of the rebuttal expert report deadline which is currently October 9, 2024). With respect to this discovery dispute, Abbott shall file its opening letter brief, which shall be three (3) pages or less, by no later than 5:00 pm ET on September 26, 2024. DexCom shall file its answering letter brief, which shall be three pages or less, by no later than 5:00 pm ET on September 30, 2024. The parties shall deliver to Chambers two (2) courtesy copies of their respective letter briefs with hard tabs inserted before exhibits.(2) Discovery Hearing to hear and resolve any other currently pending discovery dispute that the parties have already met and conferred about and previously requested a discovery teleconference, prior to September 24, 2024, that remains unheard. With respect to any such disputes, any party seeking relief shall file its opening letter brief, which shall be three (3) pages or less, identifying the dispute, setting forth its position on the dispute and the supporting authority for its position, by no later than 5:00 pm ET on September 26, 2024. The party opposing the relief sought shall file its answering letter brief, which shall be three pages or less, setting forth its position on the dispute and the supporting authority for its position, by no later than 5:00 pm ET on September 30, 2024. The parties shall deliver to Chambers two (2) courtesy copies of their respective letter briefs with hard tabs inserted before exhibits. (3) Scheduling Conference to discuss status of discovery, what discovery and other pretrial matters remain before trial, and the parties' joint proposed amended scheduling order. The parties shall meet and confer prior to the hearing and, on or before October 2, 2024, at 5:00 pm ET, submit for the Court's consideration a joint proposed amended scheduling order, consistent with the applicable scheduling order of Judge Gregory B. Williams which can be found on the Court's website, for the discovery and other pretrial matters remaining before trial.Civil Action No. 21-977 (1)Scheduling Conference to discuss status of action, what, if anything needs to happen before the retrial of damages, and the scheduling of the retrial on damages.Civil Action No. 23-239 (1)Scheduling Conference to discuss status of discovery, what discovery and other pretrial matters remain before trial, and the parties' joint proposed scheduling order. The parties shall meet and confer prior to the hearing and, on or before October 2, 2024, at 5:00 pm ET, submit for the Court's consideration a joint proposed scheduling order, consistent with the applicable scheduling order of Judge Gregory B. Williams which can be found on the Court's website. ORDERED by Judge Gregory B. Williams on 9/25/2024. Associated Cases: 1:22-cv-00605-GBW, 1:21-cv-00977-KAJ, 1:21-cv-01699-GBW, 1:23-cv-00239-GBW(lnb) (Entered: 09/25/2024)
2024-09-25
1
Set/Reset Hearings
2024-09-25
1
No Actions
Set Hearings: A Discovery Hearing and Scheduling Conference is set for 10/4/2024 at 10:00 AM in Courtroom 6B before Judge Gregory B. Williams. Associated Cases: 1:22-cv-00605-GBW, 1:21-cv-00977-KAJ, 1:21-cv-01699-GBW, 1:23-cv-00239-GBW(lnb)
2024-09-25
1
No Actions
Order
2024-09-25
1
No Actions
[SEALED] Letter to The Honorable Gregory B. Williams from Rodger D. Smith II regarding Scheduling Dispute - re 813 Order,,,,,,,,,,,,,. (Attachments: # 1 Appendix A, # 2 Exs. 1-10)(Smith, Rodger) (Entered: 09/26/2024)
2024-09-26
1
[SEALED] Letter to The Honorable Gregory B. Williams from John W. Shaw regarding Answering Letter Brief regarding Discovery Dispute - re 814 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Shaw, John) (Entered: 09/30/2024)
2024-09-30
1
PROPOSED ORDER - [Proposed] Scheduling Order re 813 Order,,,,,,,,,,,,, by Dexcom, Inc.. (Attachments: # 1 Cover Letter)(Hoeschen, Nathan) (Entered: 10/02/2024)
2024-10-02
1
Scheduling Conference
2024-10-04
1
No Actions
Minute Entry for proceedings held before Judge Gregory B. Williams - Scheduling Conference held on 10/4/2024. (Court Reporter B. Archer) Associated Cases: 1:22-cv-00605-GBW, 1:21-cv-01699-GBW, 1:23-cv-00239-GBW(lnb)
2024-10-04
1
No Actions
REDACTED VERSION of 815 Letter, to The Honorable Gregory B. Williams from John W. Shaw regarding Answering Letter Brief regarding Discovery Dispute by Dexcom, Inc.. (Shaw, John) (Entered: 10/07/2024)
2024-10-07
1
ORAL ORDER: Consolidated Case No. 21-1699 and Case No. 22-605 having recently been transferred to the undersigned Judge, IT IS HEREBY ORDERED that: (1) all dates and deadlines for these case in their current operative scheduling order(s) are VACATED; (2) the parties shall meet and confer and, on or before October 18, 2024, at 5:00 pm ET, submit for the Court's consideration a joint proposed amended scheduling order, consistent with the applicable scheduling order of Judge Gregory B. Williams which can be found on the Court's website, for the discovery and other pretrial matters remaining before trial. As stated during the October 4, 2024 hearing: (1) a Markman Hearing is scheduled for 9/18/2025 at 01:00 PM ET in Courtroom 6B before Judge Gregory B. Williams; (2) a Final Pretrial Conference is scheduled for 1/5/2027 at 03:00 PM ET in Courtroom 6B before Judge Gregory B. Williams; and (3) a 5-day Jury Trial is scheduled for 1/11/2027 at 09:30 AM ET in Courtroom 6B before Judge Gregory B. Williams. ORDERED by Judge Gregory B. Williams on 10/7/2024. Associated Cases: 1:21-cv-01699-GBW, 1:22-cv-00605-GBW(lnb) (Entered: 10/07/2024)
2024-10-07
1
Order
2024-10-07
1
No Actions
REDACTED VERSION of 814 Letter by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1-10)(Raucci, Anthony) (Entered: 10/08/2024)
2024-10-08
1
STIPULATION TO EXTEND TIME to submit a joint proposed amended scheduling order pursuant to the Courts Oral Order of October 7, 2024 (C.A. No. 22-605, D.I. 818; C.A. No. 23-239, D.I. 221) to November 1, 2024 - filed by Dexcom, Inc.. (DiBenedetto, Emily) (Entered: 10/18/2024)
2024-10-18
1
SO ORDERED
2024-10-21
1
No Actions
Proposed Order
2024-11-01
1
Scheduling Order - Patent
2024-11-20
1
Order
2024-11-20
1
No Actions
- CORRECTING ENTRY
2024-11-21
1
No Actions
Order AND ~Util - Case Referred to Mediation
2024-12-03
1
No Actions
- CORRECTING ENTRY
2024-12-04
1
No Actions
Notice of Change of Address
2024-12-16
1
Stipulation of Dismissal
2024-12-23
1
SO ORDERED AND ~Util - Terminate Civil Case
2024-12-30
1
No Actions
Letter
2026-04-17
1
Letter
2026-04-29
1
Acknowledgment of Receipt
2026-05-04
1